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Abstract 
The low-affinity leukaemia inhibitory factor receptor (LIF-R) is 
believed to be required for the biological activities of a family of 
cytokines including LIF, ciliary neurotrophic factor (CNTF), oncostatin 
(OSM) and cardiotrophin-1 (CT-1). These are pleiotropic cytokines 
which have effects on a variety of cell types. One important property is 
their ability to maintain embryonic stem (ES) cells in vitro. To evaluate 
a requirement for LIF-R in mouse development in vivo, mice deficient 
for LIF-R have been generated via homologous recombination in ES 
cells. 
The functions of LIF family of cytokines are dependent on the 
heterodimerization between LIF-R and gp130 following ligand 
binding. To ensure a null mutation, 20 kb segment of the lzf-r gene 
encoding the presumed ligand binding domain has been deleted and 
replaced by a promoterless Internal Ribosome Entry Site-LacZ-neo-
polyA (IRESgeopA) cassette. Following homologous recombination, 
the expression of Pgeo will be under the control of LIF-R promoter. 
Therefore Pgeo serves as a selectable marker as well as a LIF-R 
expression reporter in ES cells and during mouse development. 
Homologous recombination in ES cells was achieved at high frequency 
(11/58). Germline transmission has been obtained from two 
independent clones. 
Expression of the lacZ reporter gene integrated into the targeted 
locus has been visualized by histological staining for -galactosidase. 
In vitro in ES cells, -galactosidase activity is predominantly confined 
to morphologically undifferentiated ES cells, although particular sub-
populations of differentiated cells also stain. In vivo, staining is seen in 
specific regions of the developing nervous system, heart, gut, cartilage 
and muscles. 
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Mice heterozygous for the mutated allele showed no overt 
phenotype. Homozygous newborns, however, were runted, lacked 
vigor and died within the first postnatal day. Detailed examination of 
the nervous system of lif-r mutant mice showed specific - 
galactosidase staining in motor neurons of the facial nucleus and 
spinal cord as well as neurons of the nucleus ambiguus. Neuronal 
counting of neonatal lf-r -I- mice revealed a severe loss of neurons in 
these structures, which probably accounts for the observed lethality. 
ES cells lacking a functional lf-r gene have been generated by a 
second round of gene targeting with a construct bearing a hygromycin 
resistance gene. LIF-R-deficient cells can be propagated in culture in 
the presence of IL-6 and soluble IL-6 receptor. However, these cells 
have lost responsiveness to LIF, CNTF, OSM and CT-1. When injected 
into blastocysts, LIF-R-deficient ES cells could contribute to a variety of 
cell types and tissues in the resulting chimeras, including motor 
neurons in the facial nucleus and spinal cord. These results establish 
that the maintenance of pluripotent stem cells can be achieved in the 
absence of LIEF-R. 
lf-r -I-  motor neurons could be detected in chimeras at 
postnatal day 13, when the period of programmed cell death is over. 
This result indicates that a subpopulation of motor neurons is not 
dependent on LIF-R during early postnatal life. 
Finally, to establish definitively whether the gp130/LIF-R 
signalling pathway is required for early embryogenesis, mice carrying 
compound mutations at Ii  and gp130 gene were generated. 
Genotyping analysis demonstrated that embryos homozygous 
deficient for both lif-r and gp130 are able to progress through 
gastrulation and organogenesis. This result indicates the existence of 
an alternative signal transduction pathway for stem cells maintenance 




1.1 Embryonic Stem Cells 
Blastocyst stage mouse pre-implantation embryos are composed of 
two distinct cell types: the outer layer trophectoderm and an internal 
group of cells attached to the polar region of tropectoderm called the 
inner cell mass (1CM). The trophectoderm cells colonize the trophoblast 
and form the embryonic component of placenta; cells of the 1CM are 
pluripotent, giving rise to the fetus proper as well as most of the extra-
embryonic membranes (Gardner, 1983). Cells, derived from the 1CM can 
be cultured permanently in vitro as embryonic stem (ES) cell (Evans and 
Kaufman, 1981; Martin, 1981). ES cells retain their pluripotency even after 
prolonged periods in culture. This can be demonstrated by their 
differentiation into a wide variety of cell types during embryoid body 
formation in vitro (Doetschman et al., 1985) and in vivo following 
transplantation to ectopic sites in adult mice (Evans and Kaufman, 1981). 
When transferred to the blastocoelic cavity of a normal blastocyst, ES 
cells incorporate into the 1CM and generate mice that are chimeric both in 
somatic and germ tissues. The ES genotype can thus be transmitted to 
normal offspring (Bradley et al., 1984). The integration of ES cells into 
normal embryonic development demonstrates their capacity to respond 
to a repertoire of developmental regulatory signals. ES cells may 
therefore provided an invaluable in vitro system for the experimental 
identification and characterisation of factors that control early embryonic 
growth and differentiation (Smith, 1992; Smith and Rathjen, 1991). 
In the past decade, it has become possible to manipulate the 
genome of ES cells by homologous recombination. The planned alteration 
of a gene is first generated in genome of ES cell in tissue culture by 
homologous recombination between the genomic locus of interest and 
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DNA introduced into the ES cells (Smithies et al., 1985; Thomas et al., 
1986; Thomas and Capecchi, 1987). Genetically modified ES cells can then 
be injected into recipient blastocysts, where they contribute differentiated 
progeny to their host, resulting in the birth of genetically chimeric pups. 
Depending upon the degree of colonisation of the germ cell lineage by 
the ES cells, a proportion of the chimeras transmit the ES cell genome to 
their offspring, and thereby mice that carry a defined mutation of a gene 
are generated. The study of such mouse lines has so far provided 
considerable information about the biological function of many 
mammalian genes in vivo. 
ES cells were initially isolated and maintained by co-culture on 
feeder layers of mitotically inactivated mouse embryo fibroblasts (Evans 
and Kaufman, 1981; Martin, 1981). When plated in the absence of feeders, 
these cells lose their pluripotency and undergo extensive and irreversive 
differentiation, implying that the propagation of the stem cell phenotype 
is dependent on the active suppression of differentiation. The specific 
stem cell regulator present in the co-cultures was identified and termed 
differentiation inhibiting activity (DIA, Smith et al., 1988; Smith and 
Hooper, 1987). It is now known that DIA is equivalent to the cytokine 
leukaemia inhibitory factory (LIF, Gearing et al., 1987; Tomida et al., 
1984). LIF is able to completely replace feeder layers, not only in the 
maintenance of previously established ES cell lines, but also in the de novo 
establishment of karyotypically normal and germline competent ES cell 
lines [Nichols, et al., 1990; Pease et al., 1990; Nichols and Smith, 
unpublished]. This property has enabled the culture of homogeneous 
populations of pluripotentia! ES cells in the absence of contaminating 
fibroblasts. 
1.2 LIF and Related Cytokines 
LIF is a member of pleiotropic cytokines that regulates the 
proliferation and differentiation of a variety of cell types. Other members 
of this group are ciliary neurotrophic factor (CNTF), oncostatin M (OSM), 
cardiotrophin-1 (CT-1), interleukin-6 (IL-6 ) and interleukin-11 (IL-11). 
These cytokines show significant similarities in predicted secondary 
structure (Bazan, 1991; Rose and Bruce, 1991). The analysis of the genes 
encoding these proteins reveals a shared exon organisation, suggesting 
that they have evolved from a common ancestor. Cytokines of this family 
al 
share a number of in vitro biological activities, which could be explained, 
at least in part, by the shared utilisation of common receptor subunits. 
1.2.1 leukaemia inhibitory factory (LIE) 
LIE is a glycoprotein with a molecular weight of 40-50 kDa, which 
was first purified on the basis of its ability to induce the differentiation 
and suppress the clonogenicity of the murine monocytic leukemia cell 
line, Ml (Hilton et al., 1988a; Hilton et al., 1988b; Tomida et al., 1984a; 
Tomida et al., 1984b). LIE is also able to induce the differentiation of other 
hemopoietic cell lines such as HL-60 and U937 (Metcalf, 1989). In contrast 
to these differentiation effects, LIE stimulates the proliferation of some 
hemopoietic cell lines at a similar concentration (Metcalf, 1989). LIE 
appears not not have mitogenic effect on normal hemopoietic cells on its 
own. However, it can enhance the mitogenic effect of interleukin 3 (IL-3) 
on megakaryocyte precursors in vitro and stimulates a rise in 
megakaryocyte numbers and platelet levels when injected in vivo (for 
review see Metcalf, 1992). These effects of LIF on hemopoietic cells are 
shared by IL-6. 
A polypetide termed cholinergic differentiation factor (CDF) was 
purified from heart conditioned medium based on its capacity to alter the 
neurotransmitter phenotype of sympathetic neurons (Yamamori et al., 
1989). It is now clear that CDF is identical to LIF. Culture of 
noradrenergic sympathetic neurons in the presence of LIF causes these 
neurons to express cholinergic properties, which are characterised by an 
increase in choline acetyltransferase (ChAT) and vasoactive intestinal 
peptide (VIP) levels and a reduction in tyrosine hydroxylase (TH). It was 
subsequently discovered that LIE also functions as a neurotrophic factor. 
It supports the survival of fetal sensory neurons (Hendry et al., 1992; 
Murphy et al., 1991; Thaler et al., 1994), fetal and neonatal motor neurons 
(Cheema et al, 1994; Oppenheim et al., 1992; Martinou et al., 1992), as well 
as postnatal sympathetic neurons (Kotzbauer et al., 1994). These effects of 
LIF parallel strikingly those of CNTF. Moreover, LIF promotes the 
differentiation of neurofilament negative (NF) precursors to NF+ 
immature neurons in culture, suggesting that LIE may be involved in the 
proliferation and differentiation of neural cells in vivo (Murphy et al., 
1991, Murphy et al, 1993). 
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In addition to functions in hemopoietic and nervous system, LIF 
also acts on other tissues and cell types. The role of LIF in the 
maintenance of ES cell pluripotentiality has been discussed early in this 
chapter. Moreover, LW has been found to be able to support the survival 
and proliferation of primordial germ cells (De Felici and Dolci, 1991; 
Matsui et al., 1991; Resnick et al., 1992; Cheng et al., 1994). Other activities 
of LW include the regulation of bone resorption (Abe et al., 1986; Lorenzo 
et al., 1990), induction of the acute phase response of hepatocytes 
(Baumann and Wong, 1989), inhibition of lipoprotein lipase production 
(Mori et al., 1989), and inhibition the growth of endothelial cells (Ferrara 
et al., 1992). 
1.2.2 ciliary neurotrophic factor (CM) 
CNTF is a monomeric protein with molecular weight of - 20 KDa. 
In contrast to the broad activities of LIF and IL-6, the functions of CNTF 
are restricted to the nervous system and skeletal muscles. CNTF was 
originally identified as a trophic molecule that supports the survival of 
parasympathetic chick ciliary neurons in culture (Adler, 1979; Lin et al., 
1989; Stockli et al., 1989). It soon became apparent that the spectrum of 
biological activity of CNTF is much broader than this, as it also displays 
neurotrophic effects on cultured embryonic motor (Arakawa et al., 1990), 
sensory (Barbin et al., 1984) and hippocampal neurons (Ip et al., 1991). 
CNTF was shown to block the division of chick sympathetic precursor 
cells (Ernsberger et al., 1989), reduce TH activity in culture of newborn 
rat sympathetic neurons, and reciprocally, increase ChAT activity (Saadat 
et al., 1989), similar to the actions of LW. Moreover, CNTF also promotes 
the survival of oligodendrocytes (Louise, 1993) and plays an essential role 
in the differentiation of 0-2A glial precursor cells into type-2 astrocytes in 
vitro (Lillien, 1990). In vivo, CNTF can protect embryonic spinal motor 
neurons from naturally occurring cell death (Oppenheim et al., 1992), 
neonatal rat facial motor (Sendtner et al., 1990), adult rat anterior 
thalamic (Clatterbuck et al., 1993); medial septal (Hagg et al., 1992), and 
substantia nigra (Hagg and Varon, 1993) neurons from postaxotomy 
degeneration. 
Outside of the nervous system, CNTF has been shown to exerts 
myotrophic effects by attenuating the morphological and functional 
changes associated with denervation of rat skeletal muscle (Helgren, 
1994). Recently, it has been demonstrated that CNTF can maintain the 
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pluripotentiality of embryonic stem cells, an activity shared with LW, 
OSM, CT-1 and 1L6 (in the presence of sIL-6R) (Conover et al., 1993; 
Nichols et al., 1994; Pennica et al., 1995b; Rose et al., 1994; Yoshida et al., 
1994; Wolf et al, 1994). 
Despite its wide range of biological activities, CNTF lacks a 
secretary signal and therefore is localized in the cytosol. The mechanisms 
by which CNTF is released to the sites of its responsive cells in vivo 
remains a unresolved problem. 
1.2.3 Oncostatin M (OSM) 
OSM is a 28 kDa glycoprotein originally isolated from the 
conditioned medium of U937 human leukemia cells activated by phorbol 
myristate acetate (Zarling et al., 1986). The molecule was initially 
identified by its ability to inhibit the in vitro growth of human A375 
melanoma cells. Subsequently OSM was also shown to inhibit the 
proliferation of a number of other tumor cell lines derived from a wide 
variety of tissue types (Horn et al., 1990). In addition to its effects on 
tumour cell proliferation, OSM can also induce the differentiation of 
some cell types, including stimulation of IL-6, G-CSF and GM-CSF 
production by endothelial cells, and up-regulation of the low density 
lipoprotein receptor in liver cells. OSM shares functions with LIF to 
maintain ES cells in culture and functions in common with LIF and IL-6 
to inhibit the proliferation of murine Ml myeloid leukemic cells and 
stimulate acute phase protein synthesis in liver cells (Richards et al., 
1992). OSM was also found to be mitogenic for rabbit vascular smooth 
muscle cells (Grove et al., 1993). 
1.2.4 Cardiotrophin-1 (CT-1) 
CT-1 is a recently isolated cytokine that was identified based on its 
ability to induce cardiac myocyte hypertrophy (Pennica et al., 1995a). 
Like CNTF, CT-1 also lacks a secretory signal. In vitro biological assays 
have demonstrated some overlapping functions of this cytokine with 
those of LIF, CNTF and IL-6, including the inhibition of Mi cell 
proliferation, induction of neuronal transmitter switch and the 
maintenance of ES cell pluripotentiality (Pennica et al., 1995b). 
1.2.5 Interleukin-6 (JL-6) 
IL-6 was cloned or purified independently by a number of groups 
based on different properties of this cytokine (for review see van Snick, 
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1990). In the immune system, where it was originally termed B-cell 
stimulatory factor-2, IL-6 improves the growth of B-cell hybridomas and 
plasmacytomas and stimultates the differentiation of primary B cells to 
immunoglobulin (Ig) secreting plasmacytes (Hirano et al., 1985; Hirano et 
al., 1984). IL-6 is also involved in T cell activation. It stimulates the 
proliferation of thymocytes and peripheral T cells (Lotz et al., 1988) and 
interacts synergistically with IL-1 in induction of cytolytic-T-cell 
responses (Takai et al., 1988). As mentioned along with other cytokines, 
IL-6 functions as an inducer of hepatic acute phase response (Gaukdie et 
al., 1987). In hematopoietic system, IL-6 supports the proliferation of 
granulocyte/macrophage progenitors (Wong et al., 1988), stimulates the 
maturation of megakaryocytes (Ishibashi et al., 1989). and, in synergizing 
with IL-3, reduces the Go-residence  time of the hematopoietic progenitor 
cells and triggers their entry into the cell cycle (Ikebuchi et al., 1987). In 
addition to its effects on the proliferation and differentiation of normal 
precursor cells, IL-6 exerts anti-proliferative effects on human and mouse 
myeloid leukaemia cell lines such as human histiocytic U937 cells and 
mouse myeloid Ml cells (Chiu et al., 1989; Miyaura et al., 1988). IL-6 is 
also active on cells of the nervous system. Like CNTF, IL-6 induce the 
differentiation of optic nerve 0-2A progenitor cells into type-2 astrocytes 
(Kahn and de Velis, 1995). In addition, IL-6 can promote neurite 
outgrowth of mouse embryonic sensory neurons (Hirota et al., submited). 
1.2.6 Interleukin-11 (IL-11) 
IL-11 activity was originally detected in the conditioned medium of 
a primate bone marrow stromal cell line (Neben and Tuner, 1993). The 
purified protein shows multifunctional activity, influencing 
lymphohematopoietic stem cell proliferation and differentiation, 
megakaryocyte progenitor cell proliferation and differentiation, erythroid 
progenitor cell proliferation and B lymphocyte maturation (Du and DA, 
1994). Like other cytokines in this family, IL-11 also acts on various 
cellular types outside the lymphohematopoietic system. It inhibits 
lipoprotein lipase activity in preadipocyte cells (Kawashima et al., 1991), 
stimulates acute-phase protein synthesis by hepatocytes (Baumann and 
Schendel 1992) and regulates neuronal differentiation (Mehier et al., 
1993). 
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1.3 Embryonic Development in Mice lacking LIF or CNTF 
As the first cytokine identified to be able to inhibit the 
differentiation of ES cells, LIF has been considered to be an important 
molecule in regulating embryonic development. The expression of LIF 
mRNA and LIF-R has been studied by in situ hybridization (Nichols et 
al., 1996). In normal and implantation delayed blastocyst, LIE mRNA was 
localised to the trophectoderm, whereas LIF-R was found to be 
reciprocally expressed in the 1CM. As described in section 1.1, 
trophectoderm cells surround the 1CM and blastocoele cavity and form 
the continuous wall of the blastocysts. The commitment to trophectoderm 
and 1CM lineages, which starts from 16 cell morula stage, represents the 
first differentiative event in mammalian development (Johnson and 
Ziomek, 1981). The reciprocal expression pattern of LIF and LIF-R 
suggested a paracrine interaction between differentiated trophectoderm 
cells and the totipotent 1CM cells in the blastocyst. 
The gene for LIE has been disrupted by targeted mutation [Stewart 
et a!, 1992; Escary et a!, 1993; Smith et al., unpublished]. Surprisingly, 
mice homozygous deficient for LIF are viable, indicating that the 
embryonic expression of LIP is not essential for the development of the 
early embryo. Irrespective of their genotype, blastocysts are unable to 
implant in lf -I- homozygous mothers but can develop in wild-type or 
heterozygous females. This result implies that maternal expression of LIF 
is essential in the implantation process (Stewart et al., 1992). Though near 
Mendelian ratio and normal development of LIE homozygous animals 
were reported (Escary et al., 1993; Stewart et al., 1992), recent studies 
show that the viability of homozygous mutants is dependent on genetic 
background (Smith, unpublished). 
The effects of CNTF on embryonic neurons (section 1.2.2), 
especially on motor neurons, indicated that this molecule was an 
important regulator for motor neuron survival in vivo. However, mice 
homozygous for a null mutation in the CNTF gene developed normally 
without any embryonic or early postnatal defect. These mice did show 
progressive atrophy of spinal motor neurons later in their adult life 
(Masu et al., 1993). CNTF mRNA was found to be most abundant in adult 
sciatic nerve (Stockli et al., 1991) but at very low level in the developing 
brain and spinal cord (Ip et al., 1993). The phenotype of CNTF deficient 
mice and its expression profile therefore establish that CNTF is not 
involved in neuronal development but rather acts as a maintenance factor 
in response to injury or other stresses during life. 
1.4 Receptor Complex for LIF/CNTF Family Cytokines 
The overlapping biological activities of LIF/CNTF family cytokines 
are now well explained by the multichain system of their receptors 
(Fourcin et al., 1994; Gearing et al., 1992; Stahl et al., 1993a; Taga et al., 
1989; for review see Kishsimoto et al., 1994). All of these cytokines share 
glycoprotein 130 (gp130) as a signal transducing receptor component, as 
illustrated in figure 1.1. For example, IL-6 binds to the IL-6 receptor (IL-
6R) and this complex then associates with gp130, causing it to 
homodimerize (Murakami et a!, 1993; Taga et al., 1989; see also 1.4.2). 
Another shared receptor component in this system is the low affinity LIF 
receptor (LIF-R), which forms a LIF-R/gp 130 heterodimer following 
binding of LIF (Gearing et al., 1992; Stahl et al., 1993a). The dimerization 
of LIF-R and gp130 is also triggered by OSM and CT-1 (Gearing et al., 
1992; Pennica et al., 1995a), and initiated by the interaction of CNTF with 
CNTF receptor a (CNTF-Roc; Stahl et al., 1993a) In addition to LIF -
R/gp130, OSM appears to have its specific receptor (Liu et al., 1994; 
Thoma et a!, 1994). 
IL-6,0 	 LIF CT-1 OSM 
sIL-6R 	 00 0 
V 4 1" TT 11 
gpi30/gpl3O 	LIF-R/gpi3O 	OMR/gp13O 
Figure 1.1. A schematic diagram illustrating the receptor complexes 
for LW, OSM, CT-1, CNTF, IL-6 and IL-11. 
IL-6, when bound to either a membrane-anchored or a soluble form of its 
receptor (IL-6R or sIL-6R), induces homodimerization of gp130. 
Heterodimerization of LIF-R and gp130 is induced by LIF, CT-1, OSM 
and the CNTF-CNTFR complex. OSM also induces another type of 
heterodimer composed of gp130 and OSM receptor. IL-11 binds to IL-11R 
and induces the homodimerization of gp130. 
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Structurally, all of the receptors components are members of the 
cytokine/hematopoietin receptor superfamily (Cosman et al., 1991). They 
share common extracellular features: a conserved pair of cysteine 
residues and a characteristic Trp-Ser-x-Trp-Ser (WS)(WS, in which X 
denotes any amino acid residue) motif. The region defined from the first 
conserved cysteine residue to the WS)(WS motif of the extracellular 
domain of a cytokine receptor is known as hematopoietin (or) cytokine 
receptor domain. This region contains amino acid residues essential for 
ligand binding, including the WS)(WS motif and the conserved cysteine 
residues (Miyazaki et al., 1991; Queue et al., 1992; Yawata et al., 1993), 
and therefore the cytokine receptor domain is the presumed ligand 
binding domain of cytokine receptors. 
Cytokine receptors do not prossess any intrinsic tyrosine kinase 
domain, although they do undergo tyrosine phosphorylation in response 
to ligand-stimulation. It is now becoming clear that signal transduction 
pathways initiated by cytokines binding to their receptor involve 
members of the Janus kinases (JAK) family of cytoplasmic tyrosine 
kinases (Davis et al., 1993b; Murakami 1993; Stahl et al., 1994a), which 
associate with the conserved box 1 region of cytokine receptors (Tanner et 
al., 1995). 
Signalling through cytokine receptor is dependent on the formation 
of either a gp130 homodimer (in the case of [L-6 and IL-11) (Murakami 
1993) or a heterodimer between LIF-R and gp130 (in the case of LIF, 
OSM, CT-1 and CNTF) (Davis et al., 1993b; Pennica et al., 1995a), in 
response to ligand binding. Receptor dimerization results in the JAK 
kinases phosphorylating each other, the receptor components (Davis et 
al., 1993b; Ip et al., 1992; Tàga et al., 1992), and members of the 
cytoplasmic transcriptional factors STATs (Signal Transducers and 
Activators of —Transcription, Lutticken et al., 1994; Stahl et al., 1994a; 
Walton et al., 1993; Wegenka et al., 1993). Tyrosine phosphorylated STAT 
proteins then translocate to the nucleus where they bind to specific 
sequences in the promoters of responsive gene, leading to the 
transcription of such genes. In addition to STAT pathways, the Ras-MAP 
kinase cascade is also be activated following receptor dimerization 
(Kishimoto, 1994; Schicmann et al, 1995). 
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1.4.1 LIF-R 
LIF-R was originally isolated from human placental and mouse 
liver cDNA libraries (Gearing et al., 1991). The predicted human LIF-R, as 
illustrates schematically in figure 1.2, is a transmembrane molecule which 
comprises of 1097 amino acid residues. In the extracellular domain there 
are two conserved hematopoietin receptor domains and three repeats of a 
fibronectin type III-like (FN ifi) module. Murine LIF-R cDNAs initially 
cloned from adult liver have a stop codon before the third FN ifi repeat 
and therefore encode a soluble form of LIF-R. Transmembrane form of 
murine LIF-R has later been isolated from ES cells (Chapter 3). 
Figure 1.2. Structure of transmembrane form and soluble form of LIF-R 
are illustrated. In the extracellular domains, the positions of conserved 
cysteine residues are indicated by fine vertical lines. Thick vertical lines 
indicate the positions of conserved WSXWS motifs. Fibronectin ifi repeats 
are indicated by ellipses. Transmembrane domain is indicated by a filled 
vertical box. In the intracellular region, box 1 and box 2 regions are 
indicated by thick vertical lines. 
It has been demonstrated that the membrane-proximal region of the 
cytokine receptors (which often referred to as boxi and box2 
motifs/region) are essential for signalling (Baumann et al., 1994a; 
Murakami et al., 1991). The box 1 region of LIF-R show close similarity to 
gp130, and to a lesser extent, to the granulocyte colony-stimulating factor 
receptor (G-CSFR) (Gearing et al., 1991). It is believed that G-CSFR forms 
homodimer in response to G-CSF (Fukunaga et al., 1991). The similarity 
between LIF-R, gp130 and G-CSFR suggests that the cytoplasmic domain 
of LIF-R might participate in the signal transduction process. In fact, 
transfection of a chimeric receptor composed of the extracellular domain 
of G-CSFR and the transmembrane and cytoplasmic domain of LIF-R into 
hepatic cells lead to the formation of homodimers of LIF-R in response to 
G-CSF (Baumann et al., 1994b). Furthermore, an EGF-R/LIF-R chimera 
expressed in COS cells has been shown to undergo EGF-induced tyrosine 
phosphorylation (Stahl et al., 1995). These data suggest that a homodimer 
of LIF-R is potentially capable of transducing signals. But whether such 
homodimers form in vivo is not clear. 
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1.4.2 gp130 
gp130 was originally identified from human myeloma cell line, 
U266, based on its association with IL-6 receptor (IL-6R) in the presence 
of IL-6 (Taga et al., 1989). The cDNA was subsequently cloned from the 
same cells following production of anti gp130 monoclonal antibodies 
(Hibi et al., 1990). gp130 does not bind IL-6 directly. However, in cells 
that express IL-6R, transfection of gp130 cDNA leads to an increase in 
high affinity binding sites for IL-6. Moreover, in the presence of IL-6, 
gp130 associates with IL-6R and transduces proliferation signal in 
responsive cells. This association does not require the intracellular 
domain of IL-6R as it can be replaced by soluble form of IL-6 receptor 
(sIL-6R). These results demonstrate that gp130 functions as a signal 
transducer for IL-6 (Masahiko et al., 1990). 
Subsequently, gp130 was demonstrated to convert the interaction of 
LIF with cells expressing LIF-R from low affinity (Kd-nM) to high 
affinity (Kd-lOpM) (Gearing et al., 1992). Furthermore, the combination 
of IL-6 plus sIL-6R was demonstrated to maintain the undifferentiated 
state of ES cells cultured in vitro in the absence of LIF (Yoshida et al., 
1994; Nichols et al., 1994). These results suggest that gp130 is also a signal 
transducer for LW. It is now known that gp130 is utilised in common by 
all members of LW family of cytokines (Fourcin et al., 1994; Gearing et al., 
1992; Pennica et al., 1995a; Stahl et al., 1993a). 
1.4.3 CNTFRa and receptors complex for CNTF 
CNTFRX is a specific binding protein for CNTF. Unlike other 
cytokine receptors, CNTFRX lacks a conventional transmembrane 
domain, and instead is anchored to the cell membrane through a 
glycosyl-phosphatidylinositol linkage (Davis et al., 1993a). An apparently 
unique feature for the CNTF high affinity receptor is that it is a complex 
of three components which involves the CNTFRa, gp130 and LIF-R (Stahl 
et al., 1993a). In the presence of CNTF, CNTFRo induces the formation of 
a gp130/LIF-R heterodimer (Stahl et al., 1994a; Stahl et al., 1995). Unlike 
the relatively broad expression of LIF-R, the distribution of CNTFRx is 
limited to the nervous system and skeletal muscles which could explain 




1.5 Neurotrophic Factors and Regulation of Neuronal Differentiation 
and Survival 
Neurons of the central nervous system (CNS) and peripheral 
nervous system (PNS) are derived from neuroepithelial cells of the neural 
tube and its derivative, neural crest, respectively. These neural 
progenitors proliferate, progressively lose their multipotentiality during 
development and finally differentiate into various type of post mitotic 
neurons and glial cells (Anderson, 1993; McKay, 1989). During these 
developmental processes, cells are influenced by their environment 
through the synthesis and release of endogenous, secretory (or cytosolic 
in some cases) neurotrophic factors, including neurotrophins, cytokines 
and multifunctional growth factors. The survival, proliferation, 
migration, and differentiation of cells in vitro and in vivo are regulated, at 
least in part, by the presence of these neurotrophic factors in the 
environment. 
In general, factors that control the proliferation and differentiation 
of neural precursor cells are still mostly unknown. Present understanding 
about these regulations are mainly derived from in vitro culture system. 
bFGF has been shown to stimulate the proliferation of cells from 
embryonic telencephalon, cortex, hippocampus, and subventricular zone 
(Gensburger et al., 1987; Kilpatrick and Bartlett, 1995a; Kilpatrick et al., 
1995b; Vicario-Abejon et al., 1995). Cells stimulated by bFGF are 
multipotential and can generate neurons, astrocytes, and 
oligodendrocytes. In addition to its involvement in neural precursor 
proliferation, bFGF has also been implicated in neuronal differentiation 
[for review see Baird, 1994; Vicario-Abejon et a!, 1995]. Neurotrophins are 
well established as survival factors in the PNS, as well as in the CNS (see 
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the following sections). There is evidence that these molecules may also 
play a role in the regulation of neural progenitor cells. Neurotrophin-3 
(NT-3) has been shown to stimulate the differentiation of calbindin-
positive neurons in the embryonic hippocampus in vitro (Collazo et al., 
1992). Moreover, brain-derived neurotrophic factor (BDNF), NT-3 and 
CNTF are able to induce neuronal differentiation from bFGF expanded 
stem cells into post-mitotic neurons in vitro (Ghosh and Greenberg, 1995; 
Vicario-Abejon et al., 1995). The actions of LIF and CNTF on sensory 
neuronal precursors and sympathetic neuroblast have been mentioned 
earlier in this Chapter (section 1.2, LIE and related cytokines). 
An important phenomenon in the development of the mature 
vertebrate nervous system is neuronal cell death ( or naturally occu ring cell 
death ). Neurons are initially produced at about twice the number in a 
given structure as survive in the adult organism. The excess number of 
neurons is eliminated within a narrow time span that differs among 
structures in both the PNS and CNS. The process of this naturally 
occurring cell death is thought to be regulated largely by neurotrophic 
factors derived from the neuron targets. The evidence for this theory has 
originally come from experiments on developing NGF-dependent 
sympathetic and sensory neurons. If perinatal animals are administrated 
with exogenous NGF, the death of about half of these neurons which 
normally occurs during development is largely prevented (Hamburger et 
al., 1981; Levi-Montalcini and Booker, 1960a). If, on the other hand, the 
animals are treated with neutralising antibodies to NGF, almost all of 
these neurons die (Klingman and Klingman, 1966; Levi-Montalcini and 
Booker, 1960b). A similar phenomenon is displayed by many other types 
of vertebrate neurons (Oppenheim, 1991). In addition to NGF, other 
members of neurotrophins: BDNF, NT-3, NT-4/5, as well as non-
neurotrophin neurotrophic factors (growth factors and cytokines) have 
also been shown to promote the survival of specific developing neurons 
in vitro and in vivo (Barde et al., 1982; Silos-Santiago et al., 1995; Thoenen, 
1991). The importance of neurotrophins in mediating neuronal survival 
during development has been confirmed by gene targeting (Conover et 
al., 1995; Crowley et al., 1994; Jones et al., 1994; Liu et al., 1995, Ernfors et 
al., 1994; Ernfors et al., 1995; Smeyne et al., 1994, Klein et al., 1993). Mice 
deficient in neurotrophins and their receptors showed dramatic loss of 
various classes of neurons both in PNS and CNS. Noticeably, however, 
motor neurons in these mutants are not significantly affected. 
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Cells that undergo programmed cell death during embryonic 
development or tissue turnover share common morphological features 
which comprise a progressive contraction of cell volume, widespread 
chromatin condensation and nucleus segmentation but with the initial 
preservation of the integrity of cytoplasmic organelles. This form of cell 
death has been termed apoptosis (Wyllie, 1980; Duvall and Wyllie, 1986) 
to distinguish it from necrosis caused by compromise of cellular ionic 
homeostasis, which leads to cell swelling and lysis. Neuronal death 
during the period of naturally occurring cell death (Chu-Wang and 
Oppenheim, 1978; Clark, 1980; Pilar and Landmesser, 1976) and induced 
by NGF-deprovation has much in common with apoptosis (Raff ,1992). 
Analysis in C. elegans suggest that naturally occurring cell death is 
a highly regulated genetic program which is therefore also referred to as 
programmed cell death (PCD). In C. elegans, this process involves the 
function of three genes; ced-3, ced-4 and ced-9 (Ellis et al., 1991). Ced-9 is 
structurally and functionally homologous to the mammalian proto-
oncogene bc1-2 (Hengartner and Hoivitz, 1994), a gene which has been 
shown to prevent apoptosis in hemopoietic lineages (Nakayama et al., 
1993; Veis et al., 1993). The importance of bc1-2 to neuronal survival has 
recently been demonstrated both in vitro and in vivo. In vitro, 
overexpression of bc1-2 can protect sympathetic neurons from 
programmed cell death induced by NGF withdrawal (Carcia et al., 1992). 
In vivo, motor neurons are rescued from naturally occurring cell death 
and axotomy-induced PCD in mice overexpressing bc1-2 in the CNS 
under control of the rat neuron-specific enolase promoter (Carcia et al., 
1992; Dubois-Dauphin et al., 1994; Martinou et al., 1994, Farlie et al, 1995). 
However, the nervous system of bcl-2-deficient mice seems to develop 
normally (Veis et al., 1993). This could be explained by the expression of 
other bcl-2 family members in the CNS and PNS (Gonzalez-Garcia et al, 
1994). Whether the expression of bc1-2 family members is regulated by 
neurotrophic factors or during naturally occurring cell death has not been 
addressed. The mechanisms through which the bcl-2 family function are 
also not yet elucidated. 
1.6 Mutagenesis via Homologous Recombination 
Over a decade ago, several groups observed that recombination 
between homologous portions of two exogenously introduced DNA 
molecules can take place in mammalian cells, suggesting that mammalian 
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cells possess the enzymatic machinery required to mediate homologous 
recombination (Bollag et al., 1989). Such observation led to the 
demonstration that mammalian cells could utilise this machinery to cause 
recombination between the exogenously introduced sequences with their 
cellular homologue within the genome (Smithies et al., 1985). Such event 
has been termed gene targeting. In combination with the isolation of 
embryonic stem cells gene targeting has now becoming a common 
technique to create defined mutations in mice. 
1.6.1 Two basic types of targeting vectors 
The general strategy applied to isolate homologous recombination 
events in ES cells requires the introduction of a selectable marker into a 
specific site within the target locus. The selectable marker is generally 
equipped with its own promoter and a transcription terminate signal. 
The most commonly used marker is the neo gene, which confers 
resistance to the neomycin analogue G418 (Thomas and Capecchi, 1987). 
Other markers used include the mouse Hprt (hypoxanthine 
phosphoribosyl transferase) gene and bacterial gene for hygromycin 
resistance (Reid et al., 1990; van Deursen et al., 1991). Targeted 
integration of the marker gene is achieved by homologous recombination 
between sequence in the targeting vector, which flank the selectable 
marker, and the homologous region of target gene. Two types of vectors, 
known as replacement vectors and insertion vectors, have been used for 
gene targeting in ES cells (Thomas and Capecchi, 1987). As illustrated in 
figure 1.3, sequence replacement vectors are designed such that upon 
linearization at one or both end of homologous arms, the homologous 
sequence in the vector remains co-linear with the endogenous sequences 
in the genome. Following homologous recombination, the vector 
homologous sequence, including the selectable marker would replace the 
endogenous sequences. Sequence insertion vectors were designed such 
that linearization would create a double strand break within the 
homology. The homologous recombination initiated at this double strand 
break results in the insertion of entire targeting vector. Most of the ES cell 
gene targeting experiments described in the literature use replacement 
vectors. The main reason for this bias is probably due to the lack of gene 
duplication and a more predictable mutational consequence on the target 
gene. 
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1.6.2 Strategies for enrichment 
To enrich for cells that have undergone homologous recombination 
from the excess of cells that carry the targeting vector integrated at 
random sites in their genome, Capecchi and co-workers developed the 
double selection or positive-negative selection strategy (Mansour et al., 
1988). In the procedure, a positive selection marker, such as neo, is used 
in a replacement type targeting construct to select for cells that have 
incorporated the targeting vector anywhere in the ES cell genome. The 
homologous region in the targeting vector is flanked by a negative 
selection marker, the thymidine kinase gene from herpes simplex virus 
(HSV-tk). The tk gene will be lost on homologous recombination but 
generally not on random integration. Therefore, application of 
gancyclovir (GANC) or 1 -(2-deoxy-2-fluoro--D-arabinofuranosyl)-5-
iodouracil (FIAU), which are substrates for the HSV-tk gene, but not 
cellular thymidine kinases, will select against cells that contain a 
functional HSV-tk gene and enrich the homologous recombination events 
(Figure 1.4). 
Another strategy to enhance the targeting frequency is to use 
vectors in which the selection marker gene lacks a promoter (promoter 
trap) (Charron et al., 1990; Jasin and Berg, 1988; Schwartzberg et al., 1990) 
or polyadenylation signals (polyA trap) (Joyner et al., 1989; Thomas and 
Capecchi, 1987; Zijlstra et al., 1989), if the gene to be targeted is 
transcribed in ES cells. The rationale behind this is that the homologous 
recombination between the targeting vector and the target gene will 
restore the 5' and 3' sequences necessary for expression of the marker 
gene, random non-homologous integration however, is less likely to do 
so. Thus using this approach there will be preferential selection for the 
targeted clones. Recent development in promoter trap gene targeting will 
be discussed in chapter 3. 
1.6.3 Parameters governing targeting frequency 
The length of sequence homology between the targeting construct 
and the chromosomal locus had been demonstrated to influence the 
frequency of homologous recombination (Hasty et al., 1991b; Thomas and 
Capecchi 1987). In general, there is a positive correlation between the 
total length of endogenous gene sequence present in a vector and the 
frequency of gene targeting. This is true regardless of whether they are 
sequence replacement or sequence insertion vectors, or whether they are 
Figure 1.3. Gene targeting by sequence replacement and sequence 
insertion vectors. 
The two basic forms of gene targeting vectors used in homologous 
recombination are illustrated. A. Sequence replacement type vectors are 
linearized at one or both ends of homologous arms such that these 
homologous sequences are collinear  with the equivalent endogenous 
gene sequences. Recombination between the homologous regions results 
in the replacement of the endogenous gene sequences with the targeting 
vector including the selectable marker gene. B. Sequence insertion type 
vectors are designed to be linearized within the target gene homology. 
Homologous recombination between the endogenous gene and the 
targeting vector results in the insertion of the vector sequences into the 
target locus. Note the presence of duplication of a portion of the target 
gene. Both vectors are designed to insert the target gene at exon 3. Black 
boxs represent exons, open boxes indicate introns. The shaded box 
represents the neo gene, which is equipped with its own promoter and 
polyadenylation signal. Modified from Thomas and Capecchi, 1987. 
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Figure 1.4. Enrichment for homologous recombination events via 
positive-negative selection. 
A. Incorporation of a sequence replacement vector via homologous 
recombination with endogenous gene sequences results in insertion of 
neo selectable marker into the target gene and loss of the HSV-tk gene. 
Such events produce cells which have lost target gene function and are 
resistant to both G418 and GANC. B. Integration of the targeting 
construct randomly into the genome allows the tk gene to remain linked 
to neo. Cells that have undergone such event should retain an intact 
target gene and contain both active neo and tk genes and therefore will 
be resistant to G418 but sensitive to GANC. Solid boxes represent exons, 
the shaded box represents the neo gene and the hatched box indicates the 
HSV-tk gene. From Mansour et al., 1988. 
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isogenic or nonisogenic DNA (see below) (Deng and Capecchi 1992;). For 
gene targeting with replacement vectors, the distribution of homology 
flanking the selection marker likely also influence the targeting efficiency. 
Independent studies of gene replacement events at the mouse hprt gene 
suggested that the shorter arm of homology must exceed a minimum 
length of between 472 bp and 1 kb for efficient high-fidelity sequence 
replacement to occur (Hasty et al., 1991b; Thomas et al., 1992). 
One of the most important findings for gene targeting technique is 
that the nature of homology has profound effect on targeting frequency. 
te Riele et al (1992) compared the frequency of targeting events at the 
retinoblastoma susceptibility (Rb) locus using two targeting constructs. 
The vectors were identical in structure and length of homology except 
that one contained 129 (isogenic) DNA and the other consisted of the 
same region derived from a BALB/c mouse, which show a number of 
base sequence divergence including basepair substitutions, small 
deletions /insertions and a polymorphic CA repeat. One in three G418 
resistant ES cell colonies were targeted following the transfection with 
isogenic construct, whereas with non-isogenic (BALB/c) vector this 
number was twenty-fold lower. This analysis demonstrated that 
polymorphisms can have a crucial effect on homologous recombination. 
Further evidence for this finding came from experiments carried out with 
the mismatch repair gene (MMR) deficient ES cells (de Wind et al., 1995). 
In such ES cells, targeting frequency at the Rb locus with the nonisogenic 
construct was as efficient as with the isogenic construct. The importance 
of isogenic DNA for efficient gene targeting was subsequently confirmed 
for other loci (Deng and Capecchi, 1992). 
1.7 Aim of the Project 
As described in this chapter, cytokines which utilise receptor 
components LIF-R and gp130 for signalling exhibit potent effects on a 
variety of cell activities in vitro, including survival, proliferation and 
differentiation. Therefore, these cytokines are considered as excellent 
candidates for signalling molecules with important developmental roles. 
However, targeted mutations in LIE or CNTF genes failed to reveal 
essential requirements of these cytokines during development. The lack 
of severe phenotypes in the ligand knock outs may result from the 
functional redundancy between members of this group of cytokines. The 
aim of this thesis was to determine whether LIF-R signalling is required 
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by developing embryos, and if so, what are the consequences of LIF-R 
deficiency? The strategy that was chosen to address this issue was to 
create LIF-R null mice via homologous recombination in ES cells. 
WE 
Chapter 2 
Materials and Methods 
2.1 Materials 
Unless otherwise stated, all chemicals were of analytical grade, 
and supplied by BDH laboratory Supplies or Sigma. Phenol saturated 
in Tris.Cl buffer was supplied by Fisons Bioscience. Synthetic 
oligonucleotides were supplied by Oswel, England. Ethanol was 
supplied by Hayman. Kodak XAR-5 X-ray film was supplied by H. A. 
West, Scotland. Radioisotopes were supplied by Amersham and New 
England Nuclear. 
2.1.1 Bacterial culture 
Media and additives 
All media were sterilized by autoclaving before use. Additives 
were either sterilized by autoclaving or by filtering through a 0.22 pm 
filter unit and stored in aliquots. 
L-broth, agar and top aga rose 
Per litre: 10 g tryptone (Difco), 5 g yeast extract (Difco), 10 g 
NaCl, 2.46 g MgSO4 pH 7.2. L agar contained, in addition, 15 g/litre 
agarose. 
SOC broth 
Per litre: 20 g tryptone, 5 g yeast extract, 0.59 g NaCl, 1.86 g 
KC1, 10 mM MgSO4, 20 mM glucose (from a filter sterilized stock). 
Media additives 
Antibiotics were added to media and agar when appropriate. 
Ampicillin was used at a final concentration of 50 pgIml. X-gal stock 
solution was 2% in dimethylformamide. IPTG was stored as a stock 
solution of 1 M 1 M MgSO4 was sterilized by autoclaving and used at a 
21 
final concentration of 10 mM for production of plating cells for ? 
phages. 
Bacteria were grown at 37 °C in L broth with shaking at 250-300 
rpm. Bacterial stocks were kept at -70 °C in L broth containing 20% 
glycerol. 
Bacterial strains used 
XL1-blue: rec Al, end Al, gyr 46, 1, hsd R17, (rk-, mk+), 
supE44, rel Al, ?, (lac), { F, pro AB, lac IqZA M15, 
TnlO( tetr)}, Laclq ZL\M 15 
HB-101 	sup E44, hsd S20 (rBmB), recA13, ara-14, pro A, 
lac Yl, gal 1(2, ipsL20, xyl-5, mt -1 
NM675 	supF, hsd R, trp R, lacY 
Vectors for cloning in E. coli 
pBluescript II SK: 
Contains T3 and T7 promoters for in vitro synthesis of RNA. It 
also includes a portion of the E. coli lacZ gene encoding the (X 
complementation peptide. This may be used in an appropriate host, 
such as XL1-blue, to screen for recombinants using IPTG and the 
chromogenic substrate X-gal. 
pGEMEX: 
Contains T7 and SP6 promoters for in vitro transcription of 
RNA. 
2.1.2 Eukaryotic cell lines, culture media & solutions 
Embryonic stem cell line: 
CGR8 (isolated at CGR by Dr. J. Nichols and Dr. A. Smith) 
CGR8/lf-r +1- (this study) 
EFC-1 (Nichols, et al., 1990) 
Other cell lines: 
CHO 5E27 (Gift of Dr. Taga, Osaka). 
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Cell culture medium: 
1 x Glasgow MEM/BHK21 medium (GIBCO 042-02541M); 
stock solution 10 x diluted in filter-sterilized UHP water 
0.23% sodium bicarbonate (GIBCO 043-05080 H) 
1 x MEM non-essential amino acids (GIBCO 043-01140 H) 
2 mm L-glutamine (GIBCO 043-05030 H) 
0.1 mM sodium pyruvate (GIBCO 043-01360 H) 
0.1 iM f-mercaptoethanol 
10% (v/v) fetal calf serum (Globepharm, Surrey, UK) 
Phosphate buffered saline (PBS): 
137 mM NaCl 
2.7 mM KC1 
4.3mM Na2HPO4.7H20 
1.4 mM KH2PO4 
Trypsin solution in PBS 
0.025% Trypsin solution (GIBCO 043-05090 H); Stock 2.5% 
1% chicken serum (GIBCO 033-06110 H) 
Water in cell culture was purified by passing it through an 
Elgastat Prima Reverse Osmosis Filter followed by an Elgastat Ul-IP 
water purifier. 
Prior to use, fetal calf serum batches were selected that 
supported optimum growth of established ES cell lines (tested by D 
Rout and D Colby) 
2.1.3 Mouse strains 
129 Ola (inbred); coat colour chinchilla (cchcch), 
C57BL/6 (inbred); coat colour nonagouti (a/a). 
CBA (inbred); coat colour agouti (A/A). 
MEl (outbred); coat colour albino. 
Mice were maintained in a stabilized environment in the 
animal facilities of the Centre for Genome Research, Edinburgh, on a 
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regime of 14 hour light/10 hour dark. The midpoint of the dark cycle 
was 12.00 midnight. 
2.2 E coli and X- phage manipulation 
2.2.1 Screening -cDNA library 
Preparation of plating cells 
A single colony of NTvI675 was inoculated into 50 ml of L-broth 
containing 10 mM MgSO4 and grown overnight at 37 °C. Cells were 
pelleted by centrifugation and resuspended in 10 ml of 10 mM MgSO4. 
This stock of cells could be used for two weeks without any significant 
change in their plating efficiency. 
Plating of cDNA libraries 
Libraries were titrated on NM675 cells. For large scale 
screening, 0.3 ml of plating cells were incubated with 40000 pfu of 
phage for 20 minutes at 37°C, then plated out onto a 15 cm petri dish in 
10 ml of top agarose (prewarmed to 50 °C). After overnight incubation 
at 37°C, the plates were chilled at 4 °C for at least 1 hour before further 
processing. Secondary and tertiary screens were done at a density of 
100-1000 pfu per 9 cm petri dish using 0.1 ml of plating cells and 3 ml 
top agarose. 
Bacteriophage plague lifts 
Duplicate lifts were always performed using nitrocellulose 
membranes (BA85, Schleicher & Schuell). Each filter was laid on top of 
the pre-chilled agar plate and orientation marks made by stabbing the 
filter into agar at several asymmetric points with a syringe needle. The 
filter was carefully removed and placed in 1.5 M NaCl, 0.5 M NaOH 
for 5 minutes. Lifts were neutralized in 1.5 M NaCl, 0.5 M Tris. HCl pH 
7.5 for 5 minutes. The filters were then washed in 2 x SSC and then air 
dried and baked at 80°C for 1 hour. 
Probes for library screen 
The probe used for cDNA library screening was provided by I 
Chambers. It is a 980 bp LIF-R cDNA fragment (referred to as LIF-Ri) 
cloned by PCR amplification of adult mouse liver cDNA. The fragment 
was primed with two degenerate oligonucleotides (B and C) 
corresponding to amino acids 196 to 201 and 509 to 514 of the 
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published mouse soluble LIF-R protein sequence respectively (Gearing 
et al., 1991; Chambers, unpublished). 
Screening condition 
106 pfu of a murine D3 ES cell A Zap library (Oligo dT and 
random primed, gift from Dr. Rathjen) was screened. Hybridization 
was performed in 6 x SSC containing 1 x Denhardt's solution for 24 
hours (Sambrook et al., 1989). Filters were then washed with 2 x SSC, 
0.1% SDS for 30 minutes. and 0.2 x SSC, 0.1% SDS for a further 30 
minutes. Duplicate positive plaques were picked for secondary and 
tertiary screen, plaque-pure positive clones were excised to form 
Bluescript clones. 
in vivo excision of A Zap bactriophage clones 
Bluescript plasmid was excised from plaque purified A clones 
exactly as described in the Stratagene Zap library instruction manual. 
2.2.2 Screening genomic A-library 
Probes for library screen 
In addition to the LIF-R1, another PCR fragment encoding LIF-R 
from amino acid 84 to amino acid 137 (159 bp, primed with 
oligonucleotides G and F) was also used (see also Chapter 3). 
Screening conditions 
A mouse genomic library in A DASH II (gift of Dr. W Skarns, 
Toronto) made from strain 129 mouse DNA was screened. Number of 
phages representing 1.5 mouse genomes were plated for each screen. 
The hybridisation and washing conditions were as described for cDNA 
library screen. Positive clones following 2 rounds of plaque 
purification were picked and stored in 0.5 ml of SM buffer at 4 °C. 
Isolation of phage DNA 
1010 plating cells were infected with a single plaque in 10 ml L-
broth and left shaking at 37 0C overnight. This culture was used as 
phage stock for making DNA. 
1 ml of phage stock and 2 ml of plating cells were used to 
inoculate 200 ml of L-broth containing 10 mM MgSO4 and left 
overnight at 370C with vigorous shaking. The culture was checked for 
lysis the next day and was completed by the addition of 1 ml of 
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chloroform for a further 10 minutes at 37°C. The bacterial debris was 
then pelleted at 8000 rpm for 10 minutes at 4 °C (Sorvall RC285, GSA 
rotor). Bacterial RNA and genomic DNA in the supernatant was 
digested with RNase A and DNase I (each at a final concentration of 10 
J.g/ml) at 37°C for 1 hour. An equal volume of 20% PEG, 2M NaCl was 
then added and the mixture incubated on ice for 1-2 hour. Phages were 
pelleted by centrifugation for 30 minutes at 8000 rpm, 4 °C(Sorvall 
RC285, GSA rotor). The pellet was drained well, resuspended in 10 ml 
of SM buffer (0.1 M NaCl, 10 MM  MgSO4, 50 mM Tric.HC1, pH7.5, 
0.01% gelatine) and extracted 3-4 times with chloroform to remove 
traces of PEG. Phage DNA was then extracted by adding 0.5 ml 0.5 M 
EDTA (pH 8.0), 1 ml 5 M NaC1 and mixing with TE-buffered phenol 
followed by centrifugation for 10 minutes. The phenol extraction was 
repeated and the aqueous phase was re-extracted twice with 
chloroform. Phage DNA was precipitated with 2.5 volumes of ethanol, 
washed in 70% ethanol and air dried before resuspending in TE. 
2.3 Molecular biology methods 
2.3.1 Plasmid DNA preparation 
Preparation of electroporation-competent cells 
A fresh overnight culture of XL1-blue or HB-101 was 
inoculated into 500 ml of L broth at 1: 100 dilution and the cells were 
grown with vigorous shaking to an 0D600 of approximately 0.4. The 
culture was chilled on ice for 15 minutes and the cells pelleted at 4000 
rpm (Sorval RC285, GSA rotor) for 15 minutes at 4 °C. The bacterial 
pellet was washed by resuspending twice in 250 ml ice cold dH20 and 
once in 50 ml of 10% glycerol. The cells were resuspended in a final 
volume of 2 ml of 10% glycerol giving a concentration of 
approximately 3x 1010  cells/mi and stored frozen in 40 j.tl of aliquots at 
-80°C. 
Transformation of plasmid DNA by electroporation 
An aliquot of electrocompetent cells was thawed on ice. 
Plasmid DNA or ligation reaction in 1-3 p.1 of dH20 was added, the 
mixture of cells and DNA was then transferred to a prechilled 0.2 cm 
electroporation cuvette. The electroporation conditions using Biorad's 
Gene Pulser were 250, 20OU and 2.5 Ky. The cells were pulsed once 
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and 1 ml of Soc medium was added immediately to the cells. The cells 
were 
allowed to recover within 1 hour incubation at 37 °C before plating on 
ampicillin plates. 
Small-scale plasmid preparation (mini-prep) 
Solution II 
50 mM glucose 	 0.2 M NaOH 
50 mM Tris.HC1 pH 8.0 	 1% SDS 
10 mM EDTA 
Solution ifi 
3 M potassium acetate 
2 M acetic acid 
1.5 ml of a 2 ml overnight culture of bacteria was centrifuged at 
13000 rpm for 1 minute at room temperture (Microcentrifuge Sorval 
MC12V). The pellet was resuspended in 50 p.1 of solution I. Followed 
addition of 100 p.1 of freshly prepared solution II, the lysate was left on 
ice for 5 minutes. 100 p.1 of solution ffi was then added. Following 10 
minutes incubation on ice, the sample was then centrifuged at 13000 
rpm (Microcentrifuge Sorval MC12V) for 10 minutes at 4 °C and the 
supernatant collected. The DNA was precipitated by adding 2.5 
volumes of ethanol and resuspended in 50 p.1 of TE buffer. 5 p.1 of 
sample was used per restriction digest. 
Large-scale plasmid preparation (Maxi-prep) 
Cells from a 500 ml overnight culture were centrifugated at 
5000 rpm for 10 minutes at 4 °C (Sorvail RC285, GSA rotor). The 
bacterial cell pellet was resuspended in 5 ml of solution I, 10 ml of 
freshly prepared solution II was added and the cell lysate were left on 
ice for 5-10 minutes. This was followed by the addition of 10 ml of cold 
solution Ill with gentle mixing and a further incubation of 15-30 
minutes on ice. The lysate was centrifuged at 10,000 rpm (Sorvall 
RC285, HB-6 rotor) for 30 minutes at 4 °C and the supernatant was 
carefully removed. 1 g CsCl was added per ml of supernatant. For 
every 10 ml of CsC1-nucleic acid mixture, 0.8 ml of ethidium bromide 
(10 mg/ml) was added. The plasmid DNA was then banded by 
isopycnic ultra centrifugation in an NVT65 rotor overnight at 55,000 
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rpm (Beckman L7 ultracentrifuge)at room temperature. The banded 
plasmid was collected with a syringe and the ethidium bromide was 
removed by multiple extraction with butanol. The DNA was then 
precipitated by addition of 3 volumes of 70% ethanol. The DNA pellet 
was resuspended in 0.4 ml of TE and reprecipitated by the addition of 
0.1 volume of 3 M sodium acetate (pH5.2) and two volumes of ethanol. 
The pellet was then dissolved in 0.5-2 ml TE and the DNA was 
quantified by measuring the absorbance at 0D260. Plasmid DNA was 
stored at 4°C. 
2.3.2 Enzymatic manipulation of DNA 
Restriction enzyme digestion 
Restriction enzyme digests were generally carried out as 
recommended by the manufacturer. In most cases enzymes were 
purchased from Boehringer Mannheim or Promega. 
Dephosphorylation of DNA 
To prevent self-ligation of the vector, the 5' phosphate was 
removed using alkaline phosphatase. 
Vector DNA to be used in cloning was first cleaved with the 
appropriate restriction endonuclease, then phenol extracted and 
ethanol precipitated.. 
The pellet was resuspended in calf intestine alkaline phosphatase 
buffer (10 mM Tris. Cl (pH8.3), 1 mM ZnC12, 1 MM  MgC12). 
The reaction was incubated at 37 °C for 20 minutes. 
The phosphatase was inactivated by heating the reaction mixture to 
70°C for 10 minutes in the presence of 20 mM EGTA. 
The DNA was phenol/ chloroform extracted, ethanol precipitated 
and resuspended in TE. 
Ligation of DNA 
The ligation reaction was generally carried out in a 10 gl 
volume with a 1:3 molar ratio of vector to insert. The reaction was 
performed at 16°C overnight in the following reaction mix: 
50 mlvi Tris.HC1 (pH 7.8) 
10 MM M902 
1 mM dithiothreitol (DTF) 
1 mlvi ATP 
OW 
1 U T4 DNA ligase 
Blunt ending of 5' and 3' overhangs 
The 5' overhangs were filled in by the polymerizing activity of 
the large fragment of DNA polymerase I (Klenow) as described. The 3' 
overhangs were excised by the exonucleolytic activity of the 
bacteriophage T4 DNA polymerase. 
Klenow polymerase reaction: 
Linearized DNA was resuspended in a buffer containing 70 mM 
Tns.Cl (pH7.4),50 mM NaCl and 7 mM MgC12 
dNTP to a final concentration of 1 mM, and 1 unit of Klenow 
polymerase (Boehringer) was added. 
The reaction was incubated at 37 °C for 30 minutes. 
The polymerase was inactivated by heating the reaction mixture to 
70°C for 10 minutes. 
The blunt-ended DNA was purified by phenol/ chloroform 
extration, followed by ethanol precipitation, and resuspension of the 
DNA inTE. 
T4 exonuclease reaction: 
Linearized DNA was resuspended in a buffer containing 70 mM 
Tris.Cl (pH7.4),7mM MgC12, 5 mM DTF and 0.5 mM dNTP. 
1 unit of T4 polymerase (Boehringer) was added, and the reaction 
was incubated at 37 °C for 30 minutes. 
4. The following steps were identical to steps 4 and 5 of the Kienow 
polymerase reaction. 
2.3.3 DNA preparation from ES cells and mouse tissues 
Making agarose plugs from ES clones 
Confluent cells grown in the duplicate 24-well plates were 
trypsinized, transferred into Eppendorf tubes and washed once with 
PBS, cell pellets were resuspended in 50 pi of PBS and 70 p1 of 1% low 
melting agarose (prewarmed at 37 °C) and let set in plug mould on ice. 
Agarose plugs were then transferred into Eppendorf tubes and were 
incubated at 55°C overnight in NDS buffer (1% lauryl sarcosine, 0.5M 
EDTA, pH 9.5) in the presence of 1 mg/ml of proteinase K. 
Isolation of genomic DNA from ES cells 
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Culture medium was removed by aspiration from a confluent 
layer of cells from a single well of a 24 well tissue culture dish and the 
cells were lysed by addition of 0.4 ml of DNA lysis buffer (10 mM Tris 
pH8.0, 50 mM EDTA, 100 mM NaCl, 0.5% SDS and 0.5 mg/ml 
protemase K) at 50-60 °C overnight. The cell lysate was extracted with 
an equal volume of phenol/choloroform and DNA in the upper phase 
supernatant was precipitated with an equal volume of isopropanol or 
2.5 volume of ethanol. The DNA was pelleted by microcentrifugation 
for 15 minutes, dried and left to resuspend in 50-100 p1 of TE. 
Preparation of genomic DNA from mouse tails and yolk sacs 
The day of the vaginal plug was considered as embryonic day 
(E) 0.5. The tails of neonates, the tail tip of adult mice and the yolk sacs 
of embryos older than E9.5 were placed in 0.5 ml of lysis buffer and 
digested as described above. The next day, lysate was extracted once 
with phenol /chloroform, and the DNA was precipitated with ethanol, 
washed with 70% ethanol, and resuspended in 100 p1 of TE. 
2.3.4 Southern blot analysis 
Restriction digest of DNA in agarose plugs 
Plugs were washed twice with TE containing 0.1 mM PMSF 
and once with distilled water. All washes were for at least 1 hour. 
Plugs were then equilibrated with 1 x restriction buffer for 1 hour at 
4°C. Restriction digests were performed in 60 .tl of 1 x restriction buffer 
containing 40 U of enzyme for 4 hours or overnight. Half or one third 
of a plug was used for each digest and the remainder was stored at 4 °C 
inTE buffer. 
Restriction digest of genomic DNA in solution 
A typical reaction mixture for digestion of genomic DNA was 
set up as follows: 
20 p1 genomic DNA (0.5pg/pl) 
5 4110 x appropriate restriction buffer 
1 p1 enzyme (40U/pl) 
24 p1 H20 
The digestion was normally carried out at 37 °C for 4 hours. 
Agarose gel electrophoresis for resolving DNA molecules 
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Agarose gels were used to resolve DNA fragments from 100 bp 
to 20 kb using concentrations of agarose from 0.7% to 2% in 0.5 x TBE 
or 1 x TAE buffer (Maniatis, 1991). The molecular weight marker was 
usually the 1 kb ladder purchased from BRL. DNA was visualized by 
staining the agarose gel with ethidium bromide. 
For analysis of DNA embedded in agarose plugs, restriction 
buffer was removed and plugs were melted at 65 °C before they were 
loaded in the gel. 
Southern transfer 
DNA was transferred from agarose gels onto nylon membranes 
(Boehringer) either by capillary blotting overnight in 20 x SSC 
(Southern 1975) or by vacuum blotting (VacuGene XL. Pharmacia LKB) 
with 20 x SSC at 40-50 mbars for 2 hours. Following transfer, the 
membrane was rinsed with 2 x SSC and baked at 120 °C for 20 minutes. 
Before transfer, DNA was denatured in 0.5M NaOH, 1.5M NaCl for 30 
minutes followed by neutralization in 0.5M Tris, 1.5M NaCl for 1 hour. 
2.3.5 Dot blot analysis 
The tail lysate was extracted once with chloroform and 50 p.1 of 
the aqueous phase was incubated with 150 p.1 of 0.5 M NaOH for 30 
minutes at room temperature. The denatured DNA was then 
immobilized to Hybond N filter using a dot blot apparatus (BioRad) 
according to manufacturer's instructions. 
2.3.6 Radiolabelling of DNA 
DNA was labelled with random hexanucleotides as primers for 
the Kienow polymerase in the presence of 50 p.Ci of <a- 32P>-dCTP as 
described by Feinberg and Vogeistein (1983). Generally 20-40 rig of 
DNA template was labelled for 1 hour, unincorporated nucleotides 
were removed by passing through a Sephadax G-50 column. DNA 
samples for labelling were either in solution or contained in low 
melting point agarose. 
2.3.7 Nucleic acid hybridization 
Southern hybridization 
Filters were hybridized in a buffer modified from that 
described by Church and Gilbert (1984). (0.5 M Na21-1PO4, pH7.2, 7% 
SDS, 1 mM EDTA, 100 ng/ml herring sperm DNA). Hybridization was 
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performed overnight at temperatures between 65 °C and 68°C 
depending on the specific probe. 
Following hybridisation, filters were washed for 30 minutes 
each, time in the following buffers: wash I (40 mM Na2HPO4, 1 mM 
EDTA, 5% SDS) and wash 11(40mM Na2HPO4, 1mM EDTA, 0.1% SDS, 
) at the same temperature used for the hybridization. Alternatively, 
filters were washed twice for 30 minutes each in 2 x SSC, 0.1% SDS and 
0.2 x SSC, 0.1% SDS. 
Dot blot hybridization 
Following dot blotting, filters were washed in 30 mM sodium 
phosphate, 0.1%SDS for 1 hour at 65 °C. Hybridization was performed 
at the same temperature overnight in a buffer containing 0.5M sodium 
phosphate, 7% SDS and 0.5% marvel. Following hybridization, filters 
were washed 3 times in 30mM sodium phosphate, 1% SDS at 65 °C. 
2.3.8 DNA sequencing 
Sequencing reaction 
Double-stranded sequencing of plasmids was carried out using 
the sequencase version 2.0 DNA sequencing kit (USB) according to the 
recommendations of the manufacture. Mini-prep DNA purified by 
precipitation with PEG was used as the template for sequencing 
reactions. 
Polyacrylamide gel electrophoresis 
The labelled DNA molecules were resolved on 
polyacrylamide/urea sequencing gel. Electrophoresis was at a constant 
power (60W) for various times in 1 x TBE buffer. After running, the gel 
was fixed and subsequently dried in a vacuum gel-dryer at 80 °C. 
Sequencing products were visuulized by autoradiography 
using Kodak XAR-5 film. The sequcence were read by eye and 
analyzed by DNAstar computer software packages. 
2.3.9 Amplification of DNA by polymerase chain reaction (PCR) 
Reactions were carried out in a 50 tl mix containing: 10 mM 
Tris.HC1 pH 8.2,50 mM KC1, 3 mM MgC12, 0.2 mM dNTPs, 100 pmole of 
each primer, 10 ng of DNA templete and 2.5 units of Taq polymerase 
(Promega). The mixture was overlaid with 50 .tl of mineral oil (Sigma) 
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and the DNA was amplified for 30 cycles as follows: 94 0C for 1 minute, 







R= A or G; N = A or C or G or T; Y =C or T 
(sequences are based on data of I Chambers, unpublished). 
2.4 ES cell culture methods 
For routine culture, all cells were maintained at 7.5% CO2, at 
37°C in a humidified incubator (Heraeus, B 5060 EC/CO2). Methods 
for routine culture of ES cells are based on those described in Smith, 
1991, unless otherwise indicated. 
All tissue culture manipulations were undertaken inside a 
laminar flow sterile hood (ICN, Flow). To aviod bacterial or fungal 
contamination of the cell cultures, all objects and surfaces were 
sprayed with 70% industrial methylated spirits (IMS) before use. 
Unless otherwise stated, tissue culture grade plasticware was supplied 
by Falcon and Nunc. 
2.4.1 Routine culture of ES cells 
ES cells were cultured in 0.1% gelatine-coated tissue culture 
flasks or plates in Glasgow modified Eagle's medium (GMEM) 
supplemented with 10% fetal calf serum (FCS), 1 x non-essential amino 
acids, 0.1mM 2-mercaptoethanol, 1mM sodium pyruvate and 100U/ml 
LIF (murine, obtained by transfection of COS cells with a murine LIF 
expression plasmid (Rathjen et al., 1990); the above medium without 
LIF is also referred to as complete medium). Cells were grown in a 
humidified incubator at 6% CO2 and 37 °C (Smith, 1991). 
To passage the cells, the medium was removed and the cells 
were rinsed twice with PBS, trypsin was added to just cover the cells 
and the flask was incubated at 37 °C for 2-3 minutes. The trypsin was 
neutralised by addition of 10 ml of medium and pipette into single cell 
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suspension. An aliquot of cells was seeded into a new flask containing 
pre-warmed medium to a dilution of 1/10. 
Freezing cells 
Cells in tissue culture flasks were trypsinised to obtain a single 
cell suspension and centrifuged at 2000 rpm for 2 minutes. The cell 
pellet was resuspended in 1 ml of freezing mix (GMEM complete 
medium containing 10% dimethyl suiphoxide, AnalaR, BDH) and 
transferred into a cryotube. The latter was placed at -80 °C overnight 
and then transferred to a liquid nitrogen cell bank (XCL110, Minnesota 
Valley Engineering Cryogenics). 
To freeze cells in situ in plates, the medium was removed and 
freezing mix was added to just cover the cell layer. The plate was then 
transferred into a polystyrene box and stored at -80 °C (Ure et al.,1991). 
Thawing cells 
Frozen cryovials were removed from -80 °C and thawed in a 
37°C water bath. The contents were transferred into a 50 ml Corning 
tube containing 15 ml of ES cell medium and centrifuged. The cell 
pellet was resuspended in 10 ml of fresh medium and seeded into a 25 
cm2 flask. 
To thaw cells frozen in plates, 1 ml of pre-warmed medium 
was added directly ,  into each well. The plates were then placed on top 
of a pre-warmed metal plate and transferred to 37 °C incubator. Once 
thawed, the medium was carefully removed and replaced with 0.5 ml 
of fresh medium (Ure et al., 1992). 
2.4.2 Induction of ES cell differentiation 
Retinoic acid induction: 
ES cells were seeded at a density of 10 4 cell/well in 24 well 
tissue culture plates. About 4 hour or overnight after plating, the 
medium was replaced with fresh medium supplemented with retinoic 
acid to 10 M. After 72 hours of incubation, medium was replaced 
with complete medium without retinoid acid and the cells cultured for 
a further 2-3 days. 
3-methoxybenzamide induction: 
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ES cells were seeded as described above. MBA was added 
directely to prewarmed complete medium to a final concentration of 5 
mM. The medium was left in a water bath at 37 °C for a further 20 
minutes to ensure complete dissolution of MBA. ES  cells were cultured 
in this medium but supplemented with LIF for 48 hours followed by 2 
days of culture in complete medium in the absence of MBA. 
2.4.3 Transfection and selection of recombinant ES cells 
Confluent flasks of CGR8 ES cells at passages 14 were 
harvested by trypsiriization. 108  cells were centrifuged through culture 
medium and resuspended in 0.7 ml of PBS. 150 ig of linearized 
targeting vector DNA in 100 p.1 of PBS was added to the cells. ES 
cell/DNA mixture were electroporated in sterile cuvette at 800 V and 
3 pF. Immediately after electroporation the cells were plated onto 
twenty 10 cm gelatine-coated plates at a density of 5 x 106  cells/10 
ml/plate. 24 hours after transfection, cells were transfered to selection 
medium medium containing 175 p.g/ml of G418 for about 10 days. 
Single G418 resistant colonies were then picked into 24-well plates 
coated with gelatine. Cells were expanded and each clone was split 
into 2 plates, one of which was frozen in situ as a stock (Ure et al., 
1991), while the other one was used for DNA extraction and Southern 
blot analysis. 
2.5 Animal analysis 
2.5.1 Blastocyst injection and the production of chimeras 
Chimaeric mice were produced according to Bradley, 1987, 
modified by Nichols, 1994. All of the blastocyst injections were carried 
out by either J Nichols or J Ure. 
Recombinant ES cell clones were microinjected into C57BL/6 
blastocysts. Blastocysts were usually cultured for 1-3 hours in injection 
medium (1:1 DMEM and F12) before injection to allow the blastocoel 
cavities to fully expand. ES cells were trypsinized, washed once with 
injection medium and 15-20 cells injected into each blastocyst. 6-10 of 
these blastocysts were transferred to the uterine horn of a 
pseudopregnant F1(CBA/Ca x C57BL/6J) recipient mouse. Chimeric 
pups were identified by coat colour. 
2.5.2 Breeding of LIF-R mutant mice 
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Chimeric males were initially test bred with MF1 wild type 
females and germline transmission of the mutant LIF-R allele was 
detected by dot blot analysis of tail DNA from Fl offspring with grey 
coat colour. Germline transmitting male chimeras demonstrated by 
this way were then bred with CBA and 129 wild type females to obtain 
the mutation on hybrid or pure inbred backgrounds. MF1 x 129, CBA x 
129 and 129 heterozygous offspring were subsequently backcrossed to 
wildtype MEl or CBA or 129 mice. 
When at least 6 weeks, male and female mice heterozygous for 
the LIF-R mutation were set up to interbreed to homozygosity. 
Genotyping was done by Southern analysis with the 5' flanking probe 
on EcoR I digested DNA made from mouse tails or yolk sac of embryos 
as described earlier in this chapter. 
2.5.3 -gaIactosidase staining of recombinant ES cells and embryos 
The protocol was based on Beddington et al., 1989b. 
Cells were treated with fix buffer (0.2% giutaraldehyde, 0.1 M 
phosphate buffer pH 7.3,2 mM MgC12, 5 mM EGTA) for 10 minutes at 
4°C and washed 3 times with wash buffer (0.1 M phosphate buffer, 2 
mM MgCl2, 0.1% Sodium desoxycholate, 0.02% NP40, 0.05% BSA). The 
cells were then incubated at 37°C overnight, in a mixture containing 5-
bromo-4-chloro-3-indolyl-f3 -D-galactoside (X-gal, 1 mg/ml), 4 mM 
potassium fericyanide, 4 mM potassium ferrocyanide in wash buffer. 
The staining was stopped by washing the cells 3 times with wash 
buffer at room temperature. Samples can either be stored in fix buffer 
or left to dry. 
For -gal staining of cryosectioned embryos or tissues, sections 
were fixed, washed 3 times with wash buffer for 5 minutes each at 
room temperature, and then incubated with 1 mg/ml X-Gal at 37 °C for 
4 hours or overnight. Sections were then washed in wash buffer and 
counter stained with neutral red or eosin (DBH). 
For whole embryos, Nonidet P-40 (NP-40) and sodium 
deoxycholate were added to the staining buffer at 0.2% and 0.1% 
(w/v), respectively, to enhance penetration of X-gal into deeper 
structures (eg, neural tube and skeleton). 
2.5.4 Haematopoietic analysis 
36 
Long term haematopoietic reconstitution assay 
Fetuses from Fl (129 x CBA) LIF-R heterozygous intercrosses 
were delivered by caesarean section at E16.5. Fetal livers were 
dissected and disaggregated in PBS by passing the tissue several times 
through a 26-gauge needle. Fl (129 x CBA) wild type recipient mice 
were lethally irradiated (10.5 Gy) and injected intravenously with cells 
from one liver or with PBS (negative controls). Four month after 
reconstitution, bone marrow of recipient mice was taken from femurs 
and reinjected into lethally irradiated secondary recipients. 
Flow cytometry analysis of peripheral blood 
10 drops of peripheral blood (PBL) from retro-orbital sinus 
were collected into 10 ml of PBS. Cells were pelleted and resuspended 
in 9 ml of distilled water for 12 seconds to lyse the red blood cells. 
After this water shock, 1 ml of 10 x PBS was added and the cells were 
washed twice with PBS containing 0.1 1/o BSA and 0.1% azide (complete 
PBS). Mononuclear cells enriched in this way were resuspended' in 0.5 
ml of complete PBS, counted, stained with various monoclonal 
antibodies (mAbs) and analyzed by flowcytometry using a FACScan 
(Becton-Dickinson). 
The following mAbs were used in the flow cytometry analysis: 
phycoerythrin (PE)-conjugated rat anti-mouse CD45R/B220, clone 
RA3-6B2; fluorescein isothiocyanate (FITC) -conjugated rat anti-mouse 
CD4, clone CT-CD4; PE-conjugated rat anti-mouse CD8, clone CT -
CD8a; and FJTC-conjugated rat antimouse granolocyte, clone RB6-8C5. 
All mAbs were purchased from Caltag laboratories, USA. 
10,000 cells from each sample were scanned. Red blood cells 
and dead cells were excluded using an electronic gate according to 
their forward scatter (size) and side scatter (cell) complexity. Data was 
aquired and analyzed with Lysis II software. 
Haematocrit measurement 
Blood was collected into heparinised capillaries. One end of 
each capillary was then sealed and the blood cells were spun in a 
micro-haematocritcentrifuge (Hawksley & son Ltd) for 5 minutes. The 
length of capillary from plug to top of plasma (value X) and the length 
from plug to top of the red blood cells (value Y) were measured. 
Haematocrit was presented as YIX(%). 
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2.5.5 Glucose phosphate Isomerase (GPI) analysis 
Samples to be tested were dissected and stored at -70 °C prior to 
analysis. To release enzyme, tissues were freeze-thawed at least two 
times. Samples (ijil) were loaded to a cellulose acetate sheet (Helena 
laboratories) soaked in Tris glycine buffer and electrophoresed at 200V 
for 1 hour. Following electrophoresis, the plates were submerged in 
freshly made stain buffer until bands appear, following which, they 
were fixed in 5% glacial acetic acid (BDH) for a few minutes and dried. 
Tris Glycine Buffer (12H8.1-8.5) 
Tris base 	3 g 
Glycine (Gibco) 	14.4 g 
dH20 	 to 1 litre 
Tris Citrate Buffer (12H8.0) 
Tris 	 20.1 g 
Citric acid (Sigma) 8 g 
dH20 	 to 500 ml 
Stain buffer (prepare fresh) 
Tris Citrate Buffer (pH 8.0) 	 1 ml 
(20.1 g Tris, 8 g citric acid, 
500 ml of distilled water) 
0.2% MgC12 
	 9 ml 
Fructose-6-phosphate (20 mg/ml, Sigma) 	1 ml 
NADP (2.7 mg/ml, Sigma) 	 1 ml 
NBT (2.7 mg/ml, Sigma) 1 ml 
Glucose-6-phosphate dehydrogenase 	10 p1 
(555 units/ml, Sigma) 
At the last minute, add 30p1 PMS (10 mg/mi, Sigma). 
2.6 Histological Analysis 
2.6.1 Cryostat sections 
Embryos or tissues to be analyzed were dissected in PBS, 
embedded in OCT compound (Mile laboratory), and were frozen on a 
bed of dry ice. For sectioning, the frozen block was equilibrated to the 
appropriate temperature (according to the nature of the tissues, for 
example, -12°C for brains), frozen sections were taken at 12 p.m in a 
KK 
cryostat (AS620 Cryotome, Anglia Scientific Instruments LTD), thaw 
mounted onto precleaned, TESPA-coated microscope slides (Philip 
Harris) and stained with X-Gal., 
2.6.2 Wax sections 
Embryos were washed twice in PBS and dehydrated through 
ethanol followed by clearing in Histoclear overnight. Embryos were 
then incubated subsequently in a mixture of 50% histoclear /50% wax 
and 100% wax at 60°C for 1 hour each. After mounting, embryos 
embedded in wax were sectioned at 7pm in a microtome and collected 
onto TESPA-coated microscope slides (Philip Harris). The sections 
were dewaxed in histoclear (DBH) and mounted directly with Canada 
Balsam (DBH) or rehydrated and counter stained with neutral red 
(DBH). then dried, and mounted with Canada Balsam. 
2.6.3 Skeleton preparation 
Skeletal whole mounts of newborn mice were performed on 
completely eviscerated animals with the skin removed. Corpses were 
fixed in 95% ethanol at room temperature for three days. Staining was 
carried out in 0.005% alizarian red 5, 0.015% alcian blue in 5% acetic 
acid, 5% 1-120 and 90% ethanol for 3 days at room temperature. 
Samples were then kept in 1% KPH at room temperature until tissues 
had completely cleared. Cleared skeletons were washed with 0.5% 
KOH, 50% glycerol and stored in 100% glycerol. This procedure stains 
cartilage blue and calcium-containing tissue red: 
2.6.4 Observation and photography of results 
A Vanox microscope (Olympus) was used for all detailed 
observation and photography of sections. Whole embryos were 
observed under a steromicroscope (Olympus). Photography was 
performed with Kodak gold 100 or Fuji 64 Tungsten films. 
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Chapter 3 
Targeting of LIF-R 
in Embryonic Stem Cells 
3.1 Introduction 
As discussed in chapter 1, the occurrence of homologous 
recombination events varies widely, depending on the target locus and 
the design of the targeting vector. Two criteria, however, the genetic 
background of genomic DNA and the length of genomic DNA employed 
in a targeting construct appear to be generally important in maximising 
the targeting frequency (Deng and Capecchi 1992; Hasty et al.,1991b; te 
Riele et al.,1992; Thomas and Capecchi 1987). Other features in the 
targeting construct may also enhance the frequency. For example, a 
selectable marker gene lacking its own promoter could be used in the 
targeting construct if the gene is transcribed in ES cells. The functional 
expression of such a selectable marker gene occurs only when the 
targeting construct integrates at random into an active transcriptional 
unit or following homologous recombination. This strategy can 
significantly reduce the isolation of random integration event and enrich 
for homologous recombination. 
However, to make a conventional promoterless targeting vector 
one has to fuse the marker gene in frame with the endogenous gene and 
retain the marker gene activity. Therefore, the construction of such 
targeting vectors requires detailed understanding of the genomic 
structure of the targeting gene. A promoter trap gene targeting strategy 
that enables one to bypass the constraints of reading frame, genomic 
structure and the effects of making fusions on selectable marker gene 
function has been developed in our laboratory. The approach is to 
incorporate an internal ribosome entry site (IRES) element in the 
targeting construct Gang et al., 1988; Pelletier and Sonenberg, 1988; for 
review see Mountford and Smith, 1995). IRES is a sequences of some 600 
nt in the 5' untranslated region of the picornaviruses. When incorporated 
into a RNA transcript, IRES acts as a ribosome binding/entry site and 
all 
permits the cap-independent internal initiation of translation in 
mammalian cells gang et al.,1989; Molla et al.,1992). These features 
significantly simplify the design and construction of targeting vectors 
(Mountford and Smith 1995). Figure. 3.1 illustrates schematically the 
application of IRES in gene targeting. LIF-R is expressed in 
undifferentiated ES cells which are LIF responsive (Chambers, 
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Figure 3.1. Application of IRES in gene targeting. Construct is designed to delete 
part of coding regions of the gene interest. Lines indicate intronic sequences, thin 
black boxes indicate 5' and 3' untranslated regions, and thick black boxes represent 
exons. SA, en-2 splice acceptor; pA, simian virus 40 (SV40) polyadenylylation 
sequence (Modified from Mountford and Smith, 1995). 
In this chapter, preliminary characterisation of lf-r locus, the 
strategy of lif-r gene targeting, the analysis of homologous 
recombination events and the generation of germline competent 
chimeras will be described. Analysis of the phenotypic consequences of 
lfr mutation will be presented in Chapter 5. 
3.2 Cloning and sequencing analysis of LIF-R cDNAs in ES cells 
Murine LIF-R was originally cloned from adult liver cDNA library 
and the deduced amino acid sequence was published (Gearing et 
al.,1991). This sequence was used to design oligonucleotide primers for 
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RT-PCR and a partial LIF-R cDNA (LIF-Ri), which encodes the second 
cytokine receptor domain, was cloned (Chambers, unpublished, Figure 
3.2). However, in order to characterise the genomic organisation of lf-r 
locus, more information of the mouse LIF-R cDNA sequence is 
necessary. As our laboratory is interested in LIEF-R signalling in ES cells, 
it was therefore decided to clone LIF-R from an ES cell cDNA library. 
The library, provided by Dr. P. Rathjen, was made from mouse D3 ES 
cell RNA. Approximately 2 x 106 ? phages were screened. After three 
rounds of hybridisation screening with a 980 bp probe (LIF-R1, Figure 
3.2 and materials and methods), three different positive clones, named 
LIF-R 2, 3, and 4 were isolated. cDNA containing phagemids were 
released from ? ZAP vector ( see in vitro excision of ?. ZAP 
bacteriophages, Chapter 2) and analysed by restriction enzyme mapping 
and DNA sequencing from both 5' and 3' ends with T3 and T7 primers. 
The predicted amino acid sequence matched the published mouse LIF-R 
sequence and indicated that the three clones covered most of the mouse 
LIF-R cDNA coding sequence except for the 5' portion (Figure 3.2). The 
longest cDNA, LIF-R 2 begins at amino acid 84 and extends into the 3' 
untranslated region (3' UTR). However, sequences encoding amino acid 
344 to 384 were deleted from the second cytokine receptor domain of 
this clone. The majority of DNA sequencing analysis of these cDNAs 
was performed by I Chambers and M Robertson in our laboratory. Based 
on their sequencing data, oligonucleotide primers G and F were 
designed to amplify the 5' end of cDNA clone 2. The PCR product, a 159 
bp fragment, was then used for genomic library screening and 
characterisation (Figure 3.2). 
3.3 Isolation and characterisation of lif-r genomic clones 
A ? DASH II library derived from 129 strain mouse DNA was 
consecutively screened with two PCR generated cDNA probes (Figure 
3.2). Six genomic clones for lf-r gene were plaque-purified, two clones 
were obtained with LW-R1 probe and four clones were obtained with the 
159 bp probe. 
As lf-r gene has not been previously described, the first task was to 
generate a restriction map as it would provide the foundation for 
subsequent elucidation of the structure of lf-r locus. ? DNA was 
digested using enzymes with restriction sites in the DASH II polylinker. 
Fragments were resolved by agarose electrophoresis, blotted and 
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Figure 3.2. Schematic representation and alignment of LIF-R cDNA 
clones. 
Independent cDNA clones isolated from a D3 ES cell library (LIF-R2-4) 
and the probes used for genomic library screen (159bp and LIF-R1) are 
aligned alongside a schematic representation of the LIF-R protein. The 
numbers at the begining and the end of each cDNA clone represent the 
predicted amino acids. The position of oligonucleotidies are labeled with 
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hybridised with the two original cDNA probes. Tabulation and plotting 
of these information allowed the identification of the regions of overlap 
among these clones and the ordering of restriction sites along the length 
of the genomic DNA insert. More detailed mapping was performed by 
multiple restriction digestions with additional enzymes combined with 
Southern hybridisation with various portions of LIEF-R cDNA probes. 
These analysis indicated that the six A. genomic clones cover 
approximately 40 kb of the lf-r gene. A summary of the restriction maps 
produced for these genomic clones, showing a subset of the enzymes 
mapped and the region of overlap among the clones is shown in Figure 
3.3. The linking of A.3 and ?.6 was determined by hybridisation of EcoR I, 
BamH I and Xba I restricted ES cell DNA with a PCR amplified cDNA 
probe primed with oligonucleotide B and oligonuclotide E (Figure 3.3 
and data not shown). 
A 5' RACE cDNA encoding the start codon and the secretory signal 
sequence of LIF-R has subsequently been cloned by I Chambers. This 
clone hybridised to a 500 bp Bgl II fragment within the boundary of 
BamH I and Sal I sites of A. clones 5-8. The 3' cDNA probe that A. clone 2 
hybridised to is an AccI/Bgl II fragment of cDNA clone 2 which 
encompasses the C terminal of the second cytokine receptor domain 
(amino acid residues 494 to 581). Therefore it was concluded that these A. 
clones probably contain exons which encode the entire ligand binding 
domain of LIF-R. A 0.7 kb BamH I/Hind ifi genomic fragment contained 
in the 5' end of A.3 was subcloned into Bluescript vector and the exon in 
this fragment was sequenced with T3 and T7 primer. Other coding 
regions were located roughly within a subset of restriction sites. The 
data obtained by restriction mapping and limited sequencing suggest 
that the mouse lif-r gene consists of multiple exons divided by many 
large introns. A detailed study of lzf-r genomic structure and the 
localisation of exons was later continued by A Cozens and I Chambers 
(Cozens et al., in preparation). The findings were consistent with my 
initial conclusions. A partial restriction maps and the exon organisation 
of lr gene determined by myself compared with that obtained by 
Cozens et al are shown in Figure 3.3. 
3.4 Strategy for lif-r targeting 
In order to investigate the requirement for LIF-R in ES cell self-
renewal and mouse development, vector design was aimed to create a 
al 
Figure 3.3. Partial genomic structure of lif-r 
A partial restriction map of the mouse lzf-r gene determined by the 
auther is shown. Dotted boxes identify restriction fragments which 
hybridize to LIF-R cDNA. 
Exon structure of above region of the lfr locus finalised by A Cozens 
et al., Numbered black boxes indicate exons. Exons localised between the 
Sac I site (near 3' end of A8) and the 3' EcoR I site are not shown. 
Alignment of genomic clones A.2-A.8. Arrow indicates the junction 
between ?6 and X3. Bam, BamH I; Ri, EcoR I; Hind, Hind ifi; Sac, Sac I; 
Sal, Sal I; Sms, Sma I; Xba, Xba I; Xho, Xho I. 
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null allele. The actions of LIF and other LIF-R ligands are dependent on 
the heterodimerization of LIF-R and gp130 stimulated by ligand binding. 
The deletion of the ligand binding domain is likely to inactivate LIF-R 
function. To this end, approximately 20 kb genomic DNA encoding the 
major portion of the two cytokine receptor domains (the putative LIF-R 
ligand binding domain) is deleted in lf-r targeting vector (Figure 3.4). 
Given the significant advantage of promoterless vectors over 
versions containing a promoter driven neo gene, a promoterless 
engrailed-2 (en-2) splice acceptor-IRES-3geopA (en-2SA-WES-geopA) 
cassette was employed. The inclusion of en-2 splice acceptor allows the 
IRESgeo cassette to be inserted into an intron and ensures efficient 
mRNA processing. f3geo is a fusion of lacZ reporter in-frame with neo 
selectable marker which fulfils a dual purpose: a selectable marker and a 
reporter of lf-r expression (Friedrich and Soriano 1991). Following 
homologous recombination, lacZ expression will be under the control of 
the lf-r regulatory sequences. This was anticipated to provide a sensitive 
readout of lf-r expression in ES cell cultures and during mouse 
development. The vector contains a polyadenylation signal from SV40 to 
reduce transcription of endogenous lf.r gene sequences downstream of 
the f3geo. 
3.5 Construction of the targeting vector 
Figure 3.4 illustrates schematically the cloning procedure for lf-r 
targeting vector, which was performed in four steps. 
The 3' homologous regions was a ca. 5 kb Sma I-Sac I fragment 
from X2. This fragment was firstly subcloned into Sma I-Sac I digested 
pBluescript KS- vector (the resulting plasmid was designated pKOl). 
Subsequently, the 3' homology arm was recloned into a pGEMEX-2 
(Promega) vector as a Sal I-Sac I fragment by bringing in a Sal I site at 
the 5' of the Sma I site from the Bluscript polylinker (pK02). The 5' 
homology arm was a 5.5 kb BamH I-Sal I fragment, which was ligated 
into the BamH I-Sal I sites of the plasmid pK02 to generate pK03. The 
targeting vector was completed by insertion of a 6.6 kb Sal I fragment 
from plasmid GT1.8geo (made by Dr. P Mountford) into the Sal I site of 
pK03 (pK04neo). The 6.6 kb Sal I fragment (en-2-IRES-3geopA cassette) 
contains a 1.8 kb en-2 splice acceptor, 0.6 kb IRES from 
encephalomyocarditis virus (EMCV), 4 kb lacZ-neo fusion gene and 0.25 
Figure 3.4. Construction of lif-r targeting vector 
Upper: Partial genomic structure of wild-type lf-r gene. Indicted is the 
region covered by the six lamda clones. Exons 2 to 13 are shown as 
numbered filled boxes. 
Middles: Procedures to make the targeting construct. See also text 3.5. 
A Ca. 5 kb Sma I-Sac I fragment (3' homology) was subcloned into Sma 
I-Sac I digested Bluescript II vector (pKOl). 
The 3' homology was taken out from pKOl as a Sal I-Sac I fragment 
and inserted into Sal I-Sac I digested pGMEM2 vector (pK02). 
A Ca. 5.5 kb BamH I-Sal I fragment was inserted into BamH I-Sal I 
linearized pK02 (pKO3). 
A Ca. 6 kb Sal I fragment containing the En2-WESgeopA cassette was 
excised from pGT1.81RESgeo (made by Dr. P Mountford), which was 
then ligated with the Sal I linearized pKO3 to complete the lf-r targeting 
vector. 
Bottom: The resuting targeting vector contains a total of 10.5 kb lf-r 
homologous sequence and a promoterless En2-IRESgeopA cassette 
consisting of engrailed 2 (en-2) gene intron and splice acceptor sequence, 
an EMCV IRES and a lac-Z-neopA fusion gene (geo). 
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kb SV40 polyadenalytion sequence. The resulting targeting vector was 
linearized by Sfi I and Not I double digestion to expose two homologous 
ends for electroporation into ES cells. 
The insertion of the en-2-IRES-geopA cassette and the recloning of 
the 3' homology from Bluescript vector into pGEMEX vector incorporate 
two novel EcoR I sites in the targeting construct to facilitate later 
screening for recombinant ES clones. Following homologous 
recombination, the 12.5 kb EcoR I fragment flanking the 5' homology 
will be reduced to 6.2 kb whereas the 10.5 kb EcoR I fragment in the 3' 
region will be reduced to 9.3 kb (Figure 3.5). 
Homologous integration of the targeting vector results in the 
deletion of 20 kb from the lif-r gene encompassing exons 4 to 10. 
Transcription from the targeted allele should initiated in the lf-r 
promoter and terminate at the 5V40 polyadenylation signal included at 
the end of Dgeo. Translation originating in the lif-r AUG proceeds 
through lf-r exon 3 into the en-2 exon sequence where it should be 
terminated by a inframe stop codon. lgeo fusion protein is translated 
independent of the lf-r reading frame via the IRES. 
12.5 kb 	 7.5 kb 	2jb 	10.5 kb 
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Figure 3.5 The predicted structure of mutated lif-r alleles. 
Homologous recombination at the lif-r locus results in a deletion of 20 kb region 
containing exon 4 to 10. The position of probes used is shown by circles. Expected 
lengths of restriction fragments diagnostic for wild-type allele (upper) and for 
homologous recombination (lower) are indicated by double-headed arrows. 5', 5' 
flanking probe; 3', 3' flanking probe. 
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3.6 Electroporation and screening for homologous recombinant ES 
cells 
The targeting vector was introduced into CGR8 ES cells as 
described in Materials and methods (Chapter 2). To screen for ES cell 
colonies harbouring a recombined lf.r gene, a ca. 600 bp EcoR I-BamH I 
fragment, which is immediately upstream of the 5' homology was 
chosen as the 5' external probe. This probe detects the 12.5 kb EcoR I 
fragment of the wild-type allele and the 6.2 kb fragment of the mutant 
allele (Figure 3.5). The 3' external probe was a Ca. 400 bp Sac I-Sal I 
fragment (Sal I was from the DASH II polylinker) from the 3' end of the 
?.2. When hybridised to blots with ES cell genomic DNA that had been 
digested with EcoR I, this probe gave rise to a 10.5 kb and a 9.3 kb bands 
representing the wild-type and mutant allele, respectively. 
Genomic DNA isolated from 58 individual G418 resistant ES clones 
was assayed for homologous recombination events by Southern 
hybridisation. As shown in Figure 3.6 and summarised in Table 3.1, 
following hybridisation with the 5' probe, 22 G418 resistant clones 
displayed the 12.5 kb fragment for the wildtype allele plus the novel 6.2 
kb EcoR I fragment for the disrupted allele. Concatemerization or 
recirculanzation of linearized replacement vectors can result in insertion 
type integration of vector DNA into the target locus and the duplication 
of endogenous sequences (Hasty et al.,1991b). Such events would not be 
distinguished from homologous replacement event if only one external 
probe is employed for characterization. It is therefore necessary to verify 
that the predicted replacement event has occurred by using a 3' external 
probe. When filters were rehybridized with the 3' flanking probe, only 
11 clones demonstrated the expected 9.3 kb fragment for the targeted 
allele and 12.5 kb fragment for the wildtype. One clone gave an 
anomalous band with this probe (not shown). Interestingly, all of these 
11 ES clones also had undergone homologous recombination at the 5' 
region. Therefore the frequency of the canonical homologous 
replacement event at lfr locus is 19% (Figure 3.6 and Table 3.1). 
The targeting vector could integrate into ES cell genome as multiple 
copies, as a result of random integration. If there is a restriction site 
flanking the inserted neo in the targeted locus, Southern hybridisation 
with a neo probe would reveal the presence of multiple integration of 
the targeting vector, since random integrated neo is unlikely to give a 
hybridisation fragment the same size as that of homologous 
recombinants. Unfortunately, all restriction sites mapped to the lf-r gene 
are present within the targeting vector. Digestion with such enzymes 
would release neo internally, therefore neo is not the appropriate probe 
for this study. As an alternative, a 1.8 kb en-2 splice acceptor fragment 
was used as a internal probe to examine the vector integration, 7 out of 8 
clones which had undergone the correct replacement event gave rise to 
2:1 (endogenous:vector) ratio, indicating that these clones did not 
harbour additional non-homologous integrations of the en-2 splice 
acceptor (data not shown). 
3.7 Contribution of lif-r targeted ES to the mouse germline 
Seven independent targeted ES clones were injected into 3.5-day-
old C57BL/6 recipient blastocysts by J Nichols and J Ure. Injected 
blastocysts were transferred to pseudopregant foster mothers. Of 145 
blastocysts injected, 35 animals were born and 20 of these were chimeric 
as judged by the presence of agouti coat pigmentation. Chimeric animals 
were obtained from all five cell lines. 
Table 3.2 Summary of chimeric germline transmission 
lf-r +1- 	Pups 	Chimeras 	Germline 
ES clones born (male/female) 	chimeras 
1 7 6(4/2) 	 0 
16 0 - 	 - 
28 4 3(3/0) 	 0 
30 10 7(5/2) 5 
31 10 4(3/1) 	 2 
49 2 0 	 - 
58 2 1(1/0) 	 0 
Total 35 21(16/5) 7 
All of the blastocyst injections and transfers of injected blastocysts into mice were 
carried out by either J Ure or J. Nichols. 
Chimeric male mice were bred firstly against MF1 females to test 
for germline transmission. Five chimeras from clone 30 and two 
chimeras from clone 31 transmitted the coat colour to their offspring 
(Table 3.2). Southern analysis of tail DNA with 5' flanking probe 
revealed that, as expected, 50% of these pups inherited the disrupted 
copy of the lzf-r gene (not shown). The germline transmitting chimeras 
were then crossed to CBA and 129 female mice to derive heterozygous 
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Table 3.1. Frequency of Homologous Recombinants at the lfr Locus 
Homologous recombination events 	Replacement 
events 
5' region 	3' region 
31 + 5# 
Number 	 22/58 	11/58 	 11/58 
Frequency 
38% 	19% 	 19% 
Figure 3.6 Dection for lif-r targeted ES clones. 
Southern blot of eighteen ES clones being screened for a homologous 
integration event into lif-r locus. DNA in agarose plugs was digested 
with EcoR I, separated on 0.7% agarose gel, and hybridized 
consecutively with 5' and 3' external probes. Seven homologous 
recombinants were detected with the 5' probe, however, only 3 of them 
also gave rise to the 9.3 kb recombinant band with the 3' probe. The top 
bands in the lower gel are residual signals from prior hybridisation to 
the 5' probe. Autoradiographic exposure was overnight for the 5' probe 
and three days for the 3' probe at -70 °C. 
5' external probe 
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ltf-r mutant carriers on hybrid or pure inbred genetic backgrounds 
respectively. On all the genetic background tested (MF1 x 129, CBA x 129 
and pure 129), mice heterozygous for lf-r were indistinguishable from 
their wild-type littermates and displayed no discernible abnormalities. 
When backcrossed to wild type animals, both male and female 
heterozygotes produced normal litter size and transmitted the mutated 
allele to approximately 50% of their progeny (Table 3.3). 
Table 3.3 Results of lif-r heterozygotes breeding 
Mating 	 Litters 	Genotype of offspring 
male xfemale 	 +1+ 	+1- 
+1- x  +1+ 	 11 	 59 	68 
+1+ x +1- 10 50 47 
Results obtained from CBA and MF1 crosses. 
3.8 Discussion 
As mentioned previously, replacement vectors can be designed 
simply to insert a selectable marker into the coding region of a gene, or 
to replace part of a gene with the selection marker, i.e. delete part of a 
gene. In order to ensure a null mutation, it is desirable to delete the 
entire coding sequence or the major functional domain. The six X clones 
described here do not encode the whole open reading frame of LIF-R 
and therefore the precise size of the entire genomic locus was not 
known. Based on the available information, it is likely that lif-r gene, 
similar to genes of other cytokine receptors, is relatively large and 
contains multiple exons (Kuramochi et al.,1990; Penny and Forget 1991; 
Seto et al.,1992; Shibuya et al.,1990). 
However, characterization of the genomic clones in hand indicates 
they contain exons for almost the entire putative ligand binding domain. 
Considering that the deletion of the major part of this region would 
abolish the binding of ligand to both transmembrane and soluble form of 
LIF-R and ablate the entire ligand-dependent function of LIF-R, 
targeting at lzf-r locus was therefore carried out prior to the complete 
characterisation of the lf-r genomic structure. While this study was in 
progress, four other genomic ?. clones were isolated with a probe specific 
to the cytoplasmic domain. Analysis of these new clones as well as the 
clones described in this thesis has led to a full elucidation of the genetic 
structure of LIF-R ORF (Cozens et al., unpublished). 
Gene targeting at the lif-r locus was achieved at a high frequency. 
38% of ES clones which survived drug selection exhibited homologous 
recombination between the targeting vector and the lf-r gene as assessed 
by hybridisation of Southern blots with the 5' flanking probe. Successful 
gene targeting has also been achieved by others with this promoterless 
IRESgeo cassette (Mountford et al.,1994; Mountford and Smith 1995). 
Analysis of lf-r targeted clones with 3' flanking probe revealed that only 
50% were correctly integrated in the 3' region. The other half (except one 
clone) retained a wild type gene structure. These unexpected 
recombinant structures can arise from processes referred to as 5' 
insertion (Hasty et al.,1991b; Thomas et al.,1992). Figure 3.7 illustrates 
schematically the out come of 5' and 3' insertion. A graph outlines 5' 
insertion combines with sequence deletion is also shown. An example of 
such event will be given in Chapter 6. None of the ES clones analysed 
had undergone homologous recombination only at 3' region. Since the 
selectable marker in lif-r targeting vector does not have its own 
promoter, functional expression of I3geo in ES cells that have undergone 
5' insertion can occur. This is not likely the case for analogous 3' 
insertion event, which would not be expected to generate a selectable 
phenotype. (G4181 ). 
WO 
Figure 3.7 Schematic representation of insertion type of gene targeting 
events with replacement vectors. 
5' insertion. A head-to-tail dimerized targeting vector recombines with 
the 5' region of the endogenous locus, resulting in a duplication of the 5' 
homologous arm. The 3' region retains as wild type. 
5' recombination plus sequence deletion. Homologous recombination 
occurrs at the 5' region. The targeting vector inserts into the endogenous 
locus 5' to the 3' homologous region, resulting in a deletion of the 
endogenous locus and duplication of the 3' homologous arm. No 
duplication occurs in the 5' region. 
3' insertion. A head-to-tail dimerized targeting vector recombines with 
the 3' of the endogenous locus, resulting in a duplication the 3' 
homology. The 5' region retains as wild type. 
5' insertion 




Visualisation of Sites of LIF-R Transcription by 
Histochemical Staining for f-G alactosi dase 
4.1 Introduction 
Physiological functions of a gene are generally reflected in its 
spatial and temporal expression pattern. Therefore, knowledge of the 
expression of the gene of interest is important as a complement to 
functional studies. This can be achieved by detecting the presence of 
transcripts by Northern analysis, in situ hybridisation or RT-PCR; or 
the presence of gene product by functional assays or via antibodies. In 
transgenic and knock out models, however, an in situ visual marker, 
such as the Escherichia coli lacZ gene can be used (Beddington et al., 
1989b; Cui et al., 1994; Le Mouellic et al., 1992; Mountford et al., 1994). 
LacZ has been shown to be an accurate reporter faithfully mimicking 
the expression of endogenous genes (Skarnes et al., 1992). Moreover, 
widespread or ubiquitous expression of lac Z in transgenic mice does 
not appear to impair development (Allen et al., 1988; Friedrich and 
Soriano, 1991; Gossler et al., 1989; Skarnes et al., 1992). The basis of the 
technique relies on the enzymatic activity of the lacZ product, 3-
galactosidase, which catalyses the hydrolysis of various -galactosides. 
Following glutaraldehyde or paraformaldehyde fixation of tissues and 
incubation with the chromogenic substrate 5-bromo-4-chloro-indolyl- 
-D-ga1actoside (X-gal), lacZ expression can be easily detected as a blue 
precipitate at the single cell level in eukaryotic cells. The - 
galactosidase protein can accommodate large carboxyl terminal fusions 
without affecting its enzymatic activity (Casadaban et al., 1980). f3geo, a 
fusion gene of lacZ and neo, is one such example (Friedrich and 
Soriano, 1991). 
The 8geo gene has been introduced into the lif-r locus by 
homologous recombination as described in the previous Chapter. As 
/3geo lacks its own promoter, the expression of -galactosidase in lf-r 
recombinant ES cells and in lzf-r mutant mice will be initiated from the 
endogenous LIF-R promoter. Therefore, the -galactosidase staining 
pattern should, in principle, reflect the expression pattern of LIF-R 
mRNA. 
4.2 Expression of LacZ fusion transcripts in targeted ES cells 
To test the reporter gene function, four correctly targeted ES 
cells (clones. 1, 30,31 and 58) were stained with X-gal. All of the clones 
showed detectable -galactosidase activity, though staining intensity 
varied slightly among clones. This indicates that the integrated lacZ 
reporter is function in ES cells in vitro. In a mixed culture containing 
both stem cells and spontaneously differentiated cells, staining appears 
to be confined to phenotypically undifferentiated cells (Figure 4.1a). To 
further analyse the expression of LIF-R/lacZ during ES cell 
differentiation, ES cells of clones 30 and 31 were induced to 
differentiate either by exposure to chemicals 3-methoxybenzamide (3-
MBA) or retinoic acid. No detectable 3-galactosidase staining was seen 
in all MBA and the majority of retinoic acid-induced differentiated ES 
cells (Figure 4.1b and data not shown). However, a subpopulation of 
differentiated ES cells induced by retinoic acid were strongly labelled. 
These cells are medium in size, separate from each other and 
migratory. These morphological features resemble parietal endoderm 
cells seen in egg cylinder stage embryos and in blastocyst cultures 
(Nichols, personal communication). 
4.3 General survey of -galactosidase expression in developing 
embryos in vivo 
To establish a expression profile of LacZ/UF-R in vivo, embryos 
obtained from lf-r +1- backcrosses or intercrosses were examined for 
-galactosidase activity at E75 to E10.5, E12.5 and E14.5. For E7.5-E10.5 
embryos, lacZ staining were performed in whole-mount. E9.5 and 
E10.5 embryos were then embedded in paraffin followed by sectioning. 
E12.5 and E14.5 embryos was examined by X-gal staining of serial 
cryosections. Cryosectioned spinal column and liver of E15.5 and E16.5 
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Figure 4.1 lac Z reporter gene expression in lif-r targeted ES cells 
Cultures of lzf-r +1- ES clone 31 were stained for -galactosidase and 
cells photographed under phase-contrast optics. Objective magnification 
x20. 
ES cells were allowed to overgrown and differentiate spontaneously 
in the presence of LIF. -galactosidase staining is confined to 
morphologically undifferentiated stem cells but is not present in their 
spontaneously differentiated progeny. 
ES cells were induced to differentiate by retinoid acid. A 
subpopulation of cells, morphologically resembling parietal endoderm, 
are strongly labelled. 
The expression of LIF-R mRNA in early embryos has previously 
been studied by in situ hybridisation (Nichols et al., 1996). Consistent 
with those data, 13-galactosidase activity was not detected in late 
primitive streak stage (E7.5) embryos (not shown). By the end of 
gastrulation at E8.5 embryos, strong 13-galactosidase activity was 
detected in the heart, amnion and the visceral yolk sac (data not 
shown). The expression of 3-galactosidase at these sites persisted at 
E9.5 and E10.5. In addition, 3-galactosidase activity was also detected 
in the gut, branchial arches, dorsal aorta and notochord (Figure 4.2 and 
data not shown). 
The membrane bound form of human LIF-R was initially 
isolated from a placenta cDNA library (Gearing et al., 1992). The 
presence of lif-r transcripts in placenta has also been shown by 
Northern analysis (Owczarek et al., 1996; Chambers, unpublished). In 
agreement with those data, X-gal staining of whole E9.5 placentae 
showed prominent 3-galactosidase activity (data not shown). 
At E12.5 and E14.5, intense 3-galactosidase activity were still 
observed in the heart and aorta (Figure 4.3a and data not shown). The 
expression in gut was less prominent. In addition, J3-galactosidase 
activity could be seen in notochord, developing cartilage, skeleton and 
smooth muscles (Figure 4.6a and data not shown). No detectable 3-
galactosidase staining was seen in thyroid, thymus, lungs and spleen. 
LIF-R mRNA has been detected in fetal liver by Northern 
hybridisation (Owczarek et al., 1996). f3-galactosidase activity could be 
detected in cryostat sectioned lif-r heterozygous liver between E14.5 to 
E16.5. However, the staining was restricted to a small population of 
cells (Figure 4.3b). The identity of these cells, without further 
investigation, is currently uncertain. 
LIF is able to promote the growth of mouse primordial germ 
cells (PGC) in culture (De Felici et al., 1991; Matsui et al., 1991; Resnick 
et al., 1992). LIF-R has been shown to be present on the surface of PGCs 
(Cheng et al., 1994). PGCs originate in the epiblast of the gastrulating 
embryo that migrate along the hind gut and then move into the genital 
ridges (future gonads) by E11.5 (for review see McLaren, 1994). 
However, X-gal staining of genital ridges isolated from E12.5 lif-r 
heterozygote intercross embryos failed to detect 3-galactosidase 
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Figure 4.2 -ga1actosidase activity in E9.5 Iif-r +1- embryos. 
Whole-mount X-gal staining of an E9.5 embryo is shown. 
-galactosidase activity is apparent in the branchial arches, 
heart, gut tube and blood vessels. 
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Figure 4.3. 3-galactosidase expression in heart and liver. 
Whole E14.5 embryos were embedded in OCT compound, sectioned in 
a cryostat at 12 rim, mounted onto TESPA-coated microscope slides, 
stained with X-gal overnight and counter-stained with neutral red. 
Transverse section through the heart, showing X-gal stained 
cardiomyocytes. 
Section through the liver, a minority of cells stain. 
Objective magnification lOx. 
a 
activity in the gonads, though the adjacent mesonephros stained (data 
not shown). 
4.4 Neuronal expression of n-gal during development 
Both LIF and CNTF promote the survival of facial and spinal 
motor neurons (Oppenheim et al., 1992; Sendtner et al., 1990). The 
effects of these cytokines on low density motor neuron cultures 
suggest that they act directly on these cells. To determine whether 
motor neurons express lacZ reporter and to identify other neurons that 
potentially respond to LIF-R signalling, brains, particular brain stem 
nuclei and lumbar spinal column were examined for -galactosidase 
expression at various developmental stages. In newborn brain stem, 
staining was prominent in facial, trigeminal, hypoglossal and 
ambiguus nuclei (Figure 4.4 and data not shown). -galactosidase 
activity was localised predominant in neuronal cells in these structures 
(Figure 4.4 c). The majority, if not all, neurons in facial and ambiguus 
nucleus are labelled. Other regions of the brain, including 
hippocampal neurons and the olfactory epithelium, were also - 
galactosidase positive (not shown). Non-neuronal expression of - 
galactosidase was observed in cells of the subependymal zone, 
ependyme, and glia limitans (Figure 4.3 a, b). In adult brains, 3-
galactosidase was expressed in similar neuronal populations. 
Ependymal cells, however, appeared negative in adults (not shown). In 
newborn and early postnatal spinal cord, expression of -galactosidase 
was detected in motor neurons in the ventral horn (Figure 4.5). In 
addition, -ga!actosidase staining was also visible in the glia limitans. 
All early postnatal dorsal root ganglion (DRG) neurons showed strong 
-galactosidase staining (Figure 4.5 a). No difference in f-galactosidase 
expression pattern was noticed between lf-r heterozygous and lf-r 
homozygous animals (Chapter 5). 
LIF has previously been shown to support the survival of DRG 
sensory neurons and to stimulate the generation of these neurons from 
their precursors (Murphy et al., 1993; Murphy et al., 1991). Therefore, 
the expression of lacZ reporter in DRGs was analysed in developing lf-
r mutant embryos. Week f-ga1actosidase activity could be detected at 
E10.5. The staining appeared to be localised to a proportion of 
developing DRG neurons, which intensified and more neurons became 
-galactosidase positive at late embryonic stages (Figure 4.6 b and data 
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Figure 4.4. Expression of 3-galactosidase reporter in the neonatal brain 
stem. 
Neonatal brain was embedded in OCT compound, sectioned in a 
cryostat at 12 gm, mounted onto TESPA-coated microscope slides, 
stained with X-gal overnight and counter-stained with neutral red. 
Coronal sections are shown dorsal to the top and ventral to the bottom. 
a), nucleus ambiguus; b), facial nucleus; Arrow heads indicate the brain 
stem nuclei. X-gal staining is also seen in cells of the subependymal zone 
and glia limitans in both a and b; 
c), high power of the nucleus ambiguus of a lf-r -I-  newborn mouse (not 
the same section as a), showing prominent X-gal staining in neurons. 





Figure 4.5. Expression of 0-galactosidase in P8 spinal column 
Shown is a transverse section through a lif-r +1- spinal column. 
Strong X-gal staining is seen in dorsal root ganglia neurons (DRG). 
Arrowhead indicates motor neurons. 
High power of the above section showing X-gal stained motor 
neurons. 





- - 	•&.'••• 	 ' 	F. 
'i,'.'.'tZ - 
. 
.- 	 • 	: 	,a. 
ft .... . 
-r 	- 
• r 






Figure 4.6. -galactosidase expression in E14.5 spinal column. 
Transverse section through lumbar region of the spinal cord. — 
galactosidase staining can be seen in the notochord and in the ventral 
lateral region of the spinal cord, as indicated by arrowhead. n, 
notochord. 
Section through a dorsal root ganglion, -ga1actosidase expression 
appeared heterogeneous and relatively weak compared with that of 
P8. 
Cryostat section 12 tim; Objective magnification lOx. 
not shown). After birth, all DRG neurons expressed lacZ. This 
expression pattern is consistent with the finding that the number of OF 
responsive DRG neurons increase during development (Murphy et al., 
1993). 
During development, the specification of neuroepithelial cells of 
the neural tube is regulated, at least in part, by epigenetic signals 
(Yamada et al., 1991). For instance, motor neuron differentiation in the 
spinal cord is influenced by signals derived from the notochord 
and/or floor plate. By grafting an extra notochord or floor plate in the 
dorsal aspects of the developing chick spinal cord, motor neurons can 
be induced to develop in such area. LIF has been found to promote the 
differentiation of spinal cord neuron precursors in vitro (Richards et 
al., 1992), suggesting that LIF may be a candidate for regulating 
neuronal precursor differentiation. To address this issue, expression of 
lacZ in E9.5 to E16.5 spinal cord was examined. However, no 
detectable 13-galactosidase activity was observed until embryos reach 
E14.5; at this stage, staining was localised in the ventrolateral site of the 
spinal cord where motor neurons are generated (Figure 4.6 a). 
4.5 Discussion 
The present study demonstrated that lacZ was continuously 
expressed in the developing heart of lzf-r mutant animals. - 
galactosidase activity was detected in the primitive heart tube at E8.5, 
suggesting a role for LIF-R in cardiac development. This is supported 
by a very recent study showing that both LIF and CT-1 promote 
cardiac myocyte survival and proliferation in vitro (Sheng et al., 1996). 
Expression analysis in the nervous system has established that 
LacZ is expressed in motor neurons in the facial nucleus and spinal 
cord. In addition, 3-galactosidase activity was also detected in DRG 
neurons throughout development. These data are consistent with the 
functions of LIF and/or CNTF on these neurons (Cheema et al, 1994; 
Oppenheim et al., 1992; Sendtner et al., 1990; Murphy et al., 1991; 
Murphy et al., 1993). 
While this work was in progress, in situ binding of 1251-labelled 
LIF in the nervous system of late gestation rat embryos and neonates 
has been described (Qiu et al., 1994). In agreement with the present 
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result, specific binding was seen in several motor neuron populations 
and in almost all sensory and autonomic ganglia in PNS. 
While the expression of lacZ reporter in lzf-r mutant animals 
appeared to mimic the expression of lf-r gene in the nervous system, 
placenta and fetal liver. -galactosidase activity was never apparent in 
primordial germ cells in the developing gonads, where both LIF-R 
mRNA and protein have been detected (Cheng et al., 1994). 
In lif-r mutant embryos, the expression of J-galactosidase 
protein rely directly on the function of IRES element. The activity of 
IRES could be influenced by its surrounding sequence in the 
mammalian genome or by specific cell or tissue types. Such effects 
have not been reported. However, analysis of series of random 
IRESI3geo gene trap lines showed ubiquitous expression of - 
galactosidase in embryos and adults (Mountford et al., 1994). 
The transcription level of lf-r gene is low (Owczarek et al., 1996; 
Chamber, unpublished). To reveal all lif-r transcripts by Northern 
hybridisation, poly(A)+ RNA seems necessary and an exposure to a 
phosphor screen (2 or 3 days) is generally needed. The small number of 
transcripts by l!f-r gene has limited its detection by in situ hybridisation 
in mouse embryos (Nichols et al., 1996). Since IRES mediated 
translation is strictly dependent on the activity of LIF-R promoter, this 
would be reflected by a low level of Ogeo enzyme activity. Therefore 
the lack of -galactosidase in PGCs is most likely due to a low 
transcriptional activity of LIF-R promoter. 
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Chapter 5 
Phenotypic Analysis of LIF -R 
Deficient Mice 
5.1 Inactivation of lif-r results in neonatal death 
As mentioned in Chapter 3, on three genetic backgrounds 
tested(pure 129, 129 x MF1, 129 x CBA), mice heterozygous for lf-r 
mutation had no apparent abnormalities and were fertile. 
Intercrosses were therefore set up between heterozygotes to study 
the phenotypic consequences of complete elimination of LIF-R. 
Since the number of 129 heterozygous animals was limited due to 
the poor breeding ability of this strain, the phenotypic analysis was 
done in either 129 x MR or 129 x CBA backgrounds. Progeny were 
genotyped by Southern hybridization firstly at 3 weeks after birth 
(data summarised in table 5.1). Of 97 pups, 60 (62%) were 
heterozygotes, 37 (38%) were wild type, no homozygotes were 
found. To examine whether homozygous animals were born, 185 
heterozygote intercross neonates were further genotyped. 27 (15%) 
of these pups were homozygotes, 104 (56%) were heterozygotes and 
54 (29%) were wild type. These data indicated that lf-r homozygous 
(lf-r -I -) animals can develop to term, but the presence of lf-r -I-
mice was low in progeny of Fl and Ni lzf-r heterozygote 
intercrosses. 
lzf-r -I-  neonates did not show obvious morphological 
abnormalities. However, the majority of these mice were smaller, 
with mean weights. of 80% that of their heterozygous and wildtype 
littermates (Table 5.2). Newborn lf-r -I-  animals lacked vigour and 
after 6-12 hours they had no milk in their stomach. Although they 
were observed to breathe, in some cases the breathing rates were 
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Table 5.1 Inactivation of LIF-R Results in Neonatal Death 
Age 	 Number of 	Number of 	LIF-R genotype 	Frequency of 
litters pups 
(genetic 	 +/+ 1  	+1- -I- 	homozygotes 
background)* 
2-3 weeks 	12 (Fl) 	 97 	37 	60 	0 	 0% 
Newborn 	10 (Fl) 	 94 	32 	53 	9 	9.5% 
7(N1) 	 65 	 16 	37 	12 	18% 
2(N2) 	 26 	 6 	14 	6 	23% 
19 (total) 	 185 	54 	104 	27 	15% 
* Data from both 129 x M91 and 129 x CBA genetic background were included. 
Fl, progeny of chimeras; Ni, progeny of Fl 1f-r +1- backcross; N2, progeny of N11fr +1- backcross (Lyon and Searle, 1991); 
X2 test of the observed numbers of lf-r +1+, +1- and -I- fetuses against the expected numbers according to Mendelian law: 
observed in Fl generation against expected, X2 = 12.79; Pc(0.01. 
observed in Ni and N2 generations against expected, x2 = 1.66; P<0.5 (not significant). 
reduced and irregular. In all cases to date, homozygotes died within 
the first neonatal day, the majority in the first 12 hrs after birth. The 
same result was obtained from two independently derived ES 
targeted clones, regardless of being crossed with CBA or MR mice, 
demonstrating that the phenotype observed in homozygous mice 
was a result of the lf-r gene deletion. 
Table 5.2 Body weight of lzfr wild-type, heterozygous 
and homozygous neonates 
Genotype 	 Body weight(gram) 
Mean ± SD 
lf-r +1+ 	 1.67 ± 0.20 (n=8) 
lf-r +1- 1.67±0.19 (n=18) 
lf-r -I- 	 1.33 ± 0.22 (n=7) 
Results were obtained from three lif-r +I intercross 
litters (two litters of N2 CBA and one litter of N3 MF1). 
Values are different between lif-r +1+ and lif-r -I-. 
Student t-test: P<0.02 
5.2 Characterisation of lif-r mutated allele 
To confirm that homologous recombination within the lfr 
locus had resulted in a true deletion, the structure of mutated allele 
in homozygous animals was further analysed. A cDNA fragment 
encompassing exon 5 to exon 11, which contains both deleted and 
non-deleted sequences in the targeting construct was hybridised to 
EcoR I digested tail DNA. As expected, three bands with the size of 
10.5 Kb, 7.5 Kb and 2.4 Kb were detected in wild type and 
heterozygous animals. These signals were not present in 
homozygotes. A predicted new 9.3 Kb band due to the homologous 
recombination was revealed in both heterozygotes and 
homozygotes (Figure 5.1). 
5.3 Histopathological analysis of lif-r mutants 
To reveal any abnormalities in hf-r -I- animals which may 
cause their neonatal death, serial paraffin sections through whole 
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Figure 5.1 Hybridisation analysis of tail DNA from wild-type, 
heterozygous and homozygous lif-r mutant mice 
DNA samples were digested with EcoR I and sequentially hybridised 
with a 5' genomic probe external to the targeting construct (left) and a 
cDNA fragment(right). The genomic probe was an 800bp RcoR I/BamH 
I fragment shown in Figure3.5. The cDNA probe was a 980 bp fragment 
which contains sequence from the deleted exons 5 through 10 plus 
sequence from exon 11. The 9.3 kb band present in heterozygotes and 
homozygotes corresponds to the recombinant junction fragment which 
includes exon 11. 









newborn animals were prepared and examined under light 
microscope by Professor M. Kaufman at the Department of 
Anatomy, University of Edinburgh. No obvious malformation in lf-
r -I- animals were observed in various organs including brain, 
spinal cord, heart, lung, spleen, liver and kidney (data not shown). 
It has been reported that LIF can induce bone resorption in 
vitro (Reid et al., 1990). Moreover, elevated circulating LIF 
concentrations resulted in an increase in bone deposition in vivo 
(Metcalf et al., 1990). To examine whether the absence of LIF-R 
would affect bone formation, newborn mice were stained with 
Alizarin red S and Alcian blue to detect mineralized bone and 
cartilage, respectively. Specimens were examined by Professor M 
Kaufman. The pattern of ossification of all skeletal components 
appeared normal and no congenital malformations were found 
(Figure 5.2). 
5.4 Normal hematopoietic potential of lif-r -I- cells 
Most mature blood cells have a limited life span and 
therefore must be continuously produced by the proliferation and 
differentiation of pluripotent stem cells. In adult mice, 
hematopoietic stem cells (HSC) reside in the bone marrow. In 
developing embryos, however, hematopoiesis originates firstly in 
the yolk sac, and subsequently in the fetus in the aorta-genital ridge-
mesonephros (AGM) region, and fetal liver (Abramson et al., 1977; 
Medvinsky et al., 1993; Muller, 1994; Prummer and Fliedner, 1986; 
Till and McCulloch, 1980). When injected into lethally irradiated 
mice, cells of these origins are capable of repopulating the 
hematopoietic system and supporting the long term survival of 
recipient mice. 
LIF has been shown to affect the proliferation and 
differentiation of hematopoietic cells. To test whether the stem cell 
compartment of hematopoiesis was affected in ltf-r mutants, long-
term repopulating hematopoietic stem cell (LTR-HSC) assays were 
performed. The experiments described in this section were carried 
out with the assistance of K Samuel in Dr. J Ansell's laboratory at the 
Institute of Cell, Animal and Population Biology, University of 
Edinburgh. E16.5 fetal liver cells of 33 embryos from five lzf-r +1- 
Figure 5.2 Alizarin red and alcian blue stained skeletons of 
newborn mice. 
With this method, mineralised bones are stained by Alizarin red, 
whereas cartilage are stained by alcian blue. 
Left, lif-r -I-; right, lif-r +1+ . Note the smaller size of the 
homozygous mutant mouse. 
intercross litters were intravenously injected into lethally irradiated 
adult recipient mice (cells from one liver were injected into each 
recipient). Genotyping of DNA from individual donor embryos by 
Southern blotting revealed that 7 of them were lf-r -I-. 
All mice (seven of them) that were injected with lf-r -I- fetal 
liver cells were long lived, whereas negative control mice died 
within 2 weeks after injection. To confirm that these mice were 
reconstituted by lif-r -I- cells. The GPI isoforms produced by the 
recipient peripheral blood (PBL) were compared with that of donor 
embryos (data not shown). Some of the recipient mice were also 
examined by Southern hybridisation of DNA from recipient white 
blood cells with the 5' lf-r flanking probe. As shown in Figure 5.3, 
no wildtype hybridisation band could be detected in mice injected 
with lf-r -I- liver cells. This result indicates that the white blood cell 
components of these recipient mice are differentiated progeny of lf-r 
-I- stem cells. 
56 days after reconstitution and every 2 weeks thereafter until 
day 108, mononuclear cells from PBL of the recipient mice were 
examined for the expression of a number of lymphoid and myeloid 
cell surface markers including CD4, CD8, anti-granulocytes and 
B220. CD4 and CD8 are T lymphocyte antigens, which are expressed 
by helper T cells and cytotoxic T cells respectively. B220 is expressed 
on immature pre-B and mature B cells (Coffman and Weissman, 
1983). As shown in Figure 5.4, the number of lymphoid and myeloid 
cells in PBL of mice injected with lif-r -I-  fetal liver cells was 
comparable to that in the control mice injected with wild type and 
lf-r +1- fetal liver cells. Moreover, no significant difference in 
hematocrits was observed (data not shown). 
To test whether the bone marrow of lzf-r -I- fetal liver cell 
recipients contain long term repopulating hematopoietic stem cells, 
a second round of bone marrow transplantation has been carried out 
four months after the fetal liver cell injection. The secondary 
recipient mice, which received bone marrow cells from mice 
originally transplanted with lf-r -I- liver cells, were also long lived. 
The presence of cells from different haematopoietic lineages 
appeared balanced in their PBL (data not shown). 
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Figure 5.3 Confirmation of hemopoietic reconstitution by Southern 
analysis. 
DNA from peripheral blood of 11 recipients were digested with EcoR I 
and hybridized with a 5' probe external to the targeting construct. Note 
that no wild type band could be detected in recipient mice injected with 
lf-r -I-  liver cells. One sample failed to cut. 
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Figure 5.4 Mononuclear cell populations in recipient mice reconstituted with lif-r 
+1+ and lif-r -I- fetal liver cells. 
Peripheral blood from recipient mice reconstituted with lif-r +1+ or lif-r -I- fetal 
liver cells were collected and mononuclear cells prepared. Cells were incubated with 
CD4-FITC and CD8-PE or with B220-PE and anti-granolocytes-FITC, respectively. 
The numbers of antibody positive cells are indicated as percentage of mononuclear 
cell (MNCs) populations. Data shown was obtained 82 days after reconstitution. The 
number of recipient mice are: lif-r -I-, 7; lif-r +1+, 8. 
5.5 Homozygous lif-r mutants exhibit severe neuronal defects 
5.5.1 lift null mice are born with decreased numbers of brain stem 
and spinal motor neuorns 
Given the ability of LIF and CNTF to support embryonic 
motor neuron survival in vitro and in vivo and the expression of lacZ 
reporter gene in motor neurons, we examined the nervous system of 
lzf-r -I-mice in more detail. Such analysis is very specialised, 
therefore we initiated a collaboration with Dr. Michael Sendtner at 
the University of Wurzburg, a leading expert in the field. Following 
genotyping by Southern analysis, Fixed specimens were sent to Dr. 
Sendtner at Wurzburg, where brain stems and spinal cords were 
sectioned and the number of neurons counted. 
The first structure to be studied was the facial motor nucleus. 
The facial nucleus is a clear delineated structure in the brain stem 
which does not contain interneurons. The quantification of neurons 
in this structure is therefore more reliable than other cranial nuclei. 
Qualitative comparisons of lf-r -I- mice with lf-r +1+ and lf-r +1-
control animals showed that the wild-type and lzf-r +1- facial 
nucleus had a greater density than that of the lf-r -I- mutant mice 
(Figure 5.5). Some neurons in lzf-r -I- mutant have less Nissl 
substances. In addition, pyknotic nuclei were abundant in -I-
neonates, whereas apoptotic neurons were relatively rare in control 
facial nucleus. Subsequent counting of neuronal nucleoli in facial 
nuclei show that the number of motor neurons in lif-r -I- mutant 
animals were reduced by about 40% compared with heterozygous 
or wildtype animals (Table 5.3). To determine whether motor 
neuron loss is a general defect in lf-r -I- animals, examination was 
extended to spinal cord. As shown in table 5.3, the number of motor 
neurons in lumbar spinal cord is also significantly reduced in lf-r 
-/-mice. 
As described in Chapter 4, high expression of -galactosidase 
has been detected in the nucleus ambiguus. This led to the 
examination of this structure in more detail. Morphological changes 
similar to that observed in the facial nuclei were observed in Nissl 
stained sections (Figure. 5.3). Moreover, the loss of neurons in this 
nucleus in homozygous mutants was more pronounced than that in 
facial nucleus and spinal cord. lf-r -I- animals had less than half the 
Me 
number of neurons in this nucleus compared with wild type 
controls (Table 5.3). 
Table 5.3 Counts of Neurons in Facial/ambiguus nuclei and 
Lumbar Spinal Cord 
Lumbar 	 3213±230 13±230 ND 	1856±251 
(n=3) 	 (n=5) 
Facial nucleus 	3108±310 	3377±394 	1951±135 
(n=6) (n=5) (n=11) 
Nucleus ambiguus 	883±82 	705±34 	406±32 
(n=5) (n=3) (n=5) 
The neuronal counting was carried out by Dr. M Sendtner. Average 
diameters of the nucleoli were as follows. Facial motor neurons: +1+ mice, 
1.64 ± 0.43 gm; +1- mice, 2.32 ± 0.22 I.tm; -I- mice, 2.14 ± 0.16 gm; neurons of 
the nucleus ambiguus: +1+ mice, 2.36 ± 0.36 jim; -I- mice, 2.34 ± 0.41 gm 
(means ± s.d. for at least five determinations). The counts of facial and 
ambiguus neuronal nucleoli were corrected for double counting of split 
nucleoli. Spinal motor-neuron counts are uncorrected. N. D. not 
determined. Values shown are means ± s.e.m. of each group. Numbers of 
neurons are different between +1+ and -I- mice for each group (P<0.005, 
Student's t-test). 
5.5.2 Dorsal root Lranalion sensory neuron members are not severely 
affected in lift -I- mutants 
LIF has been shown to enhance the differentiation and to 
support the growth and survival of neurons from DRG in vitro 
(Murphy et al., 1993; Murphy et al., 1991). To examine whether the 
lack of LIF-R has any effects on the development of these neurons, 
Dr. Sendtner also analysed the newborn DRG at the lumbar region 
of the spinal column. The size of the ganglia was comparable with 
those of wild type and heterozygous controls. The number of 
neurons was slightly reduced in animals. However, this difference 
was not statistically significant (data not shown). 
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Fig 5.5 Neuronal morphology in the facial nucleus. 
Nissi stained section of neonatal facial nucleus (a to d) and nucleus 
ambiguus (e to h) are shown. 
(a, c, e, g ) wild-type and (b, d, f, h)lzf-r -I- homozygous mutant. 
Apoptotic neurons are evident in d and h. Scale bars: a, b, 100 J.tm; e,f, 50 
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number of neurons in this nucleus compared with wild type 
controls (Table 5.3). 
Table 5.3 Counts of Neurons in Facial/ambiguus nuclei and 
Lumbar Spinal Cord 
Lumbar 	 3213±230 ND 1856±251 
(n=3) (n=5) 
Facial nucleus 	3108±310 3377±394 1951±135 
(n=6) (n=5) (n=11) 
Nucleus ambiguus 	883±82 705±34 406±32 
(n=5) (n=3) (n=5) 
The neuronal counting was carried out by Dr. M Sendtner. Average 
diameters of the nucleoli were as follows. Facial motor neurons: +1+ mice, 
1.64 ± 0.43 rim; +1- mice, 2.32 ± 0.22 pm; -I- mice, 2.14 ± 0.16 pm; neurons of 
the nucleus ambiguus: +1+ mice, 2.36 ± 0.36 pm; -I- mice, 2.34 ± 0.41 pm 
(means ± s.d. for at least five determinations). The counts of facial and 
ambiguus neuronal nucleoli were corrected for double counting of split 
nucleoli. Spinal motor-neuron counts are uncorrected. N. D. not 
determined. Values shown are means ± s.e.m. of each group. Numbers of 
neurons are different between +1+ and -I- mice for each group (P<0.005, 
Student's t-test). 
5.5.2 Dorsal root eanelion sensory neuron members are not severely 
affected in lift -I- mutants 
LIF has been shown to enhance the differentiation and to 
support the growth and survival of neurons from DRG in vitro 
(Murphy et al., 1993; Murphy et al., 1991). To examine whether the 
lack of LIF-R has any effects on the development of these neurons, 
Dr. Sendtner also analysed the newborn DRG at the lumbar region 
of the spinal column. The size of the ganglia was comparable with 
those of wild type and heterozygous controls. The number of 
neurons was slightly reduced in animals. However, this difference 
was not statistically significant (data not shown). 
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5.5.3 Motor neuron generation was not affected by the lift mutation 
The neuronal cell loss observed in lf-r -I- animals might be 
due either to abnormal developmental differentiation of the 
neuronal precursors or inadequate survival of postmitotic neurons. 
To discriminate between these two possibilities, the facial nucleus of 
heterozygous intercross embryos were examined at E14.5-E15.5. By 
this time of the development, neurogenesis is complete whereas 
naturally occurring cell death has not yet started (Ashwell and 
Watson, 1983). As shown in Table 5.4, the number of motor neurons 
in lf-r -I-  embryos is comparable to those in wild type controls. 
Table 5.4 Neuronal counts of E14 &E15 facial nuclei 
ly'-r genotype 	 Number of facial 
motor neurons * 
wild-type 
	
6917 ± 372 (n=4) 
hf-r -/- 6998 ± 798 (n=4) 
* Numbers are given as Mean ± SEM. 
5.6 Discussion 
It is noteworthy that the number of lzf-r -I-  embryos 
surviving to term seems to be influenced by genetic backgrounds. 
Intercross of heterozygotes generated from subsequent backcrosses 
of lf-r +1- with either CBA or MF1 wild type animals (i.e.. Ni, N2 or 
N3 of lf-r heterozygotes ) gave rise to more live born lif-r -I-
animals compared with that of chimera generated heterozygotes (Fl 
heterozygotes). The occurrence of this apparent phenotypic rescue 
suggests that a modifier gene may be present in CBA and MF1 mice. 
It would be interesting to compare this phenotype with the 
phenotype on pure 129 genetic background. Unfortunately, this has 
been hindered by the extremely poor breeding and the 
cannibalization in this line. 
It is generally believed that hematopoietic stem cells (HSC) 
first give rise to more restricted precursor cells, which in turn 
generate unipotent progenitors. These lineage committed cells then 
mature into the various specialised blood cells (for reviews see 
Heimfeldd and Weissman, 1991; Dzierzak and Medvinsky, 1995). 
Because the frequency of HSC and other precursors is very low, 
numerous hematopoietic assays have been developed to measure 
the developmental potential of these cells (Abramson et al., 1977; 
Moor and Metcalf, 1970; Muller, 1994). Among them, long-term 
repopulation of irradiated animals in vivo is the most definitive way 
to analyze self-renewal and differentiation capacity of stem cells, as 
the successful long term engraftment of a recipient mouse requires 
the active proliferation and differentiation of HSC to yield enough 
progeny cells. By using this approach, the present data 
demonstrated that lf-r -I-  fetal liver contains functional 
hematopoietic stem cells that were capable of producing long-term, 
complete, multilineage hematopoietic reconstitution in lethally 
irradiated adult mouse recipients. In a more stringent test, bone 
marrow from reconstituted mice were transferred to a second set of 
irradiated animals. Again, the hematopoietic systems of these 
recipients were repopulated. These data establish that lif-r -/ - 
hematopoietic stem cells are competent in differentiation. 
A targeted mutation in the lf gene has been reported to result 
in a reduction in myeloid progenitor cells by CFU-S assays (Escary 
et al., 1993). Following irradiation of mice, injection of cells (from 
bone marrow or other hematopoietic tissues) results in 
hematopoietic activity in the spleen, in the form of myeloid and/or 
erythroid colonies. The number of colonies in the spleen is in direct 
proportion to the number of progenitor cells injected (Till and 
McCulloch, 1980). Therefore, CFU-S assay is often used to measure 
hematopoietic potential. One point that should be emphasized here 
is that CFU-S do not represent HSCs, but rather committed 
progenitor cells. Data presented in this chapter does not suggest a 
dramatic loss of HSC or their progeny. It is possible, however, that 
the transit time from stem cells to differentiated progeny are altered 
as a result of lif-r deficiency, such alteration could result in 
decreased CFU-S. 
Both LIF and CNTF are able to protect motor neuron survival 
in vitro and, when applied artificially, in vivo. For example, CNTF 
can prevent the degeneration of motor neurons in the facial nucleus 
after transaction of the facial nerve in newborn rats (Sendtner et al., 
1991) and can rescue chick spinal motor neurons from naturally 
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occurring cell death (Oppenheim et al., 1992). However, mice 
homozygous for a null mutation in the CNTF gene did not show 
any defects in embryonic or early postnatal survival of motor 
neurons (Masu et al., 1993). No defect in the nervous system of LIF 
mutant mice has been detected (Escary et al., 1993; Stewart et al., 
1992). In the present study, analysis of lf-r -I- mice revealed an over 
40% of motor neurons loss in the facial nucleus and lumbar spinal 
cord. Furthermore, the nucleus ambiguus contained less than half of 
the neurons present in (+1+) and (+1-) controls. These results 
demonstrate that signalling through LIF-R is a key regulator of 
motor neuron survival in embryonic development. 
In addition, no significant neuronal loss was observed in mice 
lacking both LIF and CNTF at birth (Sendtner, unpublished). 
Therefore, lf-r -I- phenotype points to the existence of a distinct 
member of LIF cytokine family that plays a key role in embryonic 
development of neurons. The survival effects of LIF and CNTF on 
embryonic motor neurons, while provided artificially in vivo, may 
simply reflected the function of this potential cytokine (Martinou et 
al., 1992; Oppenheim et al., 1992). Candidates for this cytokine 
include the mouse orthologue of OSM (Yoshimura, et al., 1996) and 
the recently isolated cytokine CT-1 (Pennica et al., 1995a). However, 
it is also possible that this is a novel cytokine. CNTFRcL is expressed 
in the developing nervous system (Ip et al., 1993). A recent study 
(DeChiara et al., 1995) on CNTFRcc-deficient mice indicated that the 
lesion results in similar motor neuron defects in facial nucleus and 
spinal cord as those found in LIF-R deficient mice. This result 
suggests that the unidentified cytokine acts like CNTF through 
binding to a ternary complex of CNTFRa/LIF-R/gpl3O. Since 
neither OSM or CT-1 has been shown to bind to CNTFRX (Gearing 
and Bruce, 1992; Pennica et al., 1995b), these two cytokines are 
therefore unlikely to be candidates. 
The fact that some motor neurons in lzf-r -I- animals still 
survive at birth raises the question as to whether these neurons 
represent a developmentally distinct population. -ga1actosidase 
reporter staining of heterozygous neonatal facial and ambiguus 
nucleus has shown rather homogeneous expression in most of 
neurons. In homozygous animals the surviving neurons clearly 
express -galactosidase (Figure 4.4). The significant increase of 
pyknotic and fragmented nuclei observed in lif-r -I- newborns 
suggest that neurons in these structures die perinatally, more 
neuronal loss might be detected if these animals could survive 
longer. However, it is also possible that certain neurons that 
normally express LIF-R may survive in the absence of this receptor 
through the operation of alternative pathways. This possibility is 
investigated in experiments described in Chapter 6. 
The neuronal loss observed in lif.r -I- animals could be due 
either to a defect in differentiation and/or proliferation of 
neuroblast or to increased cell death of post-mitotic neurons. 
Programmed cell death in the facial nucleus occurs from E16 until 
postnatal day 10 in mouse (Ashwell and Watson, 1983). Many more 
pyknotic nuclei were found in lif-r -I- mice than those in (+1+) and 
(+1-) controls, suggesting that the defects seen in the lf-r -I-  mice 
resulted largely from high levels of neuronal cell death. This has 
been confirmed by neuronal counting at a stage of development 
when programmed cell death has not yet begun. This showed that 
the number of motor neurons in the facial nucleus of lif-r -/-
embryos was comparable with those in wildtype controls. This 
finding indicates that a functional LIF-R is not required for the 
establishment of the motor neuron lineage but rather is essential for 
the survival of the differentiated neurons. 
The fibres of facial nerve innervate the muscles of whisker 
and ear. Therefore the loss of motor neurons in this structure can not 
account for the high mortality of lf-r -I-  mice at birth. The nucleus 
ambiguus, however, contains neurons which innervate the striated 
muscles of the oesophagus, larynx and pharynx. The significant loss 
of neurons in this nucleus is likely to result in an inability to suck or 
swallow. This may explain the observation that LIF-R-deficient 
neonates do not feed. In addition, a population of large neurons 
(ventral respiratory group, VRG) that generate respiratory rhythm is 
either in close vicinity to or intermingled with the ventrolateral 
region of the nucleus ambiguus in rodents (Paton et al., 1994). 
Therefore, lf-r -I- mice are likely to have disrupted respiratory 
rhythm due to inefficient innervation in the diaphragm. This may 
contribute to the early death of lf-r -I-  animals. 
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Chapter 6 
Derivation and Analysis of 
LIF-R Null ES Cells 
6.1 Introduction 
Chimeric analysis using homozygous deficient ES cells has been 
employed to investigate the role of specific genes in development (Chen 
and Behringer 1995; Jakobovits et al., 1993; Nakayama et al., 1993; 
Pevny et al., 1991; Robabus Maandag et al., 1994; Tarakhovsky et al., 
1995). An advantage of this approach is that it may permit the 
avoidance of a possible early lethality of the homozygous mutant 
because of the presence of blastocyst-derived wild-type cells, and 
therefore reveal specific defects that may not be apparent in 
homozygous mutants. For example, the loss-of-function mutation in Rb-
1 gene resulted in embryonic lethality, which prevents the study of this 
gene in postnatal development and tumorigenesis. Such developmental 
defects could be rescued in chimeric mice made with Rb-I -/- ES cells. 
Analysis of these chimeric animals showed ectopic mitosis and 
substantial cell degeneration in the developing retina. Moreover, nearly 
all chimeric mice died of pituitary gland tumours which were 
exclusively derived from the mutant cells (Robabus Maandag et al., 
1994). Chimeric approach can also reveal cell autonomous function of a 
gene (Chen and Behringer 1995; Pevny et al., 1991). Analysis of GATA-
1-deficient cells is such an example. When injected into blastocysts, 
GATA-1-deficient ES cells contributed to all non-hemopoietic tissues 
and white blood cells, but failed to give rise to red blood cells, 
demonstrating that the generation of erythroid lineage is dependent on 
the presence of functional GATA-1 (Pevny et al., 1991). 
We 
As described in Chapter 5, a substantial number of neurons in 
facial/ambiguus nuclei and motor neurons in spinal cord remain in lf-r 
-I- newborns. Would these neurons survive in adult mice or eventually 
die? Since lf.r -I- mice die shortly after birth, this question could not be 
answered. It should be possible to follow the fate of these neurons, 
however, in chimeric mice produced with LIF-R deficient ES cells. 
It has been demonstrated that ES cells can be maintained in 
medium supplemented with IL-6 and sIL-6R (Yoshida et al., 1994). sIL-
6R has to be supplied because ES cells do not express IL-6R. Moreover, 
germline competent ES cell lines can be derived efficiently from 
blastocysts using the combination of IL-6 and sIL-6R (Nichols et al., 
1994). The combination of IL-6/sIL-6R acts by inducing gp130 
homodimerization instead of LIF-R/gp130 heterodimerization. This 
indicated that gp130 is a sufficient signal transducing component for ES 
cell self-renewal, and that the requirement for LIF-R can be by-passed. 
Therefore, LIF-R negative ES cells might be expected to be sustained in 
IL-6 plus sIL-6R. 
6.2 Homologous recombination at the second allele of lif-r gene 
The remaining wild-type allele of the lzf-r gene in ES cells 
heterozygous for the mutation was disrupted by a second round of 
gene targeting. The design of the targeting vector was identical to 
that used in the first round gene targeting except that the IRESgeo 
was replaced by a IRES-hyg cassette (hyg, hygromycin resistance 
gene; Figure 6.1). Insertion of IRES-hyg cassette also brought in two 
novel EcoR I sites localised at both ends of the cassette (the same 
position as those in pK04neo). Therefore, the diagnostic bands 
derived from homologous recombination between the pK04hyg and 
the wild type allele are expected to be the same size as those of 
pKO4neo targeting, when screened with either 5' or 3' external probe. 
Individual colonies resistant to both G418 and hygromycin were 
screened firstly with the 5' probe. Of 22 clones screened, 5 clones (hyg 
12, 34, 36, 37, and 49) yielded only the recombinant 6.2 kb band. 
When these clones were further characterised by hybridisation with 
the 3' flanking probe, only hyg 34 was found to have undergone 
homologous recombination at this region. The other four clones still 
gave rise to a wild type band with this probe (Figure 6.2). 
67 
1 k 	- - - 20 kb 	 - Do- 
Bam 	Sal 	 Sma 	Sac 
i•ii II 	I I 	II 	11 111 




Barn 	Sal Ri 	Ri Sa Sma 	Sac 
I I I :IRESHy II I I 
...® 	I I 	1RESMyj  
I 2 3 I 111-13 
Ri 	 RI 	RI 	 Ri 
6.2 kb 	 9.3 kb 
 No- 
Figure 6.1 Targeting of the second lif-r allele. 
Top, lfr locus, as shown previously in Figure 3.3 and Figure 3.4. 
Middle, IRES-hyg targeting vector. A 3.6 kb Sal I fragment containing 
an en-2-splice acceptor, IRES, hygromycin resistance gene and SV40 
polyadenylation sequence was inserted into the Sal I site of plasmid 
pK03 described in Chapter 3. 
Bottom, targeted lf-r locus. The position of probes and the expected 
lengths of restriction fragments diagnostic for homologous 
recombination are the same as WES-geo targeting. 5', 5' external 
probe; 3'. 3' external probe. 
Fig 6.2 Screening for lif-r -I- ES clones by Southern hybridisation 
Upper, Detection of 4f-r targeted ES cell clones by 5' flanking probe. DNA 
from 22 G418 and hygromycin resistant clones was digested with EcoR I, 
separated on a 0.7% agarose gel and transferred to Nylon membrane 
(Boehringer). Blots were hybridized to a 800 bp 5' external fragment (see 
Fig 3.5). The size of hybridisation restriction fragment are indicated on 
the left. ES clones containing only a 6.2 kb restriction fragment have 
undergone homologous recombination at the 5' region. ES clones 
containing a 12.5 kb restriction fragment in addition to the 6.2 kb are lf-r 
+1- parental cells carring a random integrated hygromycin resistant 
construct. 
Lower, Five ES clones that have undergone homologous recombination at 
5' region were further analyzed by Southern hybridisation with 3' 
external probe, only 1 of which (hyg34) gave rise to only the 9.3 kb 
recombinant restriction fragment. 
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To confirm that the targeting has resulted in a true deletion in 
clone hyg 34, EcoR I digested genomic DNA was hybridised with a 
cDNA probe containing exon 6 to exon 8, which were deleted in the 
targeting construct. As shown in Figure 6.3, two hybridisation 
fragments with the expected size of 7.5 kb and 2.4 kb were observed 
in wild type ES cells (E14TG2a) and a lzf-r heterozygous line carrying 
a randomly integrated hygromycin resistance gene (hyg 18). However, 
these two bands were absent in clone hyg 34, indicating that a 
predicted replacement event has occurred. 
As will be described in the next section, ES cells of hyg 12 have 
lost responsiveness to LIF and to other LIF-R ligands, suggesting that 
functional LIF-R is not expressed by these cells. To investigate the 
consequences of gene targeting in this clone, Southern hybridisation 
with the same cDNA probe was also performed on hyg 12. As shown 
in Figure 6.3, both the 7.5 kb and the 2.4 kb wild type bands were 
absent, indicating the loss of two EcoR I sites encompassing exons 5 
to 7. A novel 5.5 kb fragment hybridised to this cDNA probe. This 
hybridisation pattern suggests that the 3' arm of the vector integrated 
illegitimately into a region 5 to exon 8, resulting in a deletion from 
exon 4 to exon 7 (Figure 6.4). 
6.3 Response of lif-r null ES cells to cytokines 
1f-r -I- cells exhibit characteristic ES cell morphology in culture 
in the presence of IL-6 and sIL-6R. In addition to LIF, IL-6 and sIL-6R, 
cytokines CNTF, OSM and CT-1 have also been demonstrated to be 
able to inhibit ES cells differentiation in vitro (Conover et al., 1993; 
Pennica et al., 1995b; Rose et al., 1994; Yoshida et al, 1994; Wolf et al., 
1994); this function is probably mediated via heterodimerization of 
LIF-R and gp130 (Baumann et al., 1993; Gearing et al., 1992; Pennica 
et al., 1995a; Stahl et al., 1993a). If LIF-R/gp13O is the only signalling 
pathway triggered by these cytokines, ES cells carrying targeted 
deletion of 1f-r gene would not be expected to be maintained in these 
cytokines. However, it has been suggested that a different type of 
heterodimer composed of the OSM specific receptor and gp130, not 
involving LIF-R, also exists (Thoma et al, 1994). This may also true 
for CT-1. To determine the involvement of LIF-R in the 
responsiveness of ES cells to cytokines LIF, CNTF, OSM and CT-I, 
and to explore whether ES cells express OSM receptor or potential 
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Figure 6.3 Southern hybridisation of targeted ES cell DNA with a 
deleted LIF-R cDNA probe. 
Genomic DNA from control ES cells (E14TG2a), a lif.-r +1- ES cell line 
hyg18, hyg34 and hyg12 were hybridized to a 600 bp BamH I-Nsi I 
fragment of LIF-R cDNA, which contains sequence from the deleted 
exons 6 to 8. The size of hybridizing band are indicated on the left. 
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Figure 6.4 Insertion type of gene targeting event in done hyg 12. 
A possible structure of lif-r locus in cell line hyg 12, resulting from 
homologous recombination at the 5' region and a deletion of exon 4-7. 
CT-1 receptor, ES cells of clones hyg 34, hyg 12, hyg 18 as well as 
wild type ES cells were cultured at clonal density in the presence of 
various cytokines. 
As shown in figure 6.5, the total number of hyg 34 ES colonies in 
cultures supplement with LIF, CNTF, OSM or CT-1 is comparable 
with those in IL-6 plus sIL-6R, however these colonies, like those 
grown in medium alone, were morphologically differentiated and 
failed to express stem cell marker alkaline phosphatase (Figure 6.5). 
In contrast, wild-type ES cells or lzf-r +1- mutant ES cells (hyg 18) 
grew as stem cell colonies in all cytokines tested. ES cells of clone hyg 
12 (other 5' targeted clones were not tested) behaved in the same 
manner as hyg 34 cells in such colony assays, indicating that LIF-R in 
these cells is also functionally inactivated. 
Embryonic stem cell renewal factor (ESRF) is a novel factor 
identified in our laboratory which has the ability to maintain ES cells 
to certain extent in culture (Dani and Smith, unpublished). ESRF 
appears to signal independently of the gp130 pathway since its 
activity is not blocked by anti-gp130 antibody. To test whether ESRF 
signals through LIF-R, hyg 34 ES cells were cultured in conditioned 
medium containing ESRF. In contrast to cultures supplemented with 
LIF, OSM, CNTF and CT-1, LIF-R-negative ES cells formed stem cell 
colonies in ESRF; the number of alkaline phosphatase positive 
colonies is comparable to that of wild type and heterozygous cells. 
This result demonstrates that LIF-R is not required for the functional 
activity of ESRF. 
6.4 Characterisation of chimeric mice derived from LIF-R null ES 
cells 
To investigate the developmental capacity of cells deficient for 
LIF-R in competition with wild type cells, ES cells from clone hyg 34 
were micro injected by J Ure and chimeric mice were generated. The 
contribution of lf-r -I- ES cell progenies in various tissue types was 
assessed by GPI analysis. The ES cells used in this study were 
derived from 129 mice which bear the a/a form of the GPI gene, 
whereas the recipient C57BL/6 blastocysts bear the b/b form of GPI 
gene. The gene products, two enzyme isoforms, can be separated by 
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Figure 6.5 Response of Iif-r -I- ES cells to cytokines 
1000 ES cells with genotype of !zf-r +1+, +1- and -I- were grown in the 
presence of various cytokines as described in Materials and methods. 
Cells were cultured for five days followed by staining for alkaline 
phosphatase. The number of total colonies was determined subsequently 
by counter-staining with Leishman's stain. 
tissues can be measured by the relative band intensity of the two 
isoforms. The results of such analysis from six chimeras are 
summarised in Figure 6.6. a/a form of GPI was detected in a diverse 
array of organs, including heart, thymus, spleen, liver, kidney and 
brain. These findings indicated that LIF-R null stem cells are able to 
integrate into recipient embryos and subsequently to contribute to a 
variety of tissues and are therefore not generally defective in 
differentiation. 
The expression of Lac Z reporter in brain stem and spinal motor 
neurons allowed discrimination between ES-derived cells from the 
blastocyst-derived cells by staining for 3-galactosidase activity. 
Chimeras with over 20% coat colour chimerism were analysed at age 
between PlO to P13. As shown in Figure 6.7, -galactosidase positive 
motor neurons were detectable in the facial nucleus of a 12 day old 
chimera. So far, six chimeras have been examined and ES cell-derived 
motor neurons could be detected in the facial nucleus of all mice and 
in the spinal cord of two mice. This result further confirmed that the 
lack of LIF-R was not detrimental to motor neuron differentiation, as 
suggested by results described in Chapter 5. The data also establishes 
that lf-r -I- motor neurons can survive beyond the period of 
programmed cell death. 
6.5 Discussion 
The consecutive inactivation of both alleles of a gene in ES cells 
has been reported in a number of cases (Baribault and Oshima 1992; 
Braun and Arnold 1994; Chen and Behringer 1995; Jakobovits et al., 
1993; Nakayama et al., 1993; Pevny et al., 1991; Robabus Maandag et 
al., 1994; Tarakhovsky et al., 1995; te Riele et al., 1990). This can be 
achieved either by selection of heterozygous cells with elevated G418 
(Mortensen et al., 1992) or by successive gene targeting with a 
construct bearing a second selectable marker (te Riele et al., 1990). 
Attempts to derive LIF-R deficient ES cells by selection of lf-r 
+1- lines in 2 mg/ml of G418 or by second round of gene targeting 
with a vector containing hygromycin resistance gene driven by a pgk-1 
gene promoter were not successful (not shown). Subsequent 
targeting experiments with the latter vector on wild type ES cells 
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Figure 6.6. ES cell contribution in P10-13 chimeric lif-r -I- mice 
The ES cell contribution to various tissues of individual chimeras was 
determined by GPI analysis. The percentage of the a/a form enzyme was 
judged by eye according to the relative intensity of the bands. Only chimeras 
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Figure 6.7 Presence of lif-r -I- motor neurons in early postnatal 
facial nucleus 
Brain stem of a postnatal day 17 chimera was sectioned coronally 
and stained with X-gal. -galactosidase activity is seen in some 
motor neurons. 
Cryostat section 12 1m; Objective magnifications: a) lOx; b) 40x. 
clones analysed. This suggests that the rate of homologous 
recombination at lzf-r locus is low. The derivation of LIF-R-deficient 
ES cells was finally achieved with a promoterless construct, which 
once again illustrates the advantage of the promoter trap strategy. 
lf-r -I- ES cells could be propagated in IL-6 plus sIL-6R with 
characteristic ES cell morphology. This formally confirms that LIF-R 
is not essential for ES cell self-renewal in vitro. 
Since LIF-R forms heterodimer with gp130 and both of which 
are tyrosine phosphorylated following activation by LIF, CNTF and 
OSM, it might be expected that these cytokines would be unable to 
stimulate self-renewal of lif-r -I- ES cells in culture. However, an 
alternative receptor is known to exist for OSM (Thoma et al, 1994), 
and possibly also for other member of this family. In the present 
study, lfr -I- ES cells failed to reproduce themselves in response to 
any of the aforementioned cytokines. This provides additional 
evidence of a null mutation of LIF-R; it also implies that ES cells do 
not express significant levels of OSM specific receptor, or alternative 
receptors for other cytokines such as CT-1. However, it is also 
possible that a specific OSM receptor or CT-1 receptor is indeed 
expressed in ES cells, but its activation leads to cellular 
differentiation instead of self-renewal. This would not be revealed by 
colony assays. Since ESRF activity is not affected by anti-gp130 
antibody, it was presumed that it does not act through LIF-R either. 
Colony assays of lf-r -I- ES cells in the presence of ESRF confirmed 
this expectation. 
Since the initial generation of motor neurons was not affected in 
!if-r -I- animals, it is perhaps not surprising that LIF-R deficient 
motor neurons formed in chimeras. Programmed cell death of motor 
neurons occurs between E17 to PlO in the facial nucleus (Ashwell and 
Watson 1983) and between E13-E18 in spinal cord (Lance-Jones 1982). 
This process is controlled largely by the availability of neurotrophic 
factors produced by target tissues, afferent neurons or the 
neighbouring glial cells. Neurons that receive insufficient trophic 
signals die. Preliminary analysis of six 10-13 day old lzf-r -I-
chimeras demonstrated the presence of 3-gal positive motor neurons 
in facial nucleus. This result indicates that LIF-R is not absolutely 
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required by all motor neurons during the period of programmed cell 
death. Presumably those lif-R deficient motor neurons which survive 
to maturity are supported by other trophic factors, such as members 
of neurotrophins. 
6.6 Materials and Methods 
Targeting vector. Transfection and selection of null ES cells 
The construct for targeting the second allele of LIF-R was made 
by insertion of a 3.6 kb Sal I fragment containing an en-2-splice 
acceptor, IRES, hygromycin resistance gene and SV40 
polyadenylation sequence (referred to as IRES-Hyg) into the Sal I 
site of plasmid pK03 described in Chapter 3 (referred to as 
pKO4hyg). The IRES-Hyg cassette was constructed by Hitoshi Niwa. 
The targeting experiment was carried out with one of the lf-r 
+1- lines, No. 31, at passage 14. 2 x 10 7 ES cells grown in the 
presence of LIF were electroporated with 50 p.g of DNA as described 
in Chapter 3. After electroporation, cells were plated onto ten 10 cm 
tissue culture plates (i.e., 2 x 106 cells per plate) in medium 
containing 100 ng/ml of human rIL-6 and 1/30 dilution of CHO-CM 
(see next section). ES cells were selected from the second day of 
electroporation with both hygromycin B (80 pg/ml) and G418 (175 
j.tg/ml). DNA was prepared from 50 clones. 
Production of sIL-6R 
Human sIL-6R was produced by CHO 5E27 (Gift of Dr. Taga, 
Osaka), a CHO cell line transfected with a sIL-6R cDNA plasmid 
pECEdhfr 344 (Yasukawa et al., 1990). To harvest sIL-6R containing 
medium, cells were seeded at about 70% confluence in GMEM plus 
10% FCS and cultured for two days. Supernatant was then collected 
and cell debris were removed by centrifugation. 
To titre the activity of sIL-6R in CHO 5E27 conditioned medium 
(CHO-CM), the CHO-CM was serially diluted in wells of 24 well 
plate in 0.5 ml medium. 5 x 103  ES cells and 100 ng of recombinant 
human IL-6 (rIL-6, gift from Dr. Taga, Osaka) was added into each 
well in a volume of 0.5 ml. Cells were then cultured for four days and 
colonies stained with Leishmants stain. The activity of sIL-6R was 
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scored by the number of ES cell colonies presented in culture. 
Usually it was used as a 1/10 to 1/30 dilution in medium. 
Colony assay 
1000 ES cells with genotype of lf-r +1+, +1- and -/- were seeded 
per well of gelatine coated 6-well plate in duplicate in GMEM plus 
10% FCS. Specified cytokines were added as follows: LIF: human, 100 
U/mi, LIF: murine, 100 U/mi, CNTF: rat, 10 ng/ml (Genzyme), 
OSM: human, 200 ng/ml (Genzyme), CT-1: murine, 6 ng/ml (gift 
from D. Pennica, Genetech), ESRF: 50% of PE conditioned medium 
(Darn and Smith, unpublished), and human IL-6: 100 ng/mi plus 
human sIL-6R. One set of cells were grown in medium without any 
growth factors as a negative control. Cells were cultured for five days 
(four days for ESRF) and stained for alkaline phosphatase. After 
counting alkaline phosphatase positive stem cell colonies, cells were 
counter-stained with Leishman's stain and the total number of 
colonies were counted. 
Alkaline phosphatase staining 
Staining of ES cell colonies by alkaline phosphatase was 
performed with a Sigma diagnostic kit (Procedure No. 86). Briefly, 
cells were permeabilized and fixed for 30 seconds in a citrate-
acetone-formaldehyde solution, rinsed in water for 45 seconds and 
stained with alkaline-dye mixture for 15 mins. Following staining 
reaction, cells were rinsed in tap water and air dried. 
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Chapter 7 
Production and Characterisation of 
lif-r and gp130 compound mutations 
7.1 Introduction 
As the only pathway identified so far which supports ES cell self-
renewal in vitro, signalling through gp130 and LIF-R is implicated in stem 
cell regulation in the early embryo. This hypothesis is supported by the 
regulated expression of both gp130 and LIF-R mRNA in stem cell 
compartments of the mouse pen-implantation embryos (Nichols et al., 
1996). Based on these observations, it might be expected that mutations at 
lfr or gp130 gene would result in embryonic lethality. However, embryos 
homozygous for either gp130 or lf-r mutation develop normally at least to 
mid-gestation stage (Yoshida et al., 1996; Chapter 5). gp130 -I- embryos 
have defects in cardiac and hematopoietic systems and die progressively 
from E12.5 to term. These findings suggest that stem cells in the early 
embryos can be maintained by other signalling pathway(s) in vivo. 
However, it is also possible that LIF-R could function 
independently of gp130 in vivo, by forming LIF-R homodimer or 
heterodimer with an unknown partner. In vitro experiments have shown 
that dimerization of a chimeric receptor containing LIF-R cytoplasmic 
domain resulted in tyrosine phosphorylation of Stat3, suggesting that LIF -
R is capable of signalling (Stahl et al., 1995). Moreover, a preliminary 
analysis of gp130 -I- mutants at E18 did not reveal neuronal defects as 
observed in lf-r -I- mutants (T. Taga, personal communication), though 
the developmental stage and the genetic background of the animals 
analysed were not directly comparable. 
The analysis of phenotypes of gp130 and lf-r compound mutations, 
in comparison with that of gp130 mutation, would formally distinguish 
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the two aforementioned possibilities. Therefore, mice deficient for both 
gp130 and lf-r were generated at later stage of this study. 
7.2 Production of mice heterozygous for both gp130 and lif-r 
Mice heterozygous for the gp130 mutation (on pure 129 genetic 
background; Yoshida et al., 1996) were provided by Dr. T. Taga, Osaka. 
Because homozygosity of either lzf-r or gp 130 mutation results in a lethal 
phenotype, the first task was to generate mutant mice heterozygous for 
both gp130 and lf-r (1f-r1igp130 +/). In order to obtain large litter sizes, 
lf-r I mice on 129 x M171 background (N3 and N4 generation) were used 
in this experiment. Genes for gp130 and LIF-R are localised on different 
chromosomes in mice (Gearing et al., 1993; Taga, unpublished), therefore, 
the mutations will segregate independently and 1/4 progeny of such 
crosses are expected to be lf-r //gp130 I. Pups were firstly screened for 
lf-r heterozygosity by X-gal staining of ear biopsies. -ga1actosidase 
positive (lf-r +/) animals were then analysed by PCR to determine gp130 
genotype (Yoshida et al., 1996; Figure 7.1). The expected frequency of lf-r 
/igpi30 / were generated from lf-r //gp130 	and lf-r 11gp130 
crosses (data not shown). 
7.3 Mouse embryos lacking both gp130 and LIF-R develop beyond 
gastrulation 
lzf-r /1gp130 +/ - animals appeared normal and thus were 
intercrossed to generate lf-r and gp130 compound mutations. Since gp130 
/ mutants start to die from E12, embryos at E10.5 to E12.5 from lif-r / 
/gp130 +/ intercrosses were analysed for the presence of lf-r 1igp130 1 
genotypes. 
A total of 67 embryos were analysed (9 at E10.5, 28 at E11.5 and 29 
of E12.5). In terms of appearance, embryos from lzf-r /1gp130 / 
intercrosses looked grossly normal in shape and size at E11.5. No 
significant number of resorptions were observed. Dead embryos became 
apparent by E12.5. 
Genotyping of these intercross embryos for lfr homozygosity was 
determined by Southern analysis, as described previously in Chapter 3 
and 5. Following hybridisation with the 3t  external probe, 16 were proven 
to be lr /. These embryos were then examined for gp130 genotypes by 
PCR. Primers P370 and Pneo were used to identify the presence of 
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Figure 7.1 PCR amplification of wild-type and mutatedgp130 alleles 
The wild-type gp130 gene. Exons are indicated as solid boxes. 
Targeting vector. A pMClneo-pA cassette was inserted into the Hind 
ifi site in exon 2 just downsteam of the translation start codon. 
The mutated gp130 locus after homologous recombination. The 
Southern probe and PCR primers are indicated in a and c. The probe 
detects in the Xho 1-EcoR I digests a 3.7 Kb wild-type allele or 2.1 Kb 
targeted allele, respectively. E, EcoR I; H, Hind ifi; Hc, Hinc II; Sp, Spe I; 
X, Xho I. (from Yoshida et al., 1996). 
PCR analysis for gp130 genotype. Two sets of primers were used to 
identify the presence of neo (500 bp band) or the gp130 sequence (400 bp 
band) in genomic DNA from embryos. The absence of a PCR product 
using the gp130 primers confirms that these sequences are deleted in the 
gp130 homozygotes. Shown here is an example of a 1.5% ethidum 
bromide stained agarose gel where PCR products obtained from nine 
reactions. 
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homologous recombination junction downstream of neo (Ca. 500 bp), 
whereas primers P2 and P370 were used to detect gp130 wild type 
sequence (ca. 400 bp). A shown in Figure 7.1, the 500 bp DNA fragments 
could be amplified from genomic DNA made with embryos 23,46,50 and 
51; however, no wild type 400 bp band could be amplified from these 
embryos and therefore, these embryos were gp130 1. gp130 genotypes of 
all lif-r-/- embryos were subsequently confirmed by Southern blot 
analysis of EcoR I/Xho I digested DNA with a 3' gp130 external probe 
(probe containing plasmid provided by Dr. T Taga; data not shown). 
Table 7.1 Genotyping data of lf:.r /igp13O / intercrosses 
Age of 	No. of 	No. of 	 lfr 1 /gpl3O / embryos 
embryos embryos litters live*(dead**) 
E10.5 	9 	1 	 0 
E11.5 28 2 3 
E12.5 	29 	2 	 0 (1) 
Total 67 5 3(1) 
* Embryos were judged as live if they were normal in size and colour 
and if the heart appear to be beating. 
** Dead embryos were those that were smaller and whiter than live 
littermates. Some embryos were in good condition, and some 
were already undergoing resorption and were necrotic. 
7.4 Conclusion 
The aim of this experiment was to investigate whether the lack of 
gp130 and LIF-R would disrupt the maintenance of totipotent stem cells of 
the early mouse embryos. Genotyping analysis of lf-r /Vgpi30 / 
intercross embryos have demonstrated that lf-r 1igpl3O 1 embryos can 
develop normally during gastrulation and early organogenesis. This result 
indicates that, although gp130/LIF-R signalling is critical for the 
maintenance of stem cell properties in vitro, it is not absolutely required 
for the early stage of embryonic development. 
The normal appearance of E11.5 lf-r 1igpl30 1 embryos does not 
suggest a more severe phenotype in lr 1Vgpl30 / compound mutation 
compare with that of gp130 single mutation. However, a more careful 




The aim of this thesis was to evaluate a requirement for LIF-R in 
mouse development in vivo and in the regulation of ES cell self-renewal 
in vitro. To this end, mice and mouse embryonic stem cells lacking a 
functional lf-r gene were produced by gene targeting 
Homologous recombination resulted in a deletion of 20 kb of the 
lf-r gene, containing exons that encode the major portion of the 
presumed LIF-R ligand binding domain (Chapter 3). This lesion is 
predicted to disrupt signalling through LIF-R by all its ligands 
(Chapter 6). The targeting vector incorporated a promoterless 
IRESgeopA cassette. Therefore, transcription of lf-r could be 
monitored by histochemical staining for -galactosidase in lf-r mutant 
mice (Chapter 4). 
The effects of the mutation were examined in lzf-r -I-  developing 
embryos and neonates (Chapter 5), and in early postnatal chimeric 
mice produced with homozygous mutant ES cells (Chapter 6). The 
hematopoietic potential of lf-r -I-  fetal liver cells was assessed by 
reconstitution of lethally irradiated adult recipient mice (Chapter 5). In 
addition, ES cell self-renewal in the absence of LIF-R was also 
investigated in vitro. In this Chapter, I will summarise major findings 
of this study and discuss some of the future aspects. 
8.1 A overview of the mutant phenotypes and comparison with the 
report by Ware et al., 1995 
1f-r -/- mice can survive to term. However, these mice lacked 
vigor, did not feed and died within 24 hours after birth. The size and 
weight of lf.r -I- newborns were reduced by 20% on average 
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compared with wild type and heterozygous littermates. Despite the 
early mortality of these mice, histopathological inspection failed to 
reveal any obvious abnormalities. Therefore, the precise cause of 
mortality remains uncertain. However, analysis of the nucleus 
ambiguus revealed an over 50% reduction in the number of neurons in 
this structure. Consider the involvement of nucleus ambiguus neurons 
in the control of suckling and the regulation of respiratory rhythm, it is 
probable that the deficit in this structure would be sufficient to account 
for the early death of lf-r mutant animals. 
During the course of this study, another loss-of-function analysis 
at the lf-r gene was reported (Ware et al., 1995). In this study, a 
LacZ/neo fusion gene was inserted in frame down stream of the LIF-R 
start codon. Similar to the present observation, homozygosity for the 
mutation resulted in perinatal lethality. These workers reported that 
the frequency of lif-r -I- foetuses was reduced throughout 
development. In the present study (Chapter 5), the number of lif-r -I-
newborns was also low in progeny of Fl lzf-r heterozygous 
intercrosses. However, following continuous outbreeding, the 
occurrence of lzf-r -I- can achieve 25%. Effects of genetic background 
on mutant phenotype have been observed for EGF receptor (Sibilia and 
Wagner, 1995; Threadgill et al., 1995). 
Ware et al., also reported a decrease in the density of long bones 
and an increase in the number of osteoclast in lf-r -I- mutants. 
Analysis of whole mount skeleton of lf.r -I-  mice in the present study 
indicates a normal ossification pattern and normal formation of all 
skeletal components. Detailed histological analysis for bone formation, 
however, was not performed. Therefore, whether there is subtle defect 
in this system remains unknown. 
The major defect presented by Ware et al., was the disruption of 
lf-r -/- placental architecture. lf-r -I-  placentas lacked organization 
into distinct spongio- and labyrinthine trophoblast zones and 
contained excess accumulation of fibrin. Such deficits would influence 
fetal growth, therefore, the abnormalities in other tissues (such as 
astrocytes) described by Ware et al., might be a secondary effect of 
impaired placental function. 
8.2 LIF-R and neural development 
M 
8.2.1 A missing ligand for LIF-R 
An important finding of this study is the loss of motor neurons in 
lf-r -I- animals. Examination of the facial nucleus and spinal cord 
revealed approximately 40% reduction of motor neurons in lzf-r -I-
neonates compared with wild-type and heterozygous controls. 
Previous results showed that CNTF and LIF promote the survival of 
motor neurons in vitro as well as in vivo (Arakawa et al., 1990; Cheema 
et al., 1994; Martinou et al., 1992; Oppenheim et al., 1992; Sendtner et 
al., 1990). However, neither LIF knockout [Escary et al, 1993; Stewart et 
al, 1992; Smith, unpublished] nor CNTF knockout (Masu et al., 1993) 
nor LIF and CNTF double knockout [Sendtner, manuscript submitted] 
have resulted in pre-natal motor neuron loss. Therefore, the phenotype 
observed in the lzf-r -I- mutants implies the existence of an additional 
ligand for LIF-R which is active during embryonic development. 
Very recently, mice lacking CNTF receptor (CNTFR(x) have been 
generated (DeChiara et al., 1995). These mice, which also died at birth, 
exhibited a similar degree of motor neuron loss as the lf-r -I-  mutants. 
Taking these results together, it is most likely that the unidentified LIF-
R ligand is also a ligand for CNTFRx. 
8.2.2 LIF/CNTF family of cytokines are more significant motor neuron 
trophic factors in vivo than neurotrophins 
Neurotrophins have been considered as the major type of 
neurotrophic factor that regulate the survival of neurons from both the 
CNS and the PNS. In the past two years, lines of mice carrying targeted 
mutations in genes encoding neurotrophins and their receptors have 
been generated (Crowley et al., 1994; Ernfors et al., 1994; Jones et al., 
1994; Smeyne et al., 1994, Klein et al., 1993; Klein et al., 1994). Most 
recently, analysis of compound mutations of neurotrophins have 
begun to appear (Conover et al., 1995; Ernfors et al., 1995; Liu et al., 
1995). These mutations have resulted in a substantial loss of sensory 
neurons and sympathetic neurons, which confirmed the presumed 
function of neurotrophins in these neurons in vivo. Despite the 
evidence of neurotrophins supporting motor neuron survival in vitro 
(Henderson et al., 1993) and in vivo following axotomy (Sendtner et a!, 
1992; Yan, et al, 1992; Yan et al, 1993), motor neuron numbers in these 
mutants were not affected. Therefore, the findings in lf-r -I- mutant 
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mice have defined a more powerful signalling pathway for regulating 
motor neuron survival in vivo. 
It was originally reported that mice deficient in the neurotrophin 
receptor trkB showed a substantial loss of motor neurons in the facial 
nucleus and spinal cord (Klein et al., 1993). However, re-examination 
of mutant mice failed to replicate such results (DeChiara et al., 1995; 
McKay et al., 1996). In light of the lack of effects of BDNF and NT-4 
(two known trkB ligands) double knock-out on motor neurons 
(Conover et al., 1995; Liu et al., 1995), it can be interpreted that trkB 
signalling pathway does not have a significant role in regulating motor 
neuron survival during embryonic development in vivo. However, it is 
possible that such function is compensated for by alternative 
mechanisms, such as LIF-R pathway. 
8.2.3 Motor neuron generation was not affected in lift -I- mice 
The decreased neuronal numbers in lif-r -I- newborns could be 
due to alterations in proliferation and differentiation of motor neuron 
precursor cells, excessive death of post-mitotic neurons, or both. LIF 
has been reported to influence the differentiation of spinal cord 
neuronal progenitor cells (Richards et al., 1992), suggesting that LIF 
may have a role on motor neuron differentiation. However, 
examinations of E14.5 and E15.5 facial nuclei revealed no significant 
difference in the number of neurons in mutants as compared with wild 
type control embryos. This result indicates that neuronal loss in the 
facial nucleus of lif-r -I-  animals occur during the period of 
programmed cell death (Ashwell and Watson, 1983), suggesting that 
LIF-R is not necessary for the initial formation at least of facial motor 
neurons. It is likely that this is also true for motor neurons in other 
structures. 
8.2.4 Motor neuron survival and function in the absence of LIF-R 
Since homozygous mutant animals died at birth, it was not 
possible to assess directly whether lf-r -I-  motor neurons can survive 
beyond the period of programmed cell death. As an alternative 
strategy, lf-r -I-  ES cells have been generated and were injected into 
wild-type recipient blastocysts to generate chimeras. lzf-r -I- cells 
contributed substantially to a variety of cell types and tissues in 
chimeras, including motor neurons in the brain stem and spinal cord. 
These results indicate that lf-r -I-  ES cells are not compromised in 
motor neuron differentiation in competition with wild type cells. lzf-r 
-I- motor neurons can be detected in chimeras at P13, this result 
establishes that a subpopulation of lzf-r -I-  motor neurons are not 
dependent on the presence of LIF-R during the period of programmed 
cell death. It has been demonstrated that platelet-derived growth 
factor, transforming growth factor-a (Oppenheim et al., 1993), insulin-
like growth factors (Neff et al., 1993), GDNF (Oppenheim et al., 1995), 
NT-4 and BDNF (Henderson et al., 1995; Hughes et al., 1993) are 
capable of promoting motor neuron survival in vitro and/or in vivo. 
Such factors could sustain lzf-r -I-  neurons. If surviving motor neurons 
are indeed supported by other factors in lf-r -I- newborns in a cell 
type-specific manner (see also next section), it may be reflected in a 
differential responsiveness of these neurons to such factors in culture 
compared to neurons from wild-type animals. 
It remains to be determined why some lf-r -I-  motor neurons 
survive. One possibility is that there are distinct subpopulations of 
motor neurons. The motor neurons of the facial nucleus innervate 
seven different muscles or muscle groups (Ashwell, 1981). It is possible 
that, depending on the target tissues the neuron axons innervate, some 
receive alternative trophic signals which support their survival, 
whereas other neurons failed to received such signals and die. If this is 
the case, nerve-muscle connections in some targets might be absent in 
lf-r -I-  animals. Lack of sympathetic innervation at specific targets has 
been demonstrated in nt-3 -I- mice (ElShamy et al., 1996). 
It has been shown very recently that, in the chick, trkB was 
expressed in a subpopulation of spinal motor neurons, indicating that 
motor neurons are heterogeneous. Whether this is related with the 
innervation sites of these neuorns is unclear. Nevertheless, it would be 
of interest to determine whether all motor neurons in lf-r -/- neonates 
express trkB. 
8.2.5 BCL-2 and motor neuron survival 
The morphology of dying neurons in lif-r -/- animals exhibits the 
features of apoptosis. It has been demonstrated that transgenic 
expression of proto-oncogene bcl-2 under the control of neuron-
specific enolase promoter in mice protects motor neuron from 
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programmed cell death during development and induced by axotomy 
(Dubois-Dauphin et al., 1994; Farlie et al., 1995; Martinou et al., 1994). 
In vitro, BCL-2 and related proteins have been shown to prevent 
sensory and sympathetic neurons from apoptosis following 
withdrawal of neurotrophic factors (Allsopp et al., 1993; Allsopp et al., 
1995; Middleton et al., 1996). These data suggest that Bcl-2 family 
proteins are likely to be involved in the intracellular molecular events 
that regulate neuronal survival and cell death. It would be of interest 
to investigate whether transgenic expression of bcl-2 and/or its related 
genes could protect neurons from cell death in lzf-r -I- animals. A 
recent study suggested that the relative amount of Bcl-2 and Bax are 
important in regulating neuronal survival (Middleton et al., 1996); 
therefore, future studies should also aim to examine the relative 
expression level of bcl-2 versus bax in lif-r -I- embryos during different 
stages of development. 
8.2.6 Are LIF family cytokines essential for oligodendrocyte 
differentiation and survival? 
In addition to neurons, programmed cell death under trophic 
regulation has also been implicated in the developmental fate of the 
myelinating glia of both the central (oligodendrocytes) and peripheral 
(Schwann cells) nervous system (Barres and Raff, 1994; Jessen et al., 
1994). Approximately 30% of the oligodendrocytes in cerebrum 
(Gordon et al., 1992) and 50% in optic nerve (Barres et al., 1992) die 
postnatally prior to myelination. It has been demonstrated that CNTF 
and LIF can significantly enhance the survival of immature and mature 
oligodendrocytes in culture (Barres et al., 1992; Louis et al., 1993, Gard 
et al., 1995). In lif-r mutant neonates, strong n-gal staining was 
observed in glial cells derived from the subventricular zone and those 
migrating out from this region (Chapter 4). Taken together, these 
studies suggested that CNTF and LIF may have a role in gliogenesis. 
The production and survival of oligodendrocyte progenitors could be 
examined by histochemical methods with oligodendrocyte specific 
antibodies in vivo in lif-r -I- newborns. The ability of lif-r -I-
oligodendroblasts to differentiate into mature oligodendrocytes could 
be investigated in vitro in tissue culture. 
In vitro, LIF and CNTF are able to induce the differentiation of 
oligodendrocyte progenitor 0-2A cells into type-2 astrocytes (Hughes 
et al., 1988; Kahn and de Veils, 1994.). CNTF has also been shown to 
promote the production of astrocytes from bFGF amplified 
hippocampal stem cells (McKay, 1995). These observations suggest that 
signalling via LIF-R may play a role for astrocyte development. 
Although the examination of brain stem and spinal cord in the present 
study did not reveal significant astrocyte defect, a careful examination 
with astrocyte specific markers in these structures and other parts of 
the nervous system may detect subtle changes. 
8.2.7 LIF-R signalling and sympathetic development 
When late embryonic or new-born sympathetic neurons are 
cultured with LIF or CNTF, their neurotransmitter phenotype switches 
from noradrenergic to cholinergic, characterised by the increase of 
choline acetyltransferase activity and vasoactive intestinal peptide and 
a decrease of tyrosine hydroxylase (Pattern and Chun 1977; Saadat et 
al., 1989). This neurotransmitter phenotype change is seen in vivo in the 
developing sympathetic neurons innervating the sweat gland in the 
footpad (Lebanc and Landis, 1986). Extracts of developing rat footpads, 
a tissue rich in sweat glands, contain cholinergic differentiation activity 
(referred to as sweat gland factor, SGF) (Rao et al., 1993; Rohrer, 1992). 
However, several lines of evidence suggest that this activity is not 
mediated by either LLF or CNTF. Firstly, the inducing activity in the 
extract is not immunoprecipitated or blocked by LIF antisera (Rao et 
al., 1992). Secondly, while a majority of the activity can be 
immunoprecipitated with CNTF antisera (Rao et al., 1993; Rohrer, 
1992), Western and Northern blot analysis did not reveal the presence 
of authentic CNTF protein or mRNA in footpads, and the expression of 
both was localised to peripheral nerve-associated Schwann cells rather 
than sweat glands (Rao et al., 1992). Furthermore, the neurotransmitter 
properties of the sweat gland innervation in mice deficient in LIF or 
CNTF is indistinguishable from normal (Masu et al., 1993; Rao et al., 
1993). These observations suggest that SGF is distinct from but 
possibly related to CNTF. It would be interesting to know whether 
SGF signals through LIF-R. This could be explored by in vitro culture of 
lf-r -I- sympathetic neurons or ganglia in the presence of such factor. 
8.3 LIF-R signalling and cardiac development 
It has been shown that cytokine CT-1 binds to a LIEF-R/gpl3O 
complex (Pennica et al., 1995b). CT-1 was initially cloned based on its 
ability to induce hypertrophic swelling of neonatal cardiomyocytes in 
vitro (Pennica et al, 1995a). Very recently, CT-1 has also been shown to 
promote the proliferation and survival of embryonic cardiac myocytes 
in vitro (Sheng et al., 1996) and its expression was found in the heart 
tube of E8.5 mouse embryos (Sheng et al., 1996). LIF and IL-6, in 
combination with sIL-6R, also exhibit mitogenic effects on embryonic 
cardiomyocytes (Yoshida et al., 1996). In the present study, - 
galactosidase activity was observed in heart of lf-r mutant embryos 
from E8.5 (Chapter 4). Taken together, these studies suggested that 
LIF-R/gp13O signal transduction pathway may play an important role 
in embryonic cardiac development. 
Indeed, targeted disruption at the gp130 locus results in 
hypoplastic development of ventricular myocardium (Yoshida et al., 
1996). However, lif-r -I- mice do not show obvious cardiac defects 
(Chapter 5 and Ware et al., 1995). The complex of IL-6 and sIL-6R may 
compensate for the lack of functional LIF-R in lzf-r -I-  mice. An 
alternative explanation would be that CT-1 has its own receptor. 
Unlike LIF, which results in tyrosine phosphorylation of both gp130 
and LIF-R, CT-1 leads to phosphorylation of only gp130 (Sheng et al., 
1996). Binding of 1251  labelled CT-1 to cardiac cells from lif-r -I-
embryos may reveal the presence of a potential CT-1 specific receptor. 
In a complementary experiment, examination of the responsiveness of 
lif-r -I- cardiomyocytes to CT-1 would also provide valuable 
information. 
8.4 Maintenance of ES cell properties via signalling through LIF-R 
ES cells with both lf-r alleles disrupted can be generated and sustained 
by IL-6 in combination with sIL-6R (Chapter 6). Moreover, when 
injected into wild type recipient blastocysts, lif-r -I- ES cells can 
contribute differentiated progeny to a variety of cell types and tissues 
in chimeric mice. These data establish that ES cell pluripotency can be 
maintained independently of LIF-R. 
UF, CNTF, CT-1 and OSM failed to maintain lf-r -I- ES cells in 
culture, demonstrating that LIF-R is absolutely essential for ES cell self-
renewal mediated by these cytokines. Such responsiveness is restored 
when the cells are transfected with a LIF-R expression vector (T 
Burdon, unpublished). However, the molecular mechanism of LIF-R 
01 
signalling leading to ES cell maintenance remains poorly understood. 
lf-r -I- ES cells system could be exploited to delineate LIF-R essential 
functional domains and downstream signalling events, by assessing 
the capacity of various forms of LIF-R to rescue the self-renewal 
response in these cells. 
Two highly conserved regions, referred to as box 1 and box 2, are 
present in the membrane proximal region of cytokine receptors 
(Murakami et al, 1991). Point mutations and deletions of these regions 
in gp130 abolished the ligand induced receptor tyrosine 
phosphorylation and mitogenic signals in BAF3 pro-B cells. 
Subsequent studies of G-CSFR and G-CSFR/LIF-R chimeras have 
revealed that the presence of box 1 and box 2 are sufficient in 
delivering G-CSF responsiveness in hepatic and neuronal cells 
(Baumann et al., 1994). A domain of weak homology (referred to as 
box-3) is present in the membrane distal region of the cytoplasmic 
domain of gp130, LIF-R and G-CSFR. The box 3 region of gp130, which 
is not required for transducing growth regulatory signals, has been 
shown to be involved in the control of STAT protein activation and 
gene regulation in hepatic cells (Lai et al., 1995). These results 
demonstrated that effects on cellular growth and differentiation are 
conferred by different cytoplasmic elements of gp130. Similar 
observation have been made for G-CSFR (Fujunaga et al, 1993; Ziegler 
et al., 1993). The box 1, box 2 and box 3 regions are conserved in gp130, 
G-CSFR and LIF-R (Baumann et al., 1994b; Gearing et al 1992). It is 
therefore important to define the requirements of these cytoplasmic 
regions of LIF-R for ES cell self-renewal and proliferation. 
8.5 Early mouse embryos without LIF-R and gp130 
In feeder-free cultures, ES cells differentiate unless LIF, CNTF, 
CT-1, OSM or IL-6 in combination with sIL-6R are provided. Since all 
of these cytokines signal through gpl30/LIF-R heterodimer or 
gpi30/gpl3O homodimer, this signal transduction system seems to be 
crucial for the maintenance of pluripotent ES cells. In vivo, both LIF-R 
mRNA and gp130 mRNA are transiently expressed during the time of 
blastocyst formation and implantation (Nichols et al., 1996, in press), 
suggesting a role for gp130 and LIF-R in embryogenesis. However, 
embryos lacking either gp130 or LIF-R undergo implantation and 
gastrulation. Since a LIF-R homodimer has the potential for signalling 
(Baumann et al., 1994a; Stahl et al., 1995), a gp130-independent LIF-R 
function may exist and if so could account for the lack of early 
embryonic lethality of gp130 knockouts. To establish definitively 
whether the gpl30/LIF-R signalling pathway is required for early 
embryogenesis, mice carrying compound mutations at lf-r and gp130 
gene were generated during the later stage of this study (Chapter 7). 
Genotyping analysis showed that lf-r deficient, gp130 deficient, double 
mutant embryos are able to progress through gastrulation and 
organogenesis. This result suggests the existence of an as yet 
unidentified alternative regulatory pathways for stem cells of the early 
embryos. 
8.6 Summary 
In summary, targeted mutation at the lif-r gene resulted in 
substantial loss of motor neurons in the facial nucleus and spinal cord 
and of neurons of nucleus ambiguus at birth. The deficit is due to 
excessive cell death rather than a failure in generating motor neuron 
lineage. This establishes that signalling via LIF-R is essential for motor 
survival. 
Since mice lacking CNTF, or LIF, or both did not exhibit neuronal 
loss in their early postnatal life, the present study points to the 
existence of an unidentified LIF-R ligand that plays an important role 
during development. 
ES cells lacking a functional lf-r gene have been generated by a 
second round of gene targeting. When injected into blastocysts, these 
cells could contribute their differentiated progeny to a variety of cell 
types including motor neurons in the facial nucleus and spinal cord. lf-
r -I-  motor neurons could be detected in chimeras at postnatal day 13, 
when the period of programmed cell death is over. This result 
indicates that a subpopulation of motor neurons are not dependent on 
LIF-R 
The generation and propagation of lf-r -I- ES cells in vitro and the 
production of chimeric mice with these cells in vivo establish that the 
maintenance of pluripotent stem cells can be achieved in the absence of 
LIF-R. Furthermore, mice deficient in lzf-r as well as gp130 could 
develop at least as far as mid-gestation, indicating the existence of an 
alternative signal transduction pathway for stem cell maintenance in 
the early moue embryos. 
Finally, the present study has laid the foundations for the 
characterisation of the molecular mechanisms by which LIF-R and 
gp130 signalling lead to the maintenance of ES cells in vitro and the 
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)t si ol'\IF\ i and maintenance of the mammalian nerous s stem 
dependent upon neurotrophic c tokines. One class of neuro-
rophic factor acts through receptor complexes insoling the lo-
flinits leukaeniia inhibitors factor receptor subunit (LIE-R)' 3 . 
lemhers of this t'amiI of c tokines. such as ciliar neurotrophic 
actor (( \TF) and leukaemia inhibi(or factor (1.11-'). haie pro-
ound effects on the suri'al and maintenance of motor neurons' - "'. 
tecentls it isas reported that mice lacking IJF-R die shoril after 
'irth ° unlike mice lacking (\FF or hF %hich are 'iable. there 
e describe histopathological analsses of lift mutants that reseal 
loss >3f of facial motor neurons. 40 of spinal motor neurons 
nd 50 of neurons in the nucleus amhiguus. 1 hew findings point 
a the existence of a ligand for I.IF-R that is required for the 
ormal development of motor neurons in both brainstem nuclei 
nd spinal cord. 
A iIlcton ol 20kb of' the Or vcnc s as created by homolo-
ous recombination in emhrr onic stem (ES) cells (Fig. I j. The 
eleted sequence contains seven exons that encode most of the 
resumptis c ligand-binding region. This was replaced hr an 
ternal rihosome entrr site-hi(/ mo cassette 	I R ESI3- 
copS.) 	'. thereby introducing a histoehemicul reporter into 
the locus. The mutant allele was established on hybrid 129 ('BA 
and 129 M F I backgrounds by appropriate matings of transmit-
tug chimaeras. 
Breeding of the mutated allele to homozygosity resulted in 
the production of liveborn homozvgous pups on both genetic 
backgrounds. The mutant animals were smaller and had a 20 
reduction in both weight (131±0.22  g. n = 7) compared with 
heteroivgous (I .67 ± 0.19 g. it = 18) and wild-type (1,67 ± 0.22 g. 
ii = 8) littermates at birth. They lacked vigour. did not feed and 
rapidly became moribund. Although they exhibited limb move-
ments. they were incapable of' righting. In all cases so far. homo-
zygotes haxe died within 24 Ii of birth and usually within the 
first 12 h. Similar findings were recently described by Ware ci 
111. 
11 
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2 Expression of integrated (.galactosidase reporter in the 9.5-day 
o ye embryo and neonatal brain stem and spinal column. a. b. Whole 
aunt in situ hybridizations of 9.5-d mouse embryos: a, wild-type 
nmhryo hybridized with antisense lift probe: b, heterozygous embryo 
bridized with antisense lacZ probe. c-g. Localization of sites of Xgal 
:iniflg derived from expression of Jigeo integrated into the lifr gene. 
-. d. neonatal brainstem regions. Dotted regions mark ci the facial and 
J the amhiguus nuclei. Scale bar. 400 pm. e. Neonatal spinal cord 
nd dorsal root ganglia. Scale bar. 100 pm. 1. Neurons of the nucleus 
.rnbiguus of a !ifr newborn mouse showing prominent Xgal staining. 
oate bar, 50 pm. g. Neonatal spinal motor neurons. Scale bar, 25 pm. 
',IETHODS. a, b. Whole-mount in Situ hybridizations were made by using 
oigoxigenin-labelled probes". The lifr probe was generated by antisense 
nscription of the 980-hp cDNA fragment described in Fig. 1. The 
125-nt S-galactosiciase probe was complementary to sequence down-
:.ream of the unique Sac) site in the lacZ gene. c-g, Tissue processing 
rid Xgal staining for t.galactosidase on 12-pm cryostat sections was 
oe"tormed as descrihed'. 




FIG. 1 Targeted distribution of the Iifr gene. a. Deletion strategy. Top, 
schematic representation of LIF-R protein showing the two cytokine 
receptor domains boxed. Vertical lines indicate the conserved cysteine 
residues, and solid bars represent the WSXWS motifs. Bottom, partial 
genomic structure of the Iifr gene showing homology arms (thick lines) 
included in the targeting vector, positions of EcoRl restriction sites and 
sizes of diagnostic restriction fragments. Filled circles indicate the posi-
tions of flanking probes used to confirm replacement targeting events, 
The deletion region contains seven exons encoding amino acid residues 
85-444 in the cytokine receptor domains of LIF-R. This region was 
replaced by an en-2 splice acceptor- lRES-3geopA cassette', flanked 
by EcoRl restriction sites. b, Hybridization analysis of tail DNA from wild-
type, heterozygous and homozygous lift mutant mice. DNA samples 
were digested with EcoRl and sequentially hybridized with a 5 genomic 
probe external to the targeting construct (left) and a cDNA fragment 
(right). The genomic probe was an 800-hp EcoRl/BamHl fragment 
shown in a. The cDNA probe was an internal 980-bp fragment that 
contains a sequence from the deleted exons 3-9 plus a sequence from 
exon 10. The 9.3-kb band present in heterozygoteS and homozygotes 
corresponds to the recombinant junction fragment that includes exon 10. 
METHODS. a. )ifr genomic clones were isolated from a 129Sv genomic 
library and the positions of exons determined (ML.. AS., A. Cozens and 
I. Chambers. unpublished results). A promoterless targeting vector was 
constructed by subcloning the 5.5-kb BarnHl/SaIl 5 fragment and the 
5.0-kb Srnal/Sacl 3 fragment into pGEMEM (PrOmega) and inserting the 
GTlRES-geopA cassette. The construct was excised from the plasmid 
backbone by digestion with NotI and Sfil and electroporated into CGR8 
ES cells maintained in the absence of feeders". After selection in G418 
the correct replacement event was identified in 19/58 colonies by filter 
hybridization with both 5 and 3 flanking probes. Single integration 
events were confirmed by hybridization with an en-2 probe. b. T\c' 
clones injected into C57BL/6 blastocysts gave rise to germllne tro.n 
mission of the mutated allele. Animals were typed by hybridization 
lysis of tail DNA and/or by 3-galactosidase-staining of ear biopsie.. 
Heterozygous offspring were backcrossed to the appropriate pam 
strain before intercrossing at the F2 and F3 generations. Homo. -­.. 
offspring v.err ...... .: 	0 ,.. .00100.' 	no'.. 	'' , 'o 	o.:'oo 	'En 
hybridization 
'.:nTr'pr 	1 . ()! ' - a 	1 flECF\IPFP ITO 	 7251 
LETTERS TO NATURE 
The differentiation and sur\ i\,11 of motor neurons in ti/rO 
and in ciL'i) ha' e been sho n to he strongl enhanced h 
('\TF and LIF. indicatise of a requirement for LIF-R function. 
The inert condition of LI F-R-delicient neonates as sueizesti\ C 
of possible neuronal d stunction. Therefore expression o1 LI I-R 
vs ithin the ners ous s' steni and the efiects of izene ahlition on 
motor neuron populations ssere ill ,  estigated in more detail. 
The hdelit of the reporter integrated into the lift gene was 
established by the close similarit between h hridi,ation patterns 
obtained in vito ssith antisense LlF-R and 3-galactosidase probes 
and the correspondence observed between presence of I R ES-
1geo fusion transcripts and histocheniicallv detectable [-galacto-
sidase actis it\ ( Fit , . 2. and results not shown. Expression in the 
deselopin ners ous system was apparent in the hindhrain. 
cranial neural crest and neural tube of 9.5-day emhr\ Os (Fit, . 
2o. h The distribution of 1-ualactosidase activity in embryonic 
I 4.4-day I. neonatal and adult brain was then examined Specific 
staining "as cv dent in cells of the suhependvmal ione. epen-
dvme and glia limitans. Expression "as prominent in neurons 
in the brainstem motor nuclei. including the hvpoglossal and 
facial nuclei I Fig. -1. and results not shown), and also in the 
nucleus amhiguus (Fig. 1/.f I. In sections through embryonic 
and neonatal Spinal column. (3-galactosidase staling \vas most 
pronounced in sensorr neurons of the dorsal root ganglia but 
could also he detected in most of the spinal motor neurons (Fig 
1. g. and results not sho'a ii). In addition some non-neuronal 
cells were stained. notahk astrocytes of the glia limitans in the 
central ners ohs s\ stem and probably also Schvvann cells in 
Peripheral ners es. 
The significance of the expression of LI F-R in spinal motor 
neurons and hrainstem motor nuclei vs as investigated br 
counting motor neurons in the lumbar I L  L6) spinal cord and 
facial nuclei of neonatal homozr gous. heterozvgous and vs ild-
type litterniates. The high expression of the 13-galactosidase 
reporter found in the nucleus ambiguus also prompted an 
analysis of this structure. Motor neurons within the nucleus 
amhiguus inners ate the oesophagus. pharynx and larynx, and 
coordinate svs allowing. In addition there are neurons in the 
nucleus anihiguus of rats and mice that generate respiratory 
1.11\01111,4 '. Data presented in Fig. 3 and Table I show that 
the numbers of motor neurons in LI F-R-deticient animals were 
reduced by >35 in the facial nucleus and br >40. in the 
lumbar spinal cord. The nucleus umhiguus neurons were reduced 
by over SIt . Increased numbers of apparently dying cells vs ith 
pvknotic nuclei were evident in both spinal-cord and brainstem 
TABLE 1 Numbers of spinal motor neurons and neurons in facial and 
ambiguus nuclei of newborn wild-type. heterozygous and LIF-R-deficient 
mice 
++ 
Lumbar region r i  (L1-L6) 3.213 ± 230 N.D. 1.856 ± 251 
ln=3) In =5) 
Facial nucleus 3.108± 310 3.377 ±394 1,951 - 135 
(n=6) (n=5) (n=11) 
Nucleus ambiguus 883±82 705±34 406±32 
(n=5) n=3) )n=5) 
The lumbar spinal cord and brainstems of newborn mice or mice 
delivered by caesarian section at day 20 after conception were fixed by 
transcardial perfusion or immersion fixation with 4% paraformaldehyde. 
Paraffin serial sections (7 pm) were prepared and processed as 
described"'. After Niss) staining, the number of neurons was counted 
in every tenth section of the lumbar (1-1-1-6) region of the spinal cord 
and every fifth section of the brainstem nuclei. Only neurons with distin-
guishable nucleus and nucleolus and with clearly identifiable Nisst 
structure were counted. Average diameters of the nucleoli were as fol-
lows. Facial motor neurons: 4/ ± mice. 2.64 0.43 pm; ±/ -- mice. 
2.32 ± 0.22 pm; -/ - mice. 2.14 ± 0.16 pm; neurons of the nucleus 
ambiguus: --/ mice. 2.36 ± 0.36 pm: - / - mice. 2.34±- 0.41 pm 
(means ±s.d. for at least five determinations). The counts of facial and 
ambiguus neuronal nucleoli were corrected for double counting of split 
nucleoli. Spinal motor-neuron counts are uncorrected. N.D. not deter-
mined. Values shown are means ± s.e.m. of each group. Numbers of 
neurons are different between -4-/ + and -/ - mice for each group 
(P<O.005, Students t-test). 
nuclei in paraffin sections from homozvgotes (Fig. 3d, and results 
not shoss n). This suggests that des ated cell death of motor 
neurons is taking place around the time of' birth. 
Loss of facial motor neurons should not affect the viability of 
newborn mice. Impairment of the nucleus amhiguus is of greater 
significance. These neurons coordinate movements of the 
oesophagus and pharynx and are therefore required for suckling. 
Integrity of the nucleus amhiguus is also essential for generation 
of respiratory rhythm". It is probable that loss of these neurons 
is it contributory factor to the early mortality observed in LI F-
R-deficient mice. It would be of interest to know whether this 
structure is affected in other mouse mutants that die shortly after 
birth and exhibit reduced numbers of neurons in other brainsteni 
nuclei. 
FIG. 3 Neuronal morphology 
in the facial nucleus of new-
born wild-type and lifr mutant 
mice. Facial nucleus of wild-
type (a. ci and homozygous 
Iifr mutant (b. d) newborn 
mice from the same litter. 
Scale bars: a. h. 100 pm: c. d. 
25 pm. 
METHODS. Paraffin sections 
(7 pm) were prepared from 
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The motor-neuron losses and deficits in the nucleus ambie-
uus of LI F-R-deticient mice establish that these neurons are 
dependent on signalling through this receptor during 
embryonic development. Mice lacking CT\TF do not show 
loss of motor neurons before adulthood" and no severe neu-
ronal detects have been obsersed in LIF-deficient mice refs 
17. 18 and M .S. unpublished observations). Mice deficient 
for both CNTF and LI F are viable and do not show functional 
motor defects at birth (MS.. unpublished observations). The 
lesions present in newborn LI F-R-dcticient animals must there-
fore reflect the activity of one or more distinct cvtokines  
active during cmhrvogenesis. Candidates include the recently 
described cardiotrophin-1 (ref. 19) and a putative mouse 
orthologue of oncostatin MIII.  Interaction v ith the ligund ma 
also involve the CNTF-receptor 0 )CNTF-Ru) subunit. s hich 
associates with LIT-11 after (TF binding'. CNTF-Ru is 
expressed in the developing nervous ssstem. in particular in 
motor neurons". and a preliminary report indicates that its 
deletion results in developmental defects more sesere than 
produced by deletion of CNTF. The unidentified cvtokine 
ma therefore be a novel ligand for CNTF-Ru in addition to 
LIF-R. 
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